Levi & Korsinsky Reminds Alto Neuroscience, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025 – ANRO

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. (“Alto Neuroscience, Inc.” or the “Company”) (NYSE: ANRO) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Alto Neuroscience, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about February 2, 2024; and/or (b) Alto securities between February 2, 2024 and October 22, 2024, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=159584&wire=3

ANRO investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) The Company’s product pipeline, ALTO-100, was less effective in treating major depressive disorder than defendants had led investors to believe; (ii) accordingly, ALTO-100’s clinical, regulatory, and commercial prospects were overstated; (iii) as a result, Alto’s business and/or financial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in Alto Neuroscience, Inc. during the relevant time frame, you have until September 19, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



IGI Reports Second Quarter and Half Year 2025 Unaudited Financial Results

IGI Reports Second Quarter and Half Year 2025 Unaudited Financial Results

HAMILTON, Bermuda–(BUSINESS WIRE)–
International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the second quarter and first six months of 2025.

Highlights for the second quarter and first six months of 2025 include:

(in millions of U.S. Dollars, except percentages and per share information)

 

Quarter Ended

June 30,

Six Months Ended

June 30,

 

2025

2024

2025

2024

Gross written premiums

$187.8

$205.6

$394.3

$387.2

Net premiums earned

$115.0

$121.8

$227.8

$236.4

Underwriting income (1)

$35.0

$45.3

$63.0

$97.3

Net investment income

$17.1

$13.5

$32.6

$28.8

Net income

$34.1

$32.8

$61.4

$70.7

Combined ratio(1)

90.5%

81.2%

92.4%

77.7%

Earnings per share (diluted) (2)

$0.77

$0.73

$1.36

$1.55

Return on average equity(annualized) (3)

20.8%

22.9%

18.6%

25.1%

Core operating income (3)

$22.8

$33.2

$42.2

$73.3

Core operating earnings per share(diluted) (3)

$0.51

$0.74

$0.93

$1.61

Core operating return on average equity (annualized)(3)

13.9%

23.2%

12.8%

26.0%

(1)

See “Supplementary Financial Information” below.

(2)

See “Note to the Consolidated Financial Statements (Unaudited)” below.

(3)

See “Non-GAAP Financial Measures” below.

IGI Group President & CEO Mr. Waleed Jabsheh said, “The second quarter of 2025 marked a continuation of strong results in our underwriting and investment portfolios, culminating in net income of $34.1 million and an annualized return on average equity of 20.8%. These outcomes clearly demonstrate the benefit of our multi-faceted diversification strategy, our specialist expertise, and the discipline embedded in our underwriting culture at a time when insurance and reinsurance markets are becoming increasingly competitive.”

“At IGI, our business is well-diversified geographically with a predominantly international portfolio of risks much of which is denominated in foreign currencies. To date in 2025, the U.S. Dollar, which is our financial reporting currency, has seen significant weakening against our other major transactional currencies. This led to a meaningful impact on our reported results for the second quarter, most significantly on our underwriting results, specifically the revaluation of non-U.S. Dollar loss reserves.”

“Current market conditions are generally healthy though becoming more competitive in some areas of our portfolio, both by line of business and by geography. Our strategy, expertise and footprint are specifically geared towards managing the cyclicality and volatility of our business, where lines and markets behave largely independent of each other. Over the past two decades, we have demonstrated our ability to perform at a high level through all stages of the cycle, generating consistent and sustainable value for our shareholders. In the first half of 2025, we grew our book value per share by 3.4%, and in total, we returned $77 million to shareholders in the form of dividends and share repurchases.”

Results for the Periods ended June 30, 2025 and 2024

The Company generated net income for the quarter ended June 30, 2025 of $34.1 million, an increase of 3.9% over the $32.8 million reported for the second quarter of 2024. Net income for the six months ended June 30, 2025 was $61.4 million compared to $70.7 million for the six months ended June 30, 2024. The annualized return on average equity was 20.8% and 22.9% for the quarters ended June 30, 2025 and 2024, respectively. For the six months ended June 30, 2025 and 2024, the Company generated an annualized return on average equity of 18.6% and 25.0%, respectively.

Core operating income, a non-GAAP financial measure, was $22.8 million for the second quarter of 2025, compared to $33.2 million for the same period in 2024. The Company generated a core operating return on average equity (annualized) of 13.9% and 23.2% for the second quarters of 2025 and 2024, respectively. Core operating income was $42.2 million for the six months ended June 30, 2025, compared to $73.3 million for the same period in 2024. The annualized core operating return on average equity was 12.8% for the first six months of 2025, compared to 26.0% for the first six months of 2024. Core operating income for the second quarter and first six months of 2025 included a lower level of underwriting income which was negatively impacted by currency revaluation movements, as described below.

Gross written premiums were $187.8 million in the quarter ended June 30, 2025, compared to $205.6 million for the comparable period in 2024. For the first six months of 2025, gross written premiums were $394.3 million, an increase of 1.9% over gross written premiums of $387.2 million for the first six months of 2024. The increase was driven by growth in the Reinsurance segment, partially offset by a decrease in the Long-tail and Short-tail segments.

Underwriting income was $35.0 million for the second quarter of 2025 compared to $45.3 million for the second quarter of 2024, and $63.0 million for the first six months of 2025 compared to $97.3 million for the first six months of 2024. Underwriting income for the second quarter and first six months of 2025 was impacted by currency revaluation movements, as described below.

The loss ratio was 53.2% and 45.1% for the quarters ended June 30, 2025 and 2024, respectively. For the six months ended 2025 and 2024, the loss ratio was 54.3% and 42.0%, respectively. The increase in loss ratio for the second quarter was predominantly impacted by the currency revaluation of non-U.S. dollar loss reserves, driven by the weakening of the U.S. Dollar against our major transactional currencies. The increase in the loss ratio for the first half of 2025 was impacted by catastrophe losses (“CAT losses”) of $38.6 million, as well as the impact of currency revaluation movements of non-U.S. dollar loss reserves.

The net policy acquisition expense ratio was 16.3% in the second quarter of 2025 compared to 17.7% in the same quarter of 2024. The net policy acquisition expense ratio for the first six months of 2025 was 18.0%, compared to 16.8% for the same period of 2024, with the increase primarily due to $9.9 million of reinstatement premiums on loss affected business in the first six months of 2025.

The general & administrative expense ratio was 21.0% for the second quarter of 2025, compared to 18.4% for the same quarter of 2024, and 20.1% for the first six months of 2025, compared to 18.9% for the first six months of 2024.

The resulting combined ratio was 90.5% for the second quarter of 2025, compared to 81.2% for the second quarter of 2024, and 92.4% for the first six months of 2025, compared to 77.7% for the first six months of 2024. The combined ratios for both the second quarter and first six months of 2025 were negatively impacted by currency revaluation movements, as described above.

Segment Results

The Specialty Short-tail Segment, which represented 56%of the Company’s gross written premiums for the six months ended June 30, 2025, generated gross written premiums of $125.6 million for the second quarter of 2025, compared to $137.2 million for the second quarter of 2024. Net premiums earned were $60.2 million for the second quarter of 2025, compared to $65.7 million for the same quarter of 2024. Underwriting income was $25.6 million for the second quarter of 2025, reflecting an increase of 20.8% compared to $21.2 million for the same quarter of 2024, with the increase largely driven by a lower level of net loss and loss adjustment expenses.

Gross written premiums were $221.6 million for the first six months of 2025 compared to $231.4 million for the first six months of 2024. Net premiums earned for the first six months of 2025 were $117.5 million compared to $126.2 million for the first six months of 2024. Underwriting income was $50.6 million for the first six months of 2025 compared to $56.5 million for the first six months of 2024, with the decrease largely driven by a lower level of net premiums earned for the first six months of 2025 compared to the same period in 2024.

The SpecialtyLong-tail Segment, which represented 22%of the Company’s gross written premiums for the six months ended June 30, 2025, recorded gross written premiums of $45.9 million for the second quarter of 2025, compared to $52.0 million for the second quarter of 2024. Net premiums earned for the quarter ended June 30, 2025 were $30.8 million compared to $36.3 million for the same quarter of 2024. This segment recorded an underwriting loss of $2.9 million in the second quarter of 2025, compared to income of $16.3 million in the second quarter of 2024, largely due to a higher level of net loss and loss adjustment expenses and a lower level of net premiums earned for the second quarter of 2025, compared to the same period in 2024. In the second quarter of 2025, underwriting income for this segment, which is transacted primarily in Pounds, was negatively impacted by currency revaluation movements on net loss reserves amounting to $14.6 million.

Gross written premiums were $86.4 million for the first six months of 2025, compared to $90.7 million for the first six months of 2024. Net premiums earned for the first six months of 2025 were $61.4 million compared to $73.6 million for the same period of 2024. This segment recorded an underwriting loss of $10.3 million in the first six months of 2025, compared to income of $26.2 million in the first six months of 2024, largely due to a higher level of net loss and loss adjustment expenses and a lower level of net premiums earned for the first six months of 2025, compared to the same period in 2024. Underwriting income for the first six months of 2025 was negatively impacted by currency revaluation movements on net loss reserves amounting to $23.5 million.

The Reinsurance Segment,which represented 22%of the Company’s gross written premiums for the six months ended June 30, 2025, recorded gross written premiums of $16.3 million for the second quarter of 2025, effectively flat when compared to $16.4 million for the second quarter of 2024. Net premiums earned for the quarter ended June 30, 2025 were $24.0 million, an increase of $4.2 million or 21.2%, compared to $19.8 million for the same quarter in 2024. Underwriting income increased 57.7% to $12.3 million for the second quarter of 2025, compared to $7.8 million for the second quarter of 2024, primarily the result of the higher level of net premiums earned.

Gross written premiums were $86.3 million for the first six months of 2025, reflecting an increase of 32.6% compared to $65.1 million for the first six months of 2024. Net premiums earned for the first six months of 2025 were $48.9 million, an increase of $12.3 million or 33.6%, compared to $36.6 million for the same period in 2024. Underwriting income increased by 55.5% to $22.7 million for the first six months of 2025, compared to $14.6 million for the first six months of 2024, primarily the result of the higher level of net premiums earned, partially offset by a higher level of net loss and loss adjustment expenses which included a higher level of CAT losses during the first six months of 2025.

Investment Results

Investment income increased by 5.3% to $13.9 million in the second quarter of 2025, compared to $13.2 million in the second quarter of 2024, driven by higher yields on a larger fixed income portfolio. The annualized investment yield on average total investments and cash and cash equivalents was 4.5% for the second quarter of 2025 compared to 4.6% in the corresponding period of 2024. Net investment income was $17.1 million for the second quarter of 2025, an increase of 26.7% compared to $13.5 million for the corresponding period of 2024.

Investment income increased by 10.4% to $27.5 million in the first six months of 2025, compared to $24.9 million in the first six months of 2024, driven by higher yields on a larger fixed income portfolio. The annualized investment yield on average total investments and cash and cash equivalents was 4.4% for the first six months of 2025, up from 4.3% in the corresponding period of 2024. Net investment income was $32.6 million for the first six months of 2025, compared to $28.8 million for the corresponding period of 2024.

Net Foreign Exchange Gain (Loss)

The net foreign exchange gain for the second quarter of 2025 was $10.1 million, compared to a gain of $0.4 million for the second quarter of 2024. The gain on foreign exchange in the first six months of 2025 was $17.3 million, compared to a loss of $3.9 million in the first six months of 2024.

The second quarter and first six months of 2025 experienced a greater degree of positive currency movement in the Company’s major transactional currencies (mainly the Pound and the Euro) against the U.S. Dollar, compared to the same periods in 2024.

Total Shareholders’ Equity

Total shareholders’ equity increased to $662.2 million at June 30, 2025, compared to $654.8 million at December 31, 2024.

The movement in total shareholders’ equity during the quarter and six months ended June 30, 2025 is illustrated below:

 

(in millions of U.S. Dollars)

Quarter Ended

June 30, 2025

Six Months Ended

June 30, 2025

Total Shareholders’ equity at beginning of period

$650.4

$654.8

Net income

$34.1

$61.4

Unrealized gains on available-for-sale investments

$9.3

$19.4

Purchase of treasury shares (a)

($31.2)

($35.0)

Issuance of common shares under share-based compensation plan and employees stock purchase plan

$1.9

$3.6

Cash dividends declared

($2.3)

($42.0)

Total shareholders’ equity at June 30, 2025

$662.2

$662.2

 

Book value per share was $15.36 at June 30, 2025, reflecting an increase of 3.4% over book value per share of $14.85 at December 31, 2024.
 

(a)

In the second quarter of 2025, the Company repurchased 1,342,771 common shares at an average price per share of $23.28. For the first six months of 2025, the Company repurchased 1,502,024 common shares at an average price per share of $23.33. At June 30, 2025, the Company had approximately 0.8 million common shares remaining under its existing 7.5 million common share repurchase authorization.

 

International General Insurance Holdings Ltd.

Consolidated Statements of Income (Unaudited)

 

 

Quarter Ended

June 30,

Six Months Ended

June 30,

(in millions of U.S. Dollars except per share data)

 

2025

 

2024

 

2025

 

2024

 

 

 

 

 

Gross written premiums

$187.8

$205.6

$394.3

$387.2

Ceded written premiums

($67.1)

($55.4)

($116.0)

($93.8)

Net written premiums

$120.7

$150.2

$278.3

$293.4

Net change in unearned premiums

($5.7)

($28.4)

($50.5)

($57.0)

Net premiums earned

$115.0

$121.8

$227.8

$236.4

Investment income

$13.9

$13.2

$27.5

$24.9

Net realized gain on investments

$0.4

$0.1

$1.5

$0.1

Net unrealized gain on investments

$2.4

$0.5

$3.3

$3.9

Change in allowance for expected credit losses on investments

$0.4

($0.3)

$0.3

($0.1)

Net investment income

$17.1

$13.5

$32.6

$28.8

Other revenues

$0.8

$0.3

$1.5

$0.6

Total revenues

$132.9

$135.6

$261.9

$265.8

Expenses

 

 

 

 

Net loss and loss adjustment expenses

($61.2)

($54.9)

($123.8)

($99.3)

Net policy acquisition expenses

($18.8)

($21.6)

($41.0)

($39.8)

General and administrative expenses

($24.2)

($22.4)

($45.8)

($44.6)

Change in allowance for expected credit losses on receivables

($2.4)

($1.4)

($1.8)

($1.6)

Change in fair value of derivative financial liabilities

($1.1)

($3.2)

Other expenses

($1.7)

($1.0)

($3.4)

($2.3)

Net Foreign exchange gain (loss)

$10.1

$0.4

$17.3

($3.9)

Total expenses

($98.2)

($102.0)

($198.5)

($194.7)

Income before income taxes

$34.7

$33.6

$63.4

$71.1

Income tax expense

($0.6)

($0.8)

($2.0)

($0.4)

Net income for the period

$34.1

$32.8

$61.4

$70.7

Diluted earnings per share attributable to equity holders (1)

$0.77

$0.73

$1.36

$1.55

 

(1) See “Note to the Consolidated Financial Statements (Unaudited)”.

International General Insurance Holdings Ltd.

Consolidated Balance Sheets (Unaudited)

 

(in millions of U.S. Dollars)

As at June 30,

2025

As at December 31,

2024

ASSETS

 

 

Investments

 

 

Fixed maturity securities available-for-sale, at fair value

$1,008.3

$1,002.1

Fixed maturity securities held to maturity

$2.0

$2.0

Equity securities, at fair value

$23.6

$29.0

Other investments, at fair value

$13.1

$12.3

Short-term investments

$51.3

$89.5

Term deposits

$0.7

Equity-method investments measured at fair value

$2.1

$1.9

Total investments

$1,100.4

$1,137.5

Cash and cash equivalents

$164.8

$155.2

Accrued investment income

$15.7

$15.3

Premiums receivable

$330.0

$256.0

Reinsurance recoverables

$250.7

$225.7

Ceded unearned premiums

$119.3

$113.3

Deferred policy acquisition costs, net of ceding commissions

$73.2

$67.1

Deferred tax assets, net

$3.6

$7.0

Other assets

$66.3

$60.5

TOTAL ASSETS

$2,124.0

$2,037.6

 

 

 

LIABILITIES

 

 

Reserve for unpaid loss and loss adjustment expenses

$801.5

$794.2

Unearned premiums

$521.7

$465.3

Insurance and reinsurance payables

$115.5

$90.1

Other liabilities

$23.1

$33.2

TOTAL LIABILITIES

$1,461.8

$1,382.8

 

 

 

SHAREHOLDERS’ EQUITY

 

 

Common shares at par value

$0.4

$0.5

Additional paid-in capital

$125.4

$144.9

Treasury shares

($15.6)

($3.7)

Accumulated other comprehensive gain (loss), net of taxes

$0.8

($18.6)

Retained earnings

$551.2

$531.7

TOTAL SHAREHOLDERS’ EQUITY

$662.2

$654.8

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$2,124.0

$2,037.6

 

International General Insurance Holdings Ltd.

Supplementary Financial Information – Combined Ratio (Unaudited)

 

 

Quarter Ended

June 30,

Six Months Ended

June 30,

 

2025

2024

2025

2024

 

 

 

 

 

Loss ratio (a)

53.2%

45.1%

54.3%

42.0%

Net policy acquisition expense ratio (b)

16.3%

17.7%

18.0%

16.8%

General and administrative expense ratio (c)

21.0%

18.4%

20.1%

18.9%

Expense ratio (d)

37.3%

36.1%

38.1%

35.7%

Combined ratio (e)

90.5%

81.2%

92.4%

77.7%

(a)

Represents net loss and loss adjustment expenses as a percentage of net premiums earned.

 

(b)

Represents net policy acquisition expenses as a percentage of net premiums earned.

 

(c)

Represents general and administrative expenses as a percentage of net premiums earned.

 

(d)

Represents the sum of the net policy acquisition expense ratio and the general and administrative expense ratio.

 

(e)

Represents the sum of the loss ratio and the expense ratio.

 

International General Insurance Holdings Ltd.

Supplementary Financial Information – Book Value per Share (Unaudited)

 

(in millions of U.S. Dollars, except share and per share data)

As at June 30,

2025

As at December 31,

2024

 

 

 

Common shares outstanding (in millions)*

44.0

45.1

Minus: Unvested shares (in millions)**

0.9

1.0

Number of vested common outstanding shares (in millions) (a)

43.1

44.1

 

 

 

Total shareholders’ equity (b)

$662.2

$654.8

Book value per share (b)/(a)

$15.36

$14.85

* Common shares issued and outstanding as at December 31, 2024 are as follows:

 

 

No. of shares as at

 

June 30, 2025

Vested common shares as of December 31, 2024

44,117,721

Treasury shares balance as of December 31, 2024

154,011

Vested restricted share awards

467,513

Granted employee stock purchase plan

18,737

Cancelled treasury shares

(984,326)

Treasury shares balance as of June 30, 2025

(671,709)

Total vested common shares as of June 30, 2025

43,101,947

 

 

Unvested restricted shares awards as of June 30, 2025

838,306

Unvested employee stock purchase plan as of June 30, 2025

18,480

Total unvested shares as of June 30, 2025

856,786

Total common shares outstanding as of June 30, 2025

43,958,733

 

** Restricted Share Awards were issued pursuant to the Company’s 2020 Omnibus Incentive Plan and beneficiaries are entitled to dividends and voting rights. However, the Restricted Share Awards are non-transferable by their holders until they vest per the respective Restricted Share Award Agreements. At June 30, 2025, the vesting conditions attached to the unvested Restricted Share Awards to employees have not been met.

International General Insurance Holdings Ltd.

Supplementary Financial Information – Segment Results (Unaudited)

 

Segment information for IGI’s consolidated operations is as follows:

 

For the quarter ended June 30, 2025

 

 

(in millions of U.S. Dollars)

Specialty

Long-tail

 

Specialty

Short-tail

 

Reinsurance

 

Total

Underwriting revenues

 

 

 

 

 

 

 

Gross written premiums

$45.9

 

$125.6

 

$16.3

 

$187.8

Ceded written premiums

($20.0)

 

($47.1)

 

 

($67.1)

Net written premiums

$25.9

 

$78.5

 

$16.3

 

$120.7

Net change in unearned premiums

$4.9

 

($18.3)

 

$7.7

 

($5.7)

Net premiums earned

$30.8

 

$60.2

 

$24.0

 

$115.0

 

 

 

 

 

 

 

 

Net loss and loss adjustment expenses

($27.7)

 

($24.4)

 

($9.1)

 

($61.2)

Net policy acquisition expenses

($6.0)

 

($10.2)

 

($2.6)

 

($18.8)

Underwriting (loss) income

($2.9)

 

$25.6

 

$12.3

 

$35.0

 

For the quarter ended June 30, 2024

 

 

(in millions of U.S. Dollars)

Specialty

Long-tail

 

Specialty

Short-tail

 

Reinsurance

 

Total

Underwriting revenues

 

 

 

 

 

 

 

Gross written premiums

$52.0

 

$137.2

 

$16.4

 

$205.6

Ceded written premiums

($18.6)

 

($36.8)

 

 

($55.4)

Net written premiums

$33.4

 

$100.4

 

$16.4

 

$150.2

Net change in unearned premiums

$2.9

 

($34.7)

 

$3.4

 

($28.4)

Net premiums earned

$36.3

 

$65.7

 

$19.8

 

$121.8

 

 

 

 

 

 

 

 

Net loss and loss adjustment expenses

($12.3)

 

($33.8)

 

($8.8)

 

($54.9)

Net policy acquisition expenses

($7.7)

 

($10.7)

 

($3.2)

 

($21.6)

Underwriting income

$16.3

 

$21.2

 

$7.8

 

$45.3

 

International General Insurance Holdings Ltd.

Supplementary Financial Information – Segment Results (Unaudited)

 

For the six months ended June 30, 2025

 

 

(in millions of U.S. Dollars)

Specialty

Long-tail

 

Specialty

Short-tail

 

Reinsurance

 

Total

Underwriting revenues

 

 

 

 

 

 

 

Gross written premiums

$86.4

 

$221.6

 

$86.3

 

$394.3

Ceded written premiums

($31.7)

 

($82.6)

 

($1.7)

 

($116.0)

Net written premiums

$54.7

 

$139.0

 

$84.6

 

$278.3

Net change in unearned premiums

$6.7

 

($21.5)

 

($35.7)

 

($50.5)

Net premiums earned

$61.4

 

$117.5

 

$48.9

 

$227.8

 

 

 

 

 

 

 

 

Net loss and loss adjustment expenses

($57.6)

 

($46.1)

 

($20.1)

 

($123.8)

Net policy acquisition expenses

($14.1)

 

($20.8)

 

($6.1)

 

($41.0)

Underwriting (loss) income

($10.3)

 

$50.6

 

$22.7

 

$63.0

 

For the six months ended June 30, 2024

 

 

(in millions of U.S. Dollars)

Specialty

Long-tail

 

Specialty

Short-tail

 

Reinsurance

 

Total

Underwriting revenues

 

 

 

 

 

 

 

Gross written premiums

$90.7

 

$231.4

 

$65.1

 

$387.2

Ceded written premiums

($26.5)

 

($65.8)

 

($1.5)

 

($93.8)

Net written premiums

$64.2

 

$165.6

 

$63.6

 

$293.4

Net change in unearned premiums

$9.4

 

($39.4)

 

($27.0)

 

($57.0)

Net premiums earned

$73.6

 

$126.2

 

$36.6

 

$236.4

 

 

 

 

 

 

 

 

Net loss and loss adjustment expenses

($33.3)

 

($49.3)

 

($16.7)

 

($99.3)

Net policy acquisition expenses

($14.1)

 

($20.4)

 

($5.3)

 

($39.8)

Underwriting income

$26.2

 

$56.5

 

$14.6

 

$97.3

International General Insurance Holdings Ltd.

Supplementary Financial Information – Investment Yield (Unaudited)

 

The following table shows the investment yield calculation:

 

 

Quarter Ended

June 30,

 

Six Months Ended

June 30,

(in millions of U.S. Dollars, except percentages)

2025

 

2024

 

2025

 

2024

Investment income

$13.9

$13.2

$27.5

$24.9

Average total investments and cash and cash equivalents(i)

$1,257.2

$1,162.2

$1,277.6

$1,158.4

Investment Yield (annualized)

4.5%

4.6%

4.4%

4.3%

(i)

This represents the average of the month end fair value balances of total investments and cash and cash equivalents in each reporting period.

International General Insurance Holdings Ltd.
Note to the Consolidated Financial Statements (Unaudited)

 

(1)

Represents net income for the period available to common shareholders divided by the weighted average number of vested common shares – diluted calculated as follows:

 

 

Quarter Ended

June 30,

 

Six Months Ended

June 30,

(in millions of U.S. Dollars, except share and per share information)

2025

 

2024

 

2025

 

2024

Net income for the period

$34.1

$32.8

$61.4

$70.7

Minus: Net income attributable to the earnout shares

$0.6

$1.1

Minus: Dividends attributable to restricted share awards

$0.8

$0.5

Net income available to common shareholders (a)

$34.1

$32.2

$60.6

$69.1

Weighted average number of shares – diluted (in millions of shares) (b)*

44.4

44.0

44.5

44.5

Diluted earnings per share attributable to equity holders (a/b)

$0.77

$0.73

$1.36

$1.55

 

* The weighted average number of common shares refers to the number of common shares calculated after adjusting for the changes in issued and outstanding common shares over a reporting period.

International General Insurance Holdings Ltd.

Non-GAAP Financial Measures

In presenting IGI’s financial results, management has included and discussed certain non-GAAP financial measures. We believe that these non-GAAP financial measures, which may be defined and calculated differently by other companies, help to explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP.

Reconciliation of Combined Ratio to Accident Year Combined Ratio Prior to CAT Losses

The table below illustrates the reconciliation of the combined ratio on a financial and accident year basis.

 

Quarter Ended

June 30,

 

Six Months Ended

June 30,

(In millions of U.S. Dollars, except percentages)

2025

 

2024

 

2025

 

2024

Net premiums earned (a)

$115.0

$121.8

$227.8

$236.4

Net loss and loss adjustment expenses (b)

($61.2)

($54.9)

($123.8)

($99.3)

Net policy acquisition expenses (c)

($18.8)

($21.6)

($41.0)

($39.8)

General and administrative expenses (d)

($24.2)

($22.4)

($45.8)

($44.6)

Prior years unfavorable (favorable) development (e)

$6.3

($19.3)

($19.6)

($41.5)

Current accident year CAT losses (f)*

$10.4

$14.1

$38.6

$24.9

 

 

 

 

 

Combined ratio((b+c+d)/a)**

90.5%

81.2%

92.4%

77.7%

Minus: Prior years unfavorable (favorable) development (e/a)

5.5%

(15.8%)

(8.6%)

(17.6%)

Accident year combined ratio

85.0%

97.0%

101.0%

95.3%

Minus: CAT losses on an accident year basis (f/a)

9.0%

11.6%

16.9%

10.5%

Accident year combined ratio prior to CAT losses

76.0%

85.4%

84.1%

84.8%

*The CAT losses for the quarter ended June 30, 2025 include reserves for the earthquakes in Taiwan and the Bridgewater Canal breach in Manchester, UK (all in the Specialty Short-tail Segment).

The CAT losses for the quarter ended June 30, 2024 include reserves recorded for the earthquake in Taiwan (in the Specialty Short-tail and Reinsurance Segments) and flooding in United Arab Emirates and Oman (in all segments), both of which occurred in April 2024.

The CAT losses for the six months ended June 30, 2025 include reserves recorded for the Southern California wildfires (in the Reinsurance Segment), the earthquakes in Taiwan and the Bridgewater Canal breach in Manchester, UK (all in the Specialty Short-tail Segment).

The CAT losses for the six months ended June 30, 2024 include reserves recorded for the earthquake in Taiwan (in the Specialty Short-tail and Reinsurance segments) and flooding in United Arab Emirates and Oman (in all segments).

** See “Supplementary Financial Information – Combined Ratio (Unaudited)”.

International General Insurance Holdings Ltd.

Non-GAAP Financial Measures

The table below illustrates the split of loss ratio between current accident year, current accident year CAT losses, which are included in ‘Net loss and loss adjustment expenses’, and prior years’ loss development as follows:

Quarter Ended June 30,

Six Months Ended June 30,

2025

2024

2025

2024

(in millions of U.S. Dollars, except percentages)

Net loss and loss adjustment expenses

% of net premiums earned

Net loss and loss adjustment expenses

% of net premiums earned

Net loss and loss adjustment expenses

% of net premiums earned

Net loss and loss adjustment expenses

% of net premiums earned

Current accident year net incurred claims and loss ratio

$61.2

53.2%

$54.9

45.1%

$123.8

54.3%

$99.3

42.0%

Minus: Current accident year CAT losses

$10.4

9.0%

$14.1

11.6%

$38.6

16.9%

$24.9

10.5%

Minus: Effect of prior years’ loss development

$6.3

5.5%

($19.3)

(15.8%)

($19.6)

(8.6%)

($41.5)

(17.6%)

Current Accident year (Prior to CAT losses)

$44.5

38.7%

$60.1

49.3%

$104.8

46.0%

$115.9

49.1%

Core Operating Income

Core operating income measures the performance of our operations without the influence of after-tax gains or losses on investments and foreign currencies and other items as noted in the table below. We exclude these items from our calculation of core operating income because the amounts of these gains and losses are heavily influenced by, and fluctuate in part according to, economic and other factors external to the Company and/or transactions or events that are typically not a recurring part of, and are largely independent of, our core underwriting activities and including them distorts the analysis of trends in our operations. We believe the reporting of core operating income enhances an understanding of our results by highlighting the underlying profitability of our core insurance operations. Our underwriting profitability is impacted by earned premiums, the adequacy of pricing, and the frequency and severity of losses. Over time, such profitability is also influenced by underwriting discipline, which seeks to manage the Company’s exposure to loss through intelligent risk selection and diversification, IGI’s management of claims, use of reinsurance and the ability to manage the expense ratio, which the Company accomplishes through the management of acquisition costs and other underwriting expenses.

In addition to presenting net income for the period determined in accordance with U.S. GAAP, we believe that showing “core operating income” provides investors with a valuable measure of profitability and enables investors, rating agencies and other users of our financial information to analyze the Company’s results in a similar manner to the way in which Management analyzes the Company’s underlying business performance.

International General Insurance Holdings Ltd.

Non-GAAP Financial Measures

Core operating income is calculated by the addition or subtraction of certain line items reported in the “Consolidated Statements of Income” from net income for the period and tax effecting each line item (resulting in each item being a non-GAAP financial measure), as illustrated in the table below:

 

Quarter Ended

June 30,

 

Six Months Ended

June 30,

(in millions of U.S. Dollars, except for percentages and per share data)

2025

 

2024

 

2025

 

2024

Net income for the period

$34.1

$32.8

$61.4

$70.7

Reconciling items between net income for the period and core operating income:

 

 

 

 

Net realized (gain) on investments

($0.4)

($0.1)

($1.5)

($0.1)

Tax impact of net realized (gain) on investments(i)

$0.1

$0.2

Net unrealized (gain) on investments

($2.4)

($0.5)

($3.3)

($3.9)

Tax impact of net unrealized (gain) on investments(i)

$0.1

$0.2

Change in allowance for expected credit losses on investments

($0.4)

$0.3

($0.3)

$0.1

Tax impact of change in allowance for expected credit losses on investments(i)

$0.1

$0.1

Change in fair value of derivative financial liabilities

$1.1

$3.2

Net foreign exchange (gain) loss

($10.1)

($0.4)

($17.3)

$3.9

Tax impact of net foreign exchange (gain) loss(i)

$1.7

$2.7

($0.6)

Core operating income

$22.8

$33.2

$42.2

$73.3

Average shareholders’ equity (ii)

$656.4

$572.7

$658.6

$564.3

Core operating return on average equity (annualized) (iii) and (v)

13.9%

23.2%

12.8%

26.0%

Diluted core operating earnings per share (iv)

$0.51

$0.74

$0.93

$1.61

Return on average equity (annualized) (v)

20.8%

22.9%

18.6%

25.1%

i.

The tax impact was calculated by applying the prevailing corporate tax rate of each subsidiary to the gross value of the relevant reconciling items as recognized separately by the subsidiaries on a standalone basis.

 

ii.

Represents the total shareholders’ equity at the end of the reporting period plus the total shareholders’ equity as of the beginning of the reporting period, divided by 2.

 

iii.

Represents annualized core operating income for the period divided by average shareholders’ equity.

 

iv.

Represents core operating income attributable to vested equity holders divided by the weighted average number of vested common shares – diluted as follows:

 

Quarter Ended

June 30,

 

Six Months Ended

June 30,

(in millions of U.S. Dollars, except per share information)

2025

 

2024

 

2025

 

2024

Core operating income for the period

$22.8

$33.2

$42.2

$73.3

Minus: Core operating income attributable to earnout shares

$0.6

$1.1

Minus: Dividends attributable to restricted share awards

$0.8

$0.5

Core operating income available to common shareholders (a)

$22.8

$32.6

$41.4

$71.7

Weighted average number of shares – diluted (in millions of shares) (b)

44.4

44.0

44.5

44.5

Diluted core operating earnings per share (a/b)

$0.51

$0.74

$0.93

$1.61

v.

Return on average equity (annualized) and core operating return on average equity (annualized), both non-GAAP financial measures, represent the returns generated on common shareholders’ equity during the period.

The Company has posted a Second quarter 2025 investor presentation deck on its website at www.iginsure.com in the Investors section under the Presentations & Webcasts tab.

About IGI:

IGI is an international specialty risks commercial insurer and reinsurer underwriting a diverse portfolio of specialty lines. Established in 2001, IGI has a worldwide portfolio of energy, property, general aviation, construction & engineering, ports & terminals, marine cargo, marine trades, contingency, political violence, financial institutions, general third-party liability (casualty), legal expenses, professional indemnity, D&O, marine liability and reinsurance treaty business. Registered in Bermuda, with operations in Bermuda, London, Malta, Dubai, Amman, Oslo, Kuala Lumpur and Casablanca, IGI aims to deliver outstanding levels of service to clients and brokers. IGI is rated “A” (Excellent)/Stable by AM Best and “A-”(Strong)/Stable by S&P Global Ratings. For more information about IGI, please visit www.iginsure.com.

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the “safe harbour” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the business of IGI may differ from its actual results and, consequently, you should not rely on forward-looking statements as predictions of future events. Words such as “ability,” “aim,” “impact,” “seek,” “strategy,” “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believe,” “predict,” “potential,” “continue,” “commitment,” “able,” “success” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements contained in this press release may include, but are not limited to, our expectations regarding the performance of our business, our financial results, our liquidity and capital resources, the outcome of our strategic initiatives, our expectations regarding other market conditions, and our growth prospects. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the control of IGI and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) changes in demand for IGI’s services together with the possibility that IGI may be adversely affected by other economic, business, and/or competitive factors globally and in the regions in which it operates; (2) competition, the ability of IGI to grow and manage growth profitably, and IGI’s ability to retain its key employees; (3) changes in applicable laws or regulations; (4) risks related to fluctuations in global currencies including the UK Pound Sterling, the Euro, and the U.S. Dollar; (5) the outcome of any legal proceedings that may be instituted against the Company; (6) the effects of the hostilities between Russia and Ukraine, and the sanctions imposed on Russia by the United States, European Union, United Kingdom and others; (7) the effects of the military conflict between Israel, Hamas, Hezbollah, and Iran; (8) the effects of the Houthis disruption of Red Sea international shipping routes; (9) the impact of the tariffs that have been imposed or may be imposed by the U.S. administration; (10) the inability to maintain the listing of the Company’s common shares on Nasdaq; and (11) other risks and uncertainties indicated in IGI’s filings with the SEC. The foregoing list of factors is not exclusive. In addition, forward-looking statements are inherently based on various estimates and assumptions that are subject to the judgment of those preparing them and are also subject to significant economic, competitive, industry and other uncertainties and contingencies, all of which are difficult or impossible to predict and many of which are beyond the control of IGI. There can be no assurance that IGI’s financial condition or results of operations will be consistent with those set forth in such forward-looking statements. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. IGI does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based except to the extent that it is required by law.

IGI Contacts:

Investors:

Robin Sidders, Head of Investor Relations

M: + 44 (0) 7384 514785

Email: [email protected]

Media:

Aaida Abu Jaber, AVP PR & Marketing

T: +96265662082 Ext. 407

M: +962770415540

Email: [email protected]

KEYWORDS: Ireland United States Caribbean United Kingdom North America Bermuda Europe

INDUSTRY KEYWORDS: Professional Services Insurance Finance

MEDIA:

Logo
Logo

Vestis Reports Third Quarter 2025 Results

Vestis Reports Third Quarter 2025 Results

ATLANTA–(BUSINESS WIRE)–
Vestis Corporation (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced its results for the third quarter ended June 27, 2025.

Third Quarter 2025 Results

  • Revenue of $674 million
  • Operating Income of $25 million and Net Loss of $0.7 million
  • Adjusted EBITDA* of $64 million
  • Cash Flows Provided by Operating Activities of $23 million and Free Cash Flow* of $8 million
  • Available liquidity of $290 million including $24 million cash and cash equivalents on hand

Management Commentary

“I’m pleased that our third quarter results were in line with our expectations and that we generated positive cash flow during the period,” said Jim Barber, President and CEO. “Our team has been focused on taking comprehensive actions designed to strengthen our overall results and create long-term shareholder value by unlocking operating leverage through commercial and operational excellence.”

“Since I joined the company as CEO two months ago, I have been focused on engaging in a thorough review of our business,” Mr. Barber continued. “Vestis has faced challenges, but I am optimistic about the road ahead and confident in the team’s ability to deliver for our key stakeholders. Our integrated network of assets gives us scale and reach in an attractive and growing industry.”

Third Quarter 2025 Financial Performance

Third quarter fiscal 2025 revenue totaled $673.8 million, a decrease of $24.4 million year over year or 3.5%. The decline in revenue compared to the prior year reflects a $18.0 million decrease in rental revenue, a $5.6 million decline in direct sales revenue and a $0.8 million negative impact of foreign exchange on currency. The decrease in rental revenue was primarily due to a $14.6 million decline from lost business in excess of new business, and a $3.4 million decline in revenue related to existing business. The decline in direct sales revenue was primarily attributable to a $4.3 million unfavorable impact from the previously anticipated loss of a national account customer. Excluding that, direct sales decreased $1.3 million when compared to the prior year.

Gross profit for the third quarter of fiscal 2025 was $182.1 million, compared to $202.5 million in the third quarter of fiscal 2024, a decrease of 10.1%. The decrease in gross profit compared to the prior year period is primarily attributable to the decremental margin on lost revenues, unfavorable changes in product mix and increased merchandise amortization from new installations, which more than offset the incremental margin from new business and a decline in delivery costs.

Selling, general and administrative (“SG&A”) expenses were $122.3 million in the third quarter of fiscal 2025, which was $7.7 million lower than the same period in the prior year. The year-over-year decrease in SG&A was due primarily to a $6.0 million decline in share-based compensation, a $3.6 million decrease in separation related costs and a $2.6 million reduction in other administrative costs, offset by a $4.5 million increase in selling expenses related to additional field sales personnel.

Interest expense was $22.5 million in the third quarter of fiscal 2025, compared to $29.9 million in the prior year period. The $7.4 million year-over-year decrease in interest expense reflects a decrease in net term loan borrowings resulting from the receipt of net proceeds from establishing the accounts receivable securitization facility during the fiscal fourth quarter of 2024.

Net loss was $0.7 million or $(0.01) per diluted share, in the third quarter of fiscal 2025 versus net income of $5.0 million, or $0.04 per diluted share, in the prior year period and Adjusted EBITDA* was $64.0 million for the third quarter of 2025 as compared to $86.9 million in the third quarter of 2024.

Capital Allocation and Financial Position

During the third quarter of 2025, we invested $14.9 million in property and equipment, the majority of which is related to market center facility improvements.

Net cash provided by operating activities was $22.9 million for the third quarter of 2025 and Free Cash Flow* was $8.0 million for the quarter, a decrease of $25.8 million and $19.7 million, respectively, from the comparative prior year periods. The reduction in cash flow was primarily due to the decrease in earnings and the current quarter includes the impact of allowable deferred cash tax payments from the first half of fiscal 2025 of $9.6 million.

As of June 27, 2025, Vestis had total cash and excess availability under its revolving credit facility of $290 million as compared to $324 million at the end of the third quarter of 2024. Total debt outstanding at the end of the third quarter was $1.32 billion including principal bank debt outstanding of $1.17 billion. The Net Leverage Ratioa* was 4.50x at the end of the third quarter of fiscal 2025. Pursuant to the credit agreement, as amended, the Net Leverage Ratio cannot exceed 5.25x for any fiscal quarter ending prior to July 3, 2026.

Third Quarter 2025 Results Conference Call & Webcast

Vestis will host a conference call on Wednesday, August 6, 2025, at 8:30 a.m. Eastern Time to discuss its fiscal third quarter 2025 results.

For a live webcast of the conference call and to access the accompanying investor presentation, please visit the investor relations section of the Company’s website at www.vestis.com.

To participate in the live teleconference:

Unites States Live: 800-267-6316

International Live: 203-518-9783

Access Code: VSTSQ325

A replay of the live event will also be available on the Company’s website shortly after the conclusion of the call.

AboutVestis™

Vestis is a leader in the B2B uniform and workplace supplies category. Vestis provides uniform services and workplace supplies to a broad range of North American customers from Fortune 500 companies to locally owned small businesses across a broad set of end sectors. The Company’s comprehensive service offering primarily includes a full-service uniform rental program, floor mats, towels, linens, managed restroom services, first aid supplies, and cleanroom and other specialty garment processing.

_______________________________

a
The Company incurred a net loss during the third quarter of fiscal 2025, resulting in a negative debt to net income ratio, which is the most directly comparable GAAP measure to Net Leverage Ratio.

* A non-GAAP measure, see accompanying non-GAAP measure explanations and reconciliations later in this release.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the securities laws. All statements that reflect our expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, forecasts relating to discussions of future operations and financial performance and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures. In some cases, forward-looking statements can be identified by words such as “potential,” “outlook,” “guidance,” “anticipate,” “continue,” “estimate,” “expect,” “will,” and “believe,” and other words and terms of similar meaning or the negative versions of such words. Examples of forward-looking statements in this release include, but are not limited to, statements regarding: the potential effects of our comprehensive actions to enhance both our commercial and operational processes, and our expectations regarding our fourth quarter 2025 performance outlook. These forward-looking statements are subject to risks and uncertainties that may change at any time, and actual results or outcomes may differ materially from those that we expected. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and changes in circumstances that are difficult to predict including, but not limited to: unfavorable macroeconomic conditions including inflationary pressures and higher interest rates; the failure to retain current customers, renew existing customer contracts and obtain new customer contracts, which could result in continued stock volatility and potential future goodwill impairment charges; competition in our industry; our ability to comply with certain financial ratios, tests and covenants in our credit agreement, including the Net Leverage Ratio; our significant indebtedness and ability to meet debt obligations and our reliance on an accounts receivable securitization facility; increases in fuel and energy costs and other supply chain challenges and disruptions, including as a result of ongoing military conflicts in Ukraine and the Middle East; implementation of new or increased tariffs and ongoing changes in U.S. and foreign government trade policies, including potential modifications to existing trade agreements and retaliatory measures by foreign governments; increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our support services contracts; a determination by our customers to reduce their outsourcing or use of preferred vendors; the outcome of legal proceedings to which we are or may become subject; risks associated with suppliers from whom our products are sourced; challenge of contracts by our customers; currency risks and other risks associated with international operations, including compliance with a broad range of laws and regulations, including the United States Foreign Corrupt Practices Act; increases in labor costs or inability to hire and retain key or sufficient qualified personnel; continued or further unionization of our workforce; our expansion strategy and our ability to successfully integrate the businesses we acquire and costs and timing related thereto; natural disasters, global calamities, climate change, pandemics, and other adverse incidents; liability resulting from our participation in multiemployer-defined benefit pension plans; liability associated with noncompliance with applicable law or other governmental regulations; laws and governmental regulations including those relating to the environment, wage and hour and government contracting; unanticipated changes in tax law; new interpretations of or changes in the enforcement of the government regulatory framework; a cybersecurity incident or other disruptions in the availability of our computer systems or privacy breaches; stakeholder expectations relating to environmental, social and governance (“ESG”) considerations which may expose us to liabilities and other adverse effects on our business; any failure by Aramark to perform its obligations under the various separation agreements entered into in connection with the separation; and a determination by the IRS that the distribution or certain related transactions are taxable. The above list of factors is not exhaustive or necessarily in order of importance. For additional information on identifying factors that may cause actual results to vary materially from those stated in forward-looking statements, see the Company’s filings with the Securities and Exchange Commission (“SEC”), including “Item 1A-Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in “Item 1A-Risk Factors” of Part II in subsequently-filed Quarterly Reports on Form 10-Q, which are available on the SEC’s website at www.sec.gov. Any forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise such statement, whether as a result of new information, future events or otherwise, except as required by applicable law.

Non-GAAP Financial Measures

Vestis reports its financial results in accordance with U.S. GAAP, but in this release and the non-GAAP reconciliations that follow, Vestis also uses the following non-GAAP measures: Adjusted EBITDA, Free Cash Flow, Net Debt, Net Leverage Ratio, and Trailing Twelve Months Covenant Adjusted EBITDA. Vestis believes that non-GAAP financial measures, both together with and in addition to the corresponding U.S. GAAP financial measure, are important supplemental measures that exclude non-cash or other items that may not be indicative of or are unrelated to Vestis’ core operating results. Vestis uses these non-GAAP financial measures with U.S. GAAP financial measures and other comparable tools to assist in the evaluation of its operating performance. Vestis believes that presentation of these measures also helps investors because the measures enable better comparisons of Vestis’ historical results and allow investors to evaluate Vestis’ performance based on the same metrics that Vestis uses to evaluate its performance and trends in its results. However, these measures have limitations as analytical tools and should not be considered in isolation or as a substitute for Vestis’ results as reported under U.S. GAAP. Specifically, you should not consider these measures as alternatives to revenue, operating income, operating income margin, net income, net income margin or net cash provided by operating activities determined in accordance with U.S. GAAP. These non-GAAP financial measures also should not be considered as measures of cash available to Vestis to invest in the growth of Vestis’ business or cash that will be available to Vestis to meet its obligations. Non-GAAP financial measures as presented by Vestis may not be comparable to other similarly titled measures of other companies because not all companies use identical calculations. These non-GAAP measures are reconciled in the tables at the end of this release.

Adjusted EBITDA

Adjusted EBITDA represents net income adjusted for provision for income taxes; interest expense, net; and depreciation and amortization (EBITDA), further adjusted for share-based compensation expense; severance; separation related charges; securitization fees; loss (gain) on sale of equity investment; third party debt amendment fees; legal reserves and settlements; gains, losses, and other items impacting comparability. Adjusted EBITDA is presented in order to reflect Vestis’ results in a manner that allows a better understanding of operational activities separate from the financial impact of decisions made for the long-term benefit of Vestis and other items impacting comparability between periods. Similar adjustments have been recorded in Adjusted EBITDA for earlier periods and similar types of adjustments can reasonably be expected to be recorded in Adjusted EBITDA in future periods.

Free Cash Flow

Free Cash Flow represents net cash provided by operating activities adjusted for purchases of property and equipment and other. Free Cash Flow is presented because it relates the operating cash flow of Vestis to the capital that is spent to continue and improve business operations, and indicates the amount of cash generated or used after capital expenditures that can be used for, among other things, investment in the Vestis business, strengthening the balance sheet, and repayment of debt obligations. Free cash flow does not represent the residual cash flow available for discretionary expenditures since there may be other nondiscretionary expenditures that are not deducted from the measure.

Net Leverage Ratio, Net Debt, Covenant Adjusted EBITDA and Trailing Twelve Months Covenant Adjusted EBITDA

Net Leverage Ratio is defined in Vestis’ credit agreement and is calculated as consolidated total indebtedness in excess of unrestricted cash (referred to herein as “Net Debt”), divided by the Trailing Twelve Months Covenant Adjusted EBITDA. Net Debt represents total principal debt outstanding, letters of credit outstanding, and finance lease obligations, less cash and cash equivalents. Covenant Adjusted EBITDA represents Adjusted EBITDA, as further modified by certain items specifically permitted under the credit agreement to assess compliance with its financial covenants. Trailing Twelve Months Covenant Adjusted EBITDA represents Covenant Adjusted EBITDA for the preceding four fiscal quarters. Vestis believes that Net Leverage Ratio and its components are useful to investors because they are indicators of Vestis’ ability to meet its future financial obligations and are measures that are frequently used by investors and creditors.

VESTIS CORPORATION

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(Unaudited)

(In thousands, except per share amounts)

 

 

Three Months Ended

 

Nine Months Ended

 

June 27,

2025

 

June 28,

2024

 

June 27,

2025

 

June 28,

2024

Revenue

$

673,799

 

 

$

698,248

 

 

$

2,022,828

 

 

$

2,121,539

 

Operating Expenses:

 

 

 

 

 

 

 

Cost of services provided (exclusive of depreciation and amortization)

 

491,681

 

 

 

495,759

 

 

 

1,476,932

 

 

 

1,502,557

 

Depreciation and amortization

 

34,856

 

 

 

34,925

 

 

 

107,674

 

 

 

105,500

 

Selling, general and administrative expenses

 

122,301

 

 

 

130,041

 

 

 

391,432

 

 

 

385,307

 

Total Operating Expenses

 

648,838

 

 

 

660,725

 

 

 

1,976,038

 

 

 

1,993,364

 

Operating Income (Loss)

 

24,961

 

 

 

37,523

 

 

 

46,790

 

 

 

128,175

 

Interest Expense, net

 

22,495

 

 

 

29,857

 

 

 

67,921

 

 

 

96,715

 

Other Expense (Income), net

 

3,215

 

 

 

(471

)

 

 

12,270

 

 

 

(1,841

)

Income (Loss) Before Income Taxes

 

(749

)

 

 

8,137

 

 

 

(33,401

)

 

 

33,301

 

Provision (Benefit) for Income Taxes

 

(73

)

 

 

3,100

 

 

 

(5,727

)

 

 

10,033

 

Net Income (Loss)

$

(676

)

 

$

5,037

 

 

$

(27,674

)

 

$

23,268

 

 

 

 

 

 

 

 

 

Earnings (Loss) per share:

 

 

 

 

 

 

 

Basic

$

(0.01

)

 

$

0.04

 

 

$

(0.21

)

 

$

0.18

 

Diluted

$

(0.01

)

 

$

0.04

 

 

$

(0.21

)

 

$

0.18

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

Basic

 

131,812

 

 

 

131,543

 

 

 

131,719

 

 

 

131,486

 

Diluted

 

131,812

 

 

 

131,833

 

 

 

131,719

 

 

 

131,785

 

VESTIS CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

 

 

June 27,

2025

 

September 27,

2024

ASSETS

 

 

 

Current Assets:

 

 

 

Cash and cash equivalents

$

23,743

 

 

$

31,010

 

Receivables (net of allowances: $30,795 and $19,804, respectively)

 

175,789

 

 

 

177,271

 

Inventories, net

 

186,992

 

 

 

164,913

 

Rental merchandise in service, net

 

400,374

 

 

 

396,094

 

Other current assets

 

33,704

 

 

 

18,101

 

Total current assets

 

820,602

 

 

 

787,389

 

Property and Equipment, at cost:

 

 

 

Land, buildings and improvements

 

574,174

 

 

 

590,972

 

Equipment

 

1,170,736

 

 

 

1,168,142

 

 

 

1,744,910

 

 

 

1,759,114

 

Less – Accumulated depreciation

 

(1,092,415

)

 

 

(1,088,256

)

Total property and equipment, net

 

652,495

 

 

 

670,858

 

Goodwill

 

963,027

 

 

 

963,844

 

Other Intangible Assets, net

 

196,370

 

 

 

212,773

 

Operating Lease Right-of-use Assets

 

86,539

 

 

 

73,530

 

Other Assets

 

189,058

 

 

 

223,993

 

Total Assets

$

2,908,091

 

 

$

2,932,387

 

LIABILITIES AND EQUITY

 

 

 

Current Liabilities:

 

 

 

Current maturities of financing lease obligations

 

32,860

 

 

 

31,347

 

Current operating lease liabilities

 

20,576

 

 

 

19,886

 

Accounts payable

 

156,661

 

 

 

163,054

 

Accrued payroll and related expenses

 

97,329

 

 

 

96,768

 

Accrued expenses and other current liabilities

 

138,440

 

 

 

145,047

 

Total current liabilities

 

445,866

 

 

 

456,102

 

Long-Term Borrowings

 

1,156,457

 

 

 

1,147,733

 

Noncurrent Financing Lease Obligations

 

119,014

 

 

 

115,325

 

Noncurrent Operating Lease Liabilities

 

78,239

 

 

 

66,111

 

Deferred Income Taxes

 

175,069

 

 

 

191,465

 

Other Noncurrent Liabilities

 

51,218

 

 

 

52,600

 

Total Liabilities

 

2,025,863

 

 

 

2,029,336

 

Commitments and Contingencies

 

 

 

Equity:

 

 

 

Common stock, par value $0.01 per share, 350,000,000 authorized, 131,836,607 and 131,481,967 issued and outstanding as of June 27, 2025 and September 27, 2024 ,respectively.

 

1,318

 

 

 

1,315

 

Additional paid-in capital

 

937,051

 

 

 

928,082

 

(Accumulated deficit) retained earnings

 

(34,330

)

 

 

2,565

 

Accumulated other comprehensive loss

 

(21,811

)

 

 

(28,911

)

Total Equity

 

882,228

 

 

 

903,051

 

Total Liabilities and Equity

$

2,908,091

 

 

$

2,932,387

 

VESTIS CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

Three months ended

 

Nine months ended

 

June 27,

2025

 

June 28,

2024

 

June 27,

2025

 

June 28,

2024

Cash flows from operating activities:

 

 

 

 

 

 

 

Net Income (Loss)

$

(676

)

 

$

5,037

 

 

$

(27,674

)

 

$

23,268

 

Adjustments to reconcile Net Income (Loss) to Net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

34,856

 

 

 

34,925

 

 

 

107,674

 

 

 

105,500

 

Deferred income taxes

 

(8,876

)

 

 

(4,431

)

 

 

(16,002

)

 

 

(10,166

)

Share-based compensation expense

 

(2,148

)

 

 

3,856

 

 

 

11,009

 

 

 

13,303

 

Loss on sale of equity investment, net

 

 

 

 

 

 

 

2,150

 

 

 

 

Asset write-down

 

 

 

 

208

 

 

 

189

 

 

 

980

 

(Gain) Loss on disposals of property and equipment

 

246

 

 

 

376

 

 

 

(726

)

 

 

618

 

Amortization of debt issuance costs

 

891

 

 

 

679

 

 

 

2,662

 

 

 

1,478

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

3,883

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

Receivables, net

 

(11,879

)

 

 

(4,307

)

 

 

1,063

 

 

 

(17,230

)

Inventories, net

 

13,091

 

 

 

(12,702

)

 

 

(21,487

)

 

 

21,136

 

Rental merchandise in service, net

 

(4,378

)

 

 

1,668

 

 

 

(4,708

)

 

 

178

 

Other current assets

 

(1,620

)

 

 

3,053

 

 

 

(11,888

)

 

 

(6,230

)

Accounts payable

 

3,664

 

 

 

2,137

 

 

 

(1,494

)

 

 

14,471

 

Accrued expenses and other current liabilities

 

8,130

 

 

 

29,269

 

 

 

19,203

 

 

 

54,511

 

Changes in other noncurrent liabilities

 

(7,794

)

 

 

(4,875

)

 

 

(22,718

)

 

 

(16,900

)

Changes in other assets

 

(1,368

)

 

 

(4,738

)

 

 

(3,879

)

 

 

(10,932

)

Other operating activities

 

725

 

 

 

(1,497

)

 

 

(72

)

 

 

(1,668

)

Net cash provided by operating activities

 

22,864

 

 

 

48,658

 

 

 

33,302

 

 

 

176,200

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Purchases of property and equipment and other

 

(14,860

)

 

 

(20,962

)

 

 

(43,102

)

 

 

(50,787

)

Proceeds from disposals of property and equipment

 

167

 

 

 

 

 

 

5,365

 

 

 

 

Proceeds from sale of equity investment

 

 

 

 

 

 

 

36,792

 

 

 

 

Other investing activities

 

(29

)

 

 

 

 

 

(4,576

)

 

 

 

Net cash provided by (used in) investing activities

 

(14,722

)

 

 

(20,962

)

 

 

(5,521

)

 

 

(50,787

)

Cash flows from financing activities:

 

 

 

 

 

 

 

Proceeds from long-term borrowings

 

53,000

 

 

 

 

 

 

93,000

 

 

 

798,000

 

Payments of long-term borrowings

 

(55,000

)

 

 

(17,000

)

 

 

(85,000

)

 

 

(879,500

)

Payments of financing lease obligations

 

(8,808

)

 

 

(7,424

)

 

 

(25,630

)

 

 

(22,572

)

Net cash distributions to Parent

 

 

 

 

 

 

 

 

 

 

(6,051

)

Dividend payments

 

 

 

 

(4,599

)

 

 

(13,822

)

 

 

(9,199

)

Debt issuance costs

 

(1,628

)

 

 

 

 

 

(1,628

)

 

 

(11,134

)

Other financing activities

 

(242

)

 

 

(125

)

 

 

(2,037

)

 

 

(1,853

)

Net cash provided by (used in) financing activities

 

(12,678

)

 

 

(29,148

)

 

 

(35,117

)

 

 

(132,309

)

Effect of foreign exchange rates on cash and cash equivalents

 

(527

)

 

 

(109

)

 

 

69

 

 

 

(57

)

Increase (decrease) in cash and cash equivalents

 

(5,063

)

 

 

(1,561

)

 

 

(7,267

)

 

 

(6,953

)

Cash and cash equivalents, beginning of period

 

28,806

 

 

 

30,659

 

 

 

31,010

 

 

 

36,051

 

Cash and cash equivalents, end of period

$

23,743

 

 

$

29,098

 

 

$

23,743

 

 

$

29,098

 

VESTIS CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

(In thousands)

 

 

Consolidated

 

Consolidated

 

Consolidated

 

Three Months Ended

 

Nine months ended

 

Trailing Twelve Months Ended

 

June 27,

 

June 28,

 

June 27,

 

June 28,

 

June 27,

 

June 28,

 

September 27,

 

2025

 

2024

 

2025

 

2024

 

2025

 

2024

 

2024

Net Income (Loss)

$

(676

)

 

$

5,037

 

$

(27,674

)

 

$

23,268

 

$

(29,972

)

 

$

117,240

 

 

$

20,970

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and Amortization

 

34,856

 

 

 

34,925

 

 

107,674

 

 

 

105,500

 

 

142,955

 

 

 

140,292

 

 

 

140,781

Provision (Benefit) for Income Taxes

 

(73

)

 

 

3,100

 

 

(5,727

)

 

 

10,033

 

 

(4,700

)

 

 

25,389

 

 

 

11,060

Interest Expense

 

22,495

 

 

 

29,857

 

 

67,921

 

 

 

96,715

 

 

97,769

 

 

 

97,501

 

 

 

126,563

Share-Based Compensation

 

(2,148

)

 

 

3,856

 

 

11,009

 

 

 

13,303

 

 

14,042

 

 

 

16,190

 

 

 

16,336

Severance (1)

 

376

 

 

 

871

 

 

12,327

 

 

 

701

 

 

16,068

 

 

 

901

 

 

 

4,442

Separation Related Charges (2)

 

1,986

 

 

 

5,579

 

 

10,270

 

 

 

18,629

 

 

14,244

 

 

 

36,849

 

 

 

22,602

Securitization Fees

 

3,230

 

 

 

 

 

10,060

 

 

 

 

 

10,060

 

 

 

 

 

 

Loss (Gain) on Sale of Equity Investment

 

 

 

 

 

 

2,200

 

 

 

 

 

2,200

 

 

 

(51,863

)

 

 

Third Party Debt Amendment Charges

 

1,311

 

 

 

 

 

1,530

 

 

 

 

 

1,530

 

 

 

 

 

 

Legal Reserves and Settlements

 

1,182

 

 

 

3,056

 

 

3,200

 

 

 

3,556

 

 

4,165

 

 

 

3,556

 

 

 

4,521

Gains, Losses and Other(3)

 

1,468

 

 

 

611

 

 

(21

)

 

 

748

 

 

4,876

 

 

 

(2,551

)

 

 

5,644

Adjusted EBITDA (Non-GAAP)

$

64,007

 

 

$

86,893

 

$

192,769

 

 

$

272,452

 

$

273,236

 

 

$

383,503

 

 

$

352,919

Covenant Related Adjustments(4)

 

1,800

 

 

 

 

 

16,800

 

 

 

 

 

16,800

 

 

 

 

 

 

Covenant Adjusted EBITDA (Non-GAAP)

$

65,807

 

 

$

86,893

 

$

209,569

 

 

$

272,452

 

$

290,036

 

 

$

383,503

 

 

$

352,919

(1) Please refer to Note 2. Severance, in the Company’s Form 10-Q for the quarter ended June 27, 2025.

 

(2) Separation Related Charges include third-party expenses incurred in connection with the Company’s separation from Aramark on September 30, 2023, and the establishment of stand-alone public company operations. These costs primarily consist of rebranding initiatives, development of stand-alone technology infrastructure, and professional services.

 

(3) Other includes certain costs or income items that are not individually material and do not relate to core business activities.

 

(4) Includes a $15 million bad debt expense adjustment to EBITDA in the fiscal quarter ended March 28, 2025 and an adjustment of $1.8 million for the quarter ended June 27, 2025 related to a write-off of merchandise-in-service. These adjustments are solely for the purposes of determining compliance with the financial covenants in the Company’s credit agreement.

VESTIS CORPORATION

RECONCILIATION OF NON-GAAP MEASURES

FREE CASH FLOW, NET DEBT, NET LEVERAGE RATIO, AND PRO FORMA NET LEVERAGE

(In thousands)

 

 

Three months ended

 

Nine Months Ended

 

June 27, 2025

 

June 28, 2024

 

June 27, 2025

 

June 28, 2024

Net cash provided by operating activities

$

22,864

 

 

$

48,658

 

 

$

33,302

 

 

$

176,200

 

Purchases of property and equipment and other

 

(14,860

)

 

 

(20,962

)

 

 

(43,102

)

 

 

(50,787

)

Free Cash Flow (Non-GAAP)

$

8,004

 

 

$

27,696

 

 

$

(9,800

)

 

$

125,413

 

 

As of

 

June 27, 2025

 

September 27, 2024

Total principal debt outstanding

$

1,170,500

 

 

$

1,162,500

 

Letters of credit outstanding

 

5,698

 

 

 

5,298

 

Finance lease obligations

 

151,874

 

 

 

146,672

 

Less: Cash and cash equivalents

 

(23,743

)

 

 

(31,010

)

Net Debt (Non-GAAP)

$

1,304,329

 

$

1,283,460

 

Trailing Twelve Months Adjusted EBITDA (Non-GAAP)

$

273,236

 

 

$

352,919

 

Covenant Related Adjustments (1)

 

16,800

 

 

 

 

Trailing Twelve Months Covenant Adjusted EBITDA (Non-GAAP)

$

290,036

 

 

$

352,919

 

Net Leverage Ratio (Non-GAAP) (1)

 

4.50

 

 

 

3.64

 

 

(1) Includes a $15 million bad debt expense adjustment to EBITDA in the fiscal quarter ended March 28, 2025 and an adjustment of $1.8 million for the quarter ended June 27, 2025 related to a write-off of merchandise-in-service. These adjustments are solely for the purposes of determining compliance with the financial covenants in the Company’s credit agreement.

 

Investor Contact

Stefan Neely or Bill Seymour

Vallum Advisors

615-844-6248

[email protected]

Media

Danielle Holcomb

470-716-0917

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Supply Chain Management Retail Other Retail Manufacturing Specialty Textiles

MEDIA:

Logo
Logo

Finance of America Reports Second Quarter 2025 Results

Finance of America Reports Second Quarter 2025 Results

– $3.16 in basic earnings per share or $80 million of net income from continuing operations for the quarter –

– $0.55 in adjusted earnings per share(1) or $14 million of adjusted net income(1) for the quarter –

– Entered into an agreement to repurchase the entirety of Blackstone’s equity stake in Finance of America –

PLANO, Texas–(BUSINESS WIRE)–Finance of America Companies Inc. (“Finance of America” or the “Company”)(NYSE: FOA), a leading provider of home equity-based financing solutions for a modern retirement, reported financial results for the quarter ended June 30, 2025.

Second Quarter 2025 Highlights(2)

  • $3.16 in basic earnings per share or $80 million of net income from continuing operations for the quarter.
  • $0.55 in adjusted earnings per share(1) or $14 million of adjusted net income(1) for the quarter.
  • Adjusted EBITDA(1) of $30 million for the quarter.
  • Funded volume of $602 million in the second quarter, exceeding the top end of the stated quarterly guidance and representing a 35% increase in funded volume from the second quarter of 2024.
  • Adjusted net income(1) improved by $14 million compared to the second quarter of 2024 due to increased volumes and reduced operational expenses.
  • Adjusted net income(1) totaled $27 million year to date, compared to a $7 million loss in the first half of 2024, demonstrating the results of the Company’s transformed platform.
  • Total equity increased to $473 million as of June 30, 2025.
  • In early August, repaid higher cost working capital facility and entered into an agreement to repurchase the entirety of Blackstone’s equity stake in Finance of America, reducing interest expense and enhancing financial flexibility.

(1) See the sections titled “Reconciliation to GAAP” and “Non-GAAP Financial Measures” for reconciliations to the most directly comparable GAAP measures and other important disclosures.

(2) The financial information presented in the highlights is for the Company’s continuing operations.

Graham A. Fleming, Chief Executive Officer commented, “Finance of America delivered another strong quarter, funding $602 million in loans and achieving our fifth consecutive quarter of growth. Our second quarter results reflect consistent execution, rising profitability, and the growing relevance of home equity solutions for retirement.

We continue to see encouraging signals from our new brand campaign and digital initiatives, which are helping to expand our reach and deepen engagement with the next generation of borrowers. As demand builds among a rapidly growing demographic, we believe Finance of America will continue to lead this market and deliver long-term value.”

(unaudited)

Second Quarter Financial Summary of Continuing Operations

($ amounts in millions, except per share data)

 

 

 

Variance (%)

 

 

 

Variance (%)

 

 

 

 

 

Variance (%)

 

 

Q2’25

 

Q1’25

 

Q2’25 vs

Q1’25

 

Q2’24

 

Q2’25 vs

Q2’24

 

YTD 2025

 

YTD 2024

 

2025 vs

2024

Funded volume

 

$

602

 

$

561

 

7

%

 

$

447

 

 

35

%

 

$

1,163

 

$

871

 

 

34

%

Total revenues

 

 

177

 

 

166

 

7

%

 

 

79

 

 

124

%

 

 

343

 

 

154

 

 

123

%

Total expenses and other, net

 

 

95

 

 

84

 

13

%

 

 

83

 

 

14

%

 

 

179

 

 

173

 

 

3

%

Pre-tax income (loss) from continuing operations

 

 

82

 

 

82

 

%

 

 

(4

)

 

2,150

%

 

 

164

 

 

(20

)

 

920

%

Net income (loss) from continuing operations

 

 

80

 

 

80

 

%

 

 

(5

)

 

1,700

%

 

 

160

 

 

(21

)

 

862

%

Adjusted net income (loss)(1)

 

 

14

 

 

13

 

8

%

 

 

 

 

N/A

 

 

 

27

 

 

(7

)

 

486

%

Adjusted EBITDA(1)

 

 

30

 

 

29

 

3

%

 

 

10

 

 

200

%

 

 

59

 

 

10

 

 

490

%

Basic earnings (loss) per share

 

$

3.16

 

$

3.17

 

%

 

$

(0.20

)

 

1,680

%

 

$

6.33

 

$

(0.78

)

 

912

%

Diluted earnings (loss) per share(2)

 

$

2.13

 

$

2.56

 

(17

)%

 

$

(0.29

)

 

834

%

 

$

4.69

 

$

(0.88

)

 

633

%

Adjusted earnings (loss) per share(1)

 

$

0.55

 

$

0.52

 

6

%

 

$

 

 

N/A

 

 

$

1.07

 

$

(0.29

)

 

469

%

(1)

See the sections titled “Reconciliation to GAAP” and “Non-GAAP Financial Measures” for reconciliations to the most directly comparable GAAP measures and other important disclosures.

(2)

Calculated using the treasury stock, if-converted, or two-class method, except when anti-dilutive.

Balance Sheet Highlights

($ amounts in millions)(1)

 

June 30,

 

March 31,

 

Variance (%)

 

 

 

2025

 

 

2025

 

Q2’25 vs Q1’25

Cash and cash equivalents

 

$

46

 

$

52

 

(12

)%

Securitized loans held for investment (HMBS & nonrecourse)

 

 

28,747

 

 

28,439

 

1

%

Total assets

 

 

30,147

 

 

29,689

 

2

%

Total liabilities

 

 

29,674

 

 

29,294

 

1

%

Total equity

 

 

473

 

 

395

 

20

%

  • For the quarter, total equity increased from $395 million as of March 31, 2025 to $473 million as of June 30, 2025, an improvement of 20%, reflecting enhanced operational performance and positive fair value adjustments on the Company’s retained interests in securitizations resulting from improving market inputs and model assumptions.
  • Additionally, tangible equity(2) increased from $187 million as of March 31, 2025 to $275 million as of June 30, 2025, an improvement of 47%.

(1)

Numbers may not foot due to rounding.

(2)

See the sections titled “Reconciliation to GAAP” and “Non-GAAP Financial Measures” for reconciliations to the most directly comparable GAAP measures and other important disclosures.

(unaudited)

Segment Results

Retirement Solutions

The Retirement Solutions segment primarily generates revenue and earnings in the form of net origination gains and origination fees earned on the origination of reverse mortgage loans.

 

 

 

 

Variance (%)

 

 

 

Variance (%)

 

 

 

 

 

Variance (%)

($ amounts in millions)

 

Q2’25

 

Q1’25

 

Q2’25 vs

Q1’25

 

Q2’24

 

Q2’25 vs

Q2’24

 

YTD 2025

 

YTD 2024

 

2025 vs

2024

Funded volume

 

$

602

 

$

561

 

7

%

 

$

447

 

 

35

%

 

$

1,163

 

$

871

 

 

34

%

Total revenue

 

 

62

 

 

52

 

19

%

 

 

47

 

 

32

%

 

 

114

 

 

93

 

 

23

%

Pre-tax income (loss)

 

 

10

 

 

3

 

233

%

 

 

(2

)

 

600

%

 

 

14

 

 

(6

)

 

333

%

Adjusted net income(1)

 

 

15

 

 

9

 

67

%

 

 

7

 

 

114

%

 

 

24

 

 

11

 

 

118

%

(1)

See the sections titled “Reconciliation to GAAP” and “Non-GAAP Financial Measures” for reconciliations to the most directly comparable GAAP measures and other important disclosures.

  • For the quarter, the segment recognized pre-tax income of $10 million and adjusted net income of $15 million as a result of increased volumes and improved margins compared to the prior quarter.
  • Compared to the second quarter of 2024, total revenue increased by 32%, primarily due to an increase in funded volume, which led to a 600% improvement in pre-tax income and a 114% improvement in adjusted net income.
  • Year to date, the segment recognized pre-tax income of $14 million versus a pre-tax loss of $6 million in the first half of 2024, a 333% improvement driven by a 34% increase in funded volumes and stable expense levels.

Portfolio Management

The Portfolio Management segment primarily generates revenue and earnings in the form of net interest income and fair value changes on our portfolio assets, monetized through securitization, sale, or other financing of those assets.

 

 

 

 

Variance (%)

 

 

 

Variance (%)

 

 

 

 

 

Variance (%)

($ amounts in millions)

 

Q2’25

 

Q1’25

 

Q2’25 vs

Q1’25

 

Q2’24

 

Q2’25 vs Q2’24

 

YTD 2025

 

YTD 2024

 

2025 vs

2024

Assets under management

 

$

29,907

 

$

29,418

 

2

%

 

$

27,655

 

8

%

 

$

29,907

 

$

27,655

 

8

%

Assets excluding HMBS and nonrecourse obligations

 

 

1,838

 

 

1,664

 

10

%

 

 

1,624

 

13

%

 

 

1,838

 

 

1,624

 

13

%

Total revenue

 

 

130

 

 

129

 

1

%

 

 

41

 

217

%

 

 

259

 

 

79

 

228

%

Pre-tax income

 

 

108

 

 

105

 

3

%

 

 

22

 

391

%

 

 

213

 

 

36

 

492

%

Adjusted net income(1)

 

 

16

 

 

20

 

(20

)%

 

 

12

 

33

%

 

 

37

 

 

17

 

118

%

(1)

See the sections titled “Reconciliation to GAAP” and “Non-GAAP Financial Measures” for reconciliations to the most directly comparable GAAP measures and other important disclosures.

  • For the quarter, the segment recognized pre-tax income of $108 million, an improvement against the prior quarter and second quarter of 2024 due to positive fair value adjustments on retained interests in securitizations, resulting from changes in market inputs and model assumptions, combined with an increase in accreted yield on the Company’s residual interests.
  • Year to date adjusted net income increased 118% to $37 million compared to $17 million in the same period in 2024.
 

Finance of America Companies Inc.

Selected Financial Information

Condensed Consolidated Statements of Financial Condition

(in thousands, except share data)

(unaudited)

 

 

June 30, 2025

 

March 31, 2025

ASSETS

 

 

 

Cash and cash equivalents

$

46,476

 

 

$

52,016

 

Restricted cash

 

190,176

 

 

 

199,836

 

Loans held for investment, subject to HMBS related obligations, at fair value

 

18,858,220

 

 

 

18,809,023

 

Loans held for investment, subject to nonrecourse debt, at fair value

 

9,888,492

 

 

 

9,630,150

 

Loans held for investment, at fair value

 

634,935

 

 

 

634,104

 

Intangible assets, net

 

198,209

 

 

 

207,506

 

Other assets, net

 

329,677

 

 

 

154,285

 

Assets of discontinued operations

 

1,264

 

 

 

1,936

 

TOTAL ASSETS

$

30,147,449

 

 

$

29,688,856

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

HMBS related obligations, at fair value

$

18,643,094

 

 

$

18,590,357

 

Nonrecourse debt, at fair value

 

9,426,194

 

 

 

9,163,399

 

Other financing lines of credit

 

1,076,434

 

 

 

1,008,894

 

Notes payable, net (includes amounts due to related parties of $162,283 as of both June 30, 2025 and March 31, 2025)

 

383,941

 

 

 

379,159

 

Payables and other liabilities

 

139,350

 

 

 

140,709

 

Liabilities of discontinued operations

 

5,011

 

 

 

11,452

 

TOTAL LIABILITIES

 

29,674,024

 

 

 

29,293,970

 

 

 

 

 

EQUITY

 

 

 

Class A Common Stock, $0.0001 par value; 6,000,000,000 shares authorized; 11,502,488 and 11,137,524 shares issued, respectively, and 11,076,638 and 10,711,674 shares outstanding, respectively

 

1

 

 

 

1

 

Class B Common Stock, $0.0001 par value; 1,000,000 shares authorized; 14 shares issued and outstanding, respectively

 

 

 

 

 

Additional paid-in capital

 

959,306

 

 

 

961,044

 

Accumulated deficit

 

(633,763

)

 

 

(668,686

)

Accumulated other comprehensive loss

 

(283

)

 

 

(285

)

Noncontrolling interest

 

148,164

 

 

 

102,812

 

TOTAL EQUITY

 

473,425

 

 

 

394,886

 

TOTAL LIABILITIES AND EQUITY

$

30,147,449

 

 

$

29,688,856

 

 

Finance of America Companies Inc.

Selected Financial Information

Condensed Consolidated Statements of Operations

(in thousands, except share data)

(unaudited)

 

 

Q2’25

 

Q1’25

 

Q2’24

 

YTD 2025

 

YTD 2024

PORTFOLIO INTEREST INCOME

 

 

 

 

 

 

 

 

 

Interest income

$

481,800

 

 

$

480,602

 

 

$

478,091

 

 

$

962,402

 

 

$

942,070

 

Interest expense

 

(422,336

)

 

 

(410,167

)

 

 

(412,618

)

 

 

(832,503

)

 

 

(806,422

)

NET PORTFOLIO INTEREST INCOME

 

59,464

 

 

 

70,435

 

 

 

65,473

 

 

 

129,899

 

 

 

135,648

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

Net origination gains

 

56,058

 

 

 

46,038

 

 

 

40,260

 

 

 

102,096

 

 

 

79,917

 

Gain on securitization of HECM tails, net

 

10,855

 

 

 

10,481

 

 

 

11,031

 

 

 

21,336

 

 

 

21,757

 

Fair value changes from model amortization

 

(35,456

)

 

 

(40,956

)

 

 

(47,813

)

 

 

(76,412

)

 

 

(105,421

)

Fair value changes from market inputs or model assumptions

 

94,939

 

 

 

88,263

 

 

 

11,260

 

 

 

183,202

 

 

 

24,822

 

Net fair value changes on loans and related obligations

 

126,396

 

 

 

103,826

 

 

 

14,738

 

 

 

230,222

 

 

 

21,075

 

Fee income

 

6,739

 

 

 

6,346

 

 

 

8,096

 

 

 

13,085

 

 

 

14,418

 

Non-funding interest expense, net

 

(15,223

)

 

 

(14,912

)

 

 

(9,268

)

 

 

(30,135

)

 

 

(17,420

)

NET OTHER INCOME (EXPENSE)

 

117,912

 

 

 

95,260

 

 

 

13,566

 

 

 

213,172

 

 

 

18,073

 

 

 

 

 

 

 

 

 

 

 

TOTAL REVENUES

 

177,376

 

 

 

165,695

 

 

 

79,039

 

 

 

343,071

 

 

 

153,721

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

Salaries, benefits, and related expenses

 

36,974

 

 

 

33,930

 

 

 

35,053

 

 

 

70,904

 

 

 

74,076

 

Loan production and portfolio related expenses

 

9,462

 

 

 

11,330

 

 

 

5,662

 

 

 

20,792

 

 

 

14,275

 

Loan servicing expenses

 

7,525

 

 

 

7,741

 

 

 

7,632

 

 

 

15,266

 

 

 

15,850

 

Marketing and advertising expenses

 

12,265

 

 

 

10,731

 

 

 

10,706

 

 

 

22,996

 

 

 

19,218

 

Depreciation and amortization

 

9,654

 

 

 

9,658

 

 

 

9,753

 

 

 

19,312

 

 

 

19,431

 

General and administrative expenses

 

13,180

 

 

 

12,979

 

 

 

16,241

 

 

 

26,159

 

 

 

33,512

 

TOTAL EXPENSES

 

89,060

 

 

 

86,369

 

 

 

85,047

 

 

 

175,429

 

 

 

176,362

 

IMPAIRMENT OF OTHER ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

(600

)

OTHER, NET

 

(6,361

)

 

 

2,367

 

 

 

2,240

 

 

 

(3,994

)

 

 

3,693

 

NET INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

81,955

 

 

 

81,693

 

 

 

(3,768

)

 

 

163,648

 

 

 

(19,548

)

Provision for income taxes from continuing operations

 

2,132

 

 

 

1,943

 

 

 

1,153

 

 

 

4,075

 

 

 

1,153

 

NET INCOME (LOSS) FROM CONTINUING OPERATIONS

 

79,823

 

 

 

79,750

 

 

 

(4,921

)

 

 

159,573

 

 

 

(20,701

)

NET LOSS FROM DISCONTINUED OPERATIONS

 

 

 

 

(4,750

)

 

 

(203

)

 

 

(4,750

)

 

 

(4,727

)

NET INCOME (LOSS)

 

79,823

 

 

 

75,000

 

 

 

(5,124

)

 

 

154,823

 

 

 

(25,428

)

Noncontrolling interest

 

44,900

 

 

 

44,791

 

 

 

(3,035

)

 

 

89,691

 

 

 

(15,801

)

NET INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTEREST

$

34,923

 

 

$

30,209

 

 

$

(2,089

)

 

$

65,132

 

 

$

(9,627

)

 

 

 

 

 

 

 

 

 

 

EARNINGS (LOSS) PER SHARE

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

11,041,337

 

 

 

10,177,266

 

 

 

9,898,182

 

 

 

10,611,689

 

 

 

9,773,370

 

Basic earnings (loss) per share from continuing operations

$

3.16

 

 

$

3.17

 

 

$

(0.20

)

 

$

6.33

 

 

$

(0.78

)

Basic earnings (loss) per share

$

3.16

 

 

$

2.97

 

 

$

(0.21

)

 

$

6.14

 

 

$

(0.99

)

Diluted weighted average shares outstanding

 

30,137,247

 

 

 

30,167,024

 

 

 

23,084,189

 

 

 

30,152,054

 

 

 

23,013,742

 

Diluted earnings (loss) per share from continuing operations

$

2.13

 

 

$

2.56

 

 

$

(0.29

)

 

$

4.69

 

 

$

(0.88

)

Diluted earnings (loss) per share

$

2.13

 

 

$

2.43

 

 

$

(0.30

)

 

$

4.56

 

 

$

(1.06

)

(unaudited)

Reconciliation to GAAP

($ amounts in millions)(1)

Q2’25

 

Q1’25

 

Q2’24

 

YTD 2025

 

YTD 2024

Reconciliation of net income (loss) from continuing operations to adjusted net income (loss) and adjusted EBITDA

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations

$

80

 

 

$

80

 

 

$

(5

)

 

$

160

 

 

$

(21

)

Add back: Provision for income taxes

 

(2

)

 

 

(2

)

 

 

(1

)

 

 

(4

)

 

 

(1

)

Net income (loss) from continuing operations before taxes

 

82

 

 

 

82

 

 

 

(4

)

 

 

164

 

 

 

(20

)

Adjustments for:

 

 

 

 

 

 

 

 

 

Changes in fair value(2)

 

(76

)

 

 

(76

)

 

 

(8

)

 

 

(151

)

 

 

(18

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

9

 

 

 

9

 

 

 

9

 

 

 

19

 

 

 

20

 

Equity-based compensation(4)

 

3

 

 

 

2

 

 

 

1

 

 

 

5

 

 

 

6

 

Certain non-recurring costs(5)

 

1

 

 

 

 

 

 

2

 

 

 

1

 

 

 

3

 

Adjusted net income (loss) before taxes

 

19

 

 

 

18

 

 

 

 

 

 

37

 

 

 

(9

)

Benefit (provision) for income taxes(6)

 

(5

)

 

 

(5

)

 

 

 

 

 

(10

)

 

 

2

 

Adjusted net income (loss)

 

14

 

 

 

13

 

 

 

 

 

 

27

 

 

 

(7

)

Provision (benefit) for income taxes(6)

 

5

 

 

 

5

 

 

 

 

 

 

10

 

 

 

(2

)

Depreciation

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

Interest expense on non-funding debt

 

11

 

 

 

11

 

 

 

10

 

 

 

22

 

 

 

18

 

Adjusted EBITDA

$

30

 

 

$

29

 

 

$

10

 

 

$

59

 

 

$

10

 

 

 

 

 

 

 

 

 

 

 

($ amounts in millions except shares and $ per share)

Q2’25

 

Q1’25

 

Q2’24

 

YTD 2025

 

YTD 2024

GAAP PER SHARE MEASURES

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations attributable to controlling interest

$

35

 

 

$

32

 

 

$

(2

)

 

$

67

 

 

$

(8

)

Weighted average outstanding share count

 

11,041,337

 

 

 

10,177,266

 

 

 

9,898,182

 

 

 

10,611,689

 

 

 

9,773,370

 

Basic earnings (loss) per share from continuing operations

$

3.16

 

 

$

3.17

 

 

$

(0.20

)

 

$

6.33

 

 

$

(0.78

)

If-converted method net income (loss) from continuing operations

$

64

 

 

$

77

 

 

$

(7

)

 

$

141

 

 

$

(20

)

Weighted average diluted share count

 

30,137,247

 

 

 

30,167,024

 

 

 

23,084,189

 

 

 

30,152,054

 

 

 

23,013,742

 

Diluted earnings (loss) per share from continuing operations(7)

$

2.13

 

 

$

2.56

 

 

$

(0.29

)

 

$

4.69

 

 

$

(0.88

)

 

 

 

 

 

 

 

 

 

 

NON-GAAP PER SHARE MEASURES

 

 

 

 

 

 

 

 

 

Adjusted net income (loss)

$

14

 

 

$

13

 

 

$

 

 

$

27

 

 

$

(7

)

Exchangeable senior secured notes interest expense(8)

 

3

 

 

 

3

 

 

 

 

 

 

5

 

 

 

 

Total

$

17

 

 

$

16

 

 

$

 

 

$

32

 

 

$

(7

)

Weighted average share count

 

30,137,247

 

 

 

30,167,024

 

 

 

23,084,189

 

 

 

30,152,054

 

 

 

23,013,742

 

Adjusted earnings (loss) per share

$

0.55

 

 

$

0.52

 

 

$

 

 

$

1.07

 

 

$

(0.29

)

 

June 30, 2025

 

March 31, 2025

Total equity

$

473

 

$

395

Less: Intangible assets, net

 

198

 

 

208

Tangible equity

$

275

 

$

187

(1)

Totals may not foot due to rounding.

(2)

Changes in fair value include changes in fair value of loans and securities held for investment and related obligations due to market inputs or model assumptions, deferred purchase price obligations, contingent earnout, warrant liability, and the exchange of our senior notes.

(3)

Includes amortization or impairment of intangibles and impairment of certain other long-lived assets.

(4)

Beginning with the third quarter of 2024, the Company revised our definitions of adjusted net income (loss), adjusted EBITDA, and adjusted earnings (loss) per share to now adjust for all equity-based compensation in this line item, excluding forfeitures and accelerations associated with restructuring activities, which are included in certain non-recurring costs. Prior to the third quarter of 2024, only equity-based compensation for Replacement Restricted Stock Units (“RSUs”) and Earnout Right RSUs were included in our adjustments. As a result of this change, prior period amounts have been recast to reflect the updated presentation. Adjusted net loss decreased $1 million and $2 million for the three and six months ended June 30, 2024, respectively, from what was previously reported. The change also resulted in a decrease to adjusted loss per share of $0.05 and $0.08 for the three and six months ended June 30, 2024, respectively, from what was previously reported.

(5)

Reflects certain non-recurring costs and adjustments that management believes should be excluded as these do not relate to a recurring part of the core business operations. These items include amounts recognized for settlement of legal and regulatory matters, acquisition or divestiture-related expenses, and other one-time charges.

(6)

Income tax provision (benefit) adjustments to apply an effective combined corporate tax rate to adjusted net income (loss) before taxes.

(7)

Calculated using the treasury stock, if-converted, or two-class method, except when anti-dilutive.

(8)

Interest expense on the exchangeable senior secured notes, net of a tax effect, if dilutive, is added to adjusted net income (loss) to calculate adjusted earnings (loss) per share.

(unaudited)

Adjusted Net Income by Segment (Continuing Operations)

 

 

For the three months ended June 30, 2025

 

 

($ amounts in millions except shares and $ per share)(1)

Retirement

Solutions

Portfolio

Management

Corporate &

Other

FOA

Pre-tax income (loss)

$

10

$

108

 

$

(37

)

$

82

 

Adjustments for:

 

 

 

 

Changes in fair value(2)

 

 

(86

)

 

11

 

 

(76

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

9

 

 

 

 

 

9

 

Equity-based compensation(4)

 

 

 

 

2

 

 

3

 

Certain non-recurring costs(5)

 

 

 

 

1

 

 

1

 

Adjusted net income (loss) before taxes

$

20

$

22

 

$

(23

)

$

19

 

Provision (benefit) for income taxes(6)

 

5

 

6

 

 

(6

)

 

5

 

Adjusted net income (loss)

$

15

$

16

 

$

(17

)

$

14

 

Exchangeable senior secured notes interest expense(7)

 

 

 

 

3

 

 

3

 

Total

$

15

$

16

 

$

(14

)

$

17

 

Weighted average share count

 

30,137,247

 

30,137,247

 

 

30,137,247

 

 

30,137,247

 

Adjusted earnings (loss) per share

$

0.49

$

0.54

 

$

(0.47

)

$

0.55

 

 

 

For the three months ended March 31, 2025

 

 

($ amounts in millions except shares and $ per share)(1)

Retirement

Solutions

Portfolio

Management

Corporate &

Other

FOA

Pre-tax income (loss)

$

3

$

105

 

$

(27

)

$

82

 

Adjustments for:

 

 

 

 

Changes in fair value(2)

 

 

(78

)

 

2

 

 

(76

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

9

 

 

 

 

 

9

 

Equity-based compensation(4)

 

 

 

 

2

 

 

2

 

Adjusted net income (loss) before taxes

$

13

$

28

 

$

(23

)

$

18

 

Provision (benefit) for income taxes(6)

 

4

 

7

 

 

(6

)

 

5

 

Adjusted net income (loss)

$

9

$

20

 

$

(17

)

$

13

 

Exchangeable senior secured notes interest expense(7)

 

 

 

 

3

 

 

3

 

Total

$

9

$

20

 

$

(14

)

$

16

 

Weighted average share count

 

30,167,024

 

30,167,024

 

 

30,167,024

 

 

30,167,024

 

Adjusted earnings (loss) per share

$

0.31

$

0.68

 

$

(0.47

)

$

0.52

 

 

 

For the three months ended June 30, 2024

 

 

($ amounts in millions except shares and $ per share)(1)

Retirement

Solutions

Portfolio

Management

Corporate &

Other

FOA

Pre-tax income (loss)

$

(2

)

$

22

 

$

(24

)

$

(4

)

Adjustments for:

 

 

 

 

Changes in fair value(2)

 

 

 

(6

)

 

(2

)

 

(8

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

9

 

 

 

 

 

 

9

 

Equity-based compensation(4)

 

 

 

 

 

1

 

 

1

 

Certain non-recurring costs(5)

 

1

 

 

 

 

1

 

 

2

 

Adjusted net income (loss) before taxes

$

9

 

$

16

 

$

(24

)

$

 

Provision (benefit) for income taxes(6)

 

2

 

 

4

 

 

(6

)

 

 

Adjusted net income (loss)

$

7

 

$

12

 

$

(18

)

$

 

Weighted average share count

 

23,084,189

 

 

23,084,189

 

 

23,084,189

 

 

23,084,189

 

Adjusted earnings (loss) per share

$

0.27

 

$

0.52

 

$

(0.77

)

$

 

 

 

For the six months ended June 30, 2025

 

 

($ amounts in millions except shares and $ per share)(1)

Retirement

Solutions

Portfolio

Management

Corporate &

Other

FOA

Pre-tax income (loss)

$

14

$

213

 

$

(63

)

$

164

 

Adjustments for:

 

 

 

 

Changes in fair value(2)

 

 

(164

)

 

13

 

 

(151

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

19

 

 

 

 

 

19

 

Equity-based compensation(4)

 

 

 

 

4

 

 

5

 

Certain non-recurring costs(5)

 

 

 

 

1

 

 

1

 

Adjusted net income (loss) before taxes

$

33

$

50

 

$

(46

)

$

37

 

Provision (benefit) for income taxes(6)

 

9

 

13

 

 

(12

)

 

10

 

Adjusted net income (loss)

$

24

$

37

 

$

(34

)

$

27

 

Exchangeable senior secured notes interest expense(7)

 

 

 

 

5

 

 

5

 

Total

$

24

$

37

 

$

(29

)

$

32

 

Weighted average share count

 

30,152,054

 

30,152,054

 

 

30,152,054

 

 

30,152,054

 

Adjusted earnings (loss) per share

$

0.80

$

1.21

 

$

(0.95

)

$

1.07

 

 

 

For the six months ended June 30, 2024

 

 

($ amounts in millions except shares and $ per share)(1)

Retirement

Solutions

Portfolio

Management

Corporate &

Other

FOA

Pre-tax income (loss)

$

(6

)

$

36

 

$

(50

)

$

(20

)

Adjustments for:

 

 

 

 

Changes in fair value(2)

 

 

 

(14

)

 

(4

)

 

(18

)

Amortization or impairment of intangibles and impairment of other assets(3)

 

19

 

 

 

 

1

 

 

20

 

Equity-based compensation(4)

 

1

 

 

 

 

4

 

 

6

 

Certain non-recurring costs(5)

 

1

 

 

 

 

2

 

 

3

 

Adjusted net income (loss) before taxes

$

15

 

$

23

 

$

(47

)

$

(9

)

Provision (benefit) for income taxes(6)

 

4

 

 

6

 

 

(12

)

 

(2

)

Adjusted net income (loss)

$

11

 

$

17

 

$

(35

)

$

(7

)

Weighted average share count

 

23,013,742

 

 

23,013,742

 

 

23,013,742

 

 

23,013,742

 

Adjusted earnings (loss) per share

$

0.48

 

$

0.74

 

$

(1.52

)

$

(0.29

)

(1)

Totals may not foot due to rounding.

(2)

Changes in fair value include changes in fair value of loans and securities held for investment and related obligations due to market inputs or model assumptions, deferred purchase price obligations, contingent earnout, warrant liability, and the exchange of our senior notes.

(3)

Includes amortization or impairment of intangibles and impairment of certain other long-lived assets.

(4)

Beginning with the third quarter of 2024, the Company revised our definitions of adjusted net income (loss), adjusted EBITDA, and adjusted earnings (loss) per share to now adjust for all equity-based compensation in this line item, excluding forfeitures and accelerations associated with restructuring activities, which are included in certain non-recurring costs. Prior to the third quarter of 2024, only equity-based compensation for Replacement RSUs and Earnout Right RSUs were included in our adjustments. As a result of this change, prior period amounts have been recast to reflect the updated presentation. Adjusted net loss decreased $1 million and $2 million for the three and six months ended June 30, 2024, respectively, from what was previously reported. The change also resulted in a decrease to adjusted loss per share of $0.05 and $0.08 for the three and six months ended June 30, 2024, respectively, from what was previously reported.

(5)

Reflects certain non-recurring costs and adjustments that management believes should be excluded as these do not relate to a recurring part of the core business operations. These items include amounts recognized for settlement of legal and regulatory matters, acquisition or divestiture-related expenses, and other one-time charges.

(6)

Income tax provision (benefit) adjustments to apply an effective combined corporate tax rate to adjusted net income (loss) before taxes.

(7)

Interest expense on the exchangeable senior secured notes, net of a tax effect, if dilutive, is added to adjusted net income (loss) to calculate adjusted earnings (loss) per share.

Webcast and Conference Call

Management will host a webcast and conference call on Tuesday, August 5th at 5:00 pm Eastern Time to discuss the Company’s results for the second quarter ended June 30, 2025. A copy of this press release will be posted prior to the call under the “Investors” section on Finance of America’s website at https://ir.financeofamericacompanies.com/.

To listen to the audio webcast of the conference call, please visit the “Investors” section of the Company’s website at https://ir.financeofamericacompanies.com/. The conference call can also be accessed by dialing the following:

  1. 1-800-715-9871 (Domestic)

  2. 1-646-307-1963 (International)

  3. Conference ID: 5706924

Replay

A replay of the call will also be available on the Company’s website approximately two hours after the conclusion of the conference call until August 12, 2025. To access the replay, visit the “Investors” section of the Company’s website at https://ir.financeofamericacompanies.com/. The replay can also be accessed by dialing 1-800-770-2030 (United States) or 1-609-800-9909 (International). The replay pin number is 5706924.

About Finance of America

Finance of America (NYSE: FOA) is a leading provider of home equity-based financing solutions for a modern retirement. In addition, Finance of America offers capital markets and portfolio management capabilities primarily to optimize the distribution of its originated loans to investors. Finance of America is headquartered in Plano, Texas.

To learn more about Finance of America Companies Inc., please visit our investor-oriented website at www.financeofamericacompanies.com and our consumer-oriented website at www.financeofamerica.com.

Forward-Looking Statements

This release includes forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These statements include, but are not limited to, statements related to our expectations regarding our repurchase of Blackstone’s equity stake and related transactions and our ability to realize the anticipated benefits of these transactions, the performance of our business, our financial results, our liquidity and capital resources, and other non-historical statements. In some cases, you can identify these forward-looking statements by the use of words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “budgets,” “forecasts,” “anticipates,” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties that could cause actual outcomes or results to differ materially from those indicated in these statements, including those risks described below. Given the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the results or conditions described in such statements or the Company’s objectives and plans will be achieved. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release. Results for any specified quarter are not necessarily indicative of the results that may be expected for the full year or any future period. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. All subsequent written and oral forward-looking statements concerning the Company or other matters and attributable to the Company or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. A number of important factors exist that could cause future results to differ materially from historical performance and these forward-looking statements. Factors that might cause such a difference include, but are not limited to, those factors indicated in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”).

All of these factors are difficult to predict, contain uncertainties that may materially affect actual results, and may be beyond our control. New factors emerge from time to time, and it is not possible for our management to predict all such factors or to assess the effect of each such new factor on our business. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and any of these statements included herein may prove to be inaccurate. Please refer to “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 14, 2025, as amended by Amendment No. 1 to our Annual Report on Form 10-K/A, filed with the SEC on May 20, 2025, for further information on risk factors affecting us, as such factors may be amended and updated from time to time in the Company’s subsequent periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov.

Non-GAAP Financial Measures

The Company’s management evaluates performance of the Company through the use of certain measures that are not prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), including adjusted net income (loss), adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”), adjusted earnings (loss) per share, and tangible equity.

The presentation of non-GAAP measures is used to enhance investors’ understanding of certain aspects of our financial performance. This discussion is not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with U.S. GAAP. Management believes these key financial measures provide an additional view of our performance over the long-term and provide useful information that we use in order to maintain and grow our business.

These non-GAAP financial measures should not be considered as an alternative to net income (loss), operating cash flows, or any other performance measures determined in accordance with U.S. GAAP. Adjusted net income (loss), adjusted EBITDA, adjusted earnings (loss) per share, and tangible equity have important limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of the limitations of these metrics are: (i) cash expenditures for future contractual commitments; (ii) cash requirements for working capital needs; (iii) cash requirements for certain tax payments; and (iv) all non-cash income/expense items.

Because of these limitations, adjusted net income (loss), adjusted EBITDA, adjusted earnings (loss) per share, and tangible equity should not be considered as measures of discretionary cash available to us to invest in the growth of our business or distribute to shareholders. We compensate for these limitations by relying primarily on our U.S. GAAP results and using our non-GAAP financial measures only as a supplement. Users of our condensed consolidated financial statements are cautioned not to place undue reliance on our non-GAAP financial measures.

Change in Non-GAAP Measures

Prior to the third quarter of 2024, the Company’s adjusted net income (loss), adjusted EBITDA, and adjusted earnings (loss) per share were adjusted for equity-based compensation for only the Replacement RSUs and Earnout Right RSUs. Beginning with the third quarter of 2024, the Company revised our definitions of adjusted net income (loss), adjusted EBITDA, and adjusted earnings (loss) per share to now adjust for all equity-based compensation in the aforementioned non-GAAP measures. As a result of the change, prior period amounts have been recast to reflect the updated presentation.

Subsequent to granting the Replacement RSUs and Earnout Right RSUs, the Company has granted other equity-based awards. As these awards are non-cash expenses that are not directly correlated with operating results, the Company believes that analysts, investors, and other users of the financial statements may find this change beneficial when analyzing our operating performance and comparability to peers.

Adjusted Net Income (Loss)

We define adjusted net income (loss) as net income (loss) from continuing operations adjusted for:

  1. Income taxes

  2. Changes in fair value of loans and securities held for investment and related obligations due to market inputs or model assumptions, deferred purchase price obligations, contingent earnout, warrant liability, and the exchange of our senior notes.

  3. Amortization or impairment of intangibles and impairment of certain other long-lived assets.

  4. Equity-based compensation, excluding forfeitures and accelerations associated with restructuring activities, which are included in certain non-recurring costs.

  5. Certain non-recurring costs and adjustments that management believes should be excluded as these do not relate to a recurring part of the core business operations. These items include amounts recognized for settlement of legal and regulatory matters, acquisition or divestiture-related expenses, and other one-time charges.

  6. Income tax benefit (provision) adjustments to apply an effective combined corporate tax rate to adjusted net income (loss) before income taxes.

Management considers adjusted net income (loss) important in evaluating our Company as a whole. This supplemental metric is utilized by our management team to assess the underlying key drivers and operational performance of the continuing operations of the business. In addition, analysts, investors, and creditors may use this measure when analyzing our operating performance and comparability to peers. Adjusted net income (loss) is not a presentation made in accordance with U.S. GAAP, and our definition and use of this measure may vary from other companies in our industry.

Adjusted net income (loss) provides visibility to the underlying operating performance by excluding the impact of certain items that management does not believe are representative of our core earnings. Adjusted net income (loss) may also include other adjustments, as applicable, based upon facts and circumstances, consistent with our intent of providing a supplemental means of evaluating our operating performance.

Adjusted EBITDA

We define adjusted EBITDA as net income (loss) from continuing operations adjusted for:

  1. Income taxes

  2. Changes in fair value of loans and securities held for investment and related obligations due to market inputs or model assumptions, deferred purchase price obligations, contingent earnout, warrant liability, and the exchange of our senior notes.

  3. Amortization or impairment of intangibles and impairment of certain other long-lived assets.

  4. Equity-based compensation, excluding forfeitures and accelerations associated with restructuring activities, which are included in certain non-recurring costs.

  5. Certain non-recurring costs and adjustments that management believes should be excluded as these do not relate to a recurring part of the core business operations. These items include amounts recognized for settlement of legal and regulatory matters, acquisition or divestiture-related expenses, and other one-time charges.

  6. Depreciation

  7. Interest expense on non-funding debt, excluding amortization of the discount related to our senior notes.

Management considers adjusted EBITDA important in evaluating the Company as a whole. This supplemental metric is utilized by our management team to assess the underlying key drivers and operational performance of the continuing operations of the business. In addition, analysts, investors, and creditors may use this measure when analyzing our operating performance and comparability to peers. Adjusted EBITDA is not a presentation made in accordance with U.S. GAAP, and our definition and use of this measure may vary from other companies in our industry.

Adjusted EBITDA provides visibility to the underlying operating performance by excluding the impact of certain items that management does not believe are representative of our core earnings. Adjusted EBITDA may also include other adjustments, as applicable, based upon facts and circumstances, consistent with our intent of providing a supplemental means of evaluating our operating performance.

Adjusted Earnings (Loss) Per Share

We define adjusted earnings (loss) per share as adjusted net income (loss) (defined above) plus interest expense on the exchangeable senior secured notes, net of a tax effect, if dilutive, divided by the weighted average shares outstanding, which includes outstanding Class A Common Stock plus the Class A Units of Finance of America Equity Capital owned by the noncontrolling interest on an if-converted basis, the exchange of the exchangeable senior secured notes on an if-converted basis if they are dilutive, and any shares under the treasury stock method.

Management considers adjusted earnings (loss) per share important in evaluating the Company as a whole. This supplemental metric is utilized by our management team to assess the underlying key drivers and operational performance of the continuing operations of the business. In addition, analysts, investors, and creditors may use this measure when analyzing our operating performance and comparability to peers. Adjusted earnings (loss) per share is not a presentation made in accordance with U.S. GAAP, and our definition and use of this measure may vary from other companies in our industry.

Tangible Equity

We define tangible equity as total equity less intangible assets, net. Management uses this metric to evaluate the Company’s capital strength exclusive of intangible assets. We believe this measure is useful to analysts, investors, and creditors as it provides additional insight into the underlying equity position of the business. Tangible equity is not a presentation made in accordance with U.S. GAAP, and our definition and use of this measure may vary from other companies in our industry.

Tangible equity provides visibility to the underlying capital position by excluding the impact of certain items that management does not believe are representative of our core equity base. Tangible equity may also include other adjustments, as applicable, based upon facts and circumstances, consistent with our intent of providing a supplemental means of evaluating our financial strength.

For Finance of America Media: [email protected]

For Finance of America Investor Relations: [email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Professional Services Consumer Other Construction & Property Residential Building & Real Estate Seniors Finance Construction & Property

MEDIA:

Logo
Logo

Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update


Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC phase 2 trial demonstrates 63% response rate observed among 43 evaluable patients and 79% overall survival rate at 12-months

– Based on the Company’s current operating plan, existing cash, cash equivalents, including successful public offering raising $345M gross proceeds, and marketable securities expected to fund Merus’ operations at least into 2028

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced financial results for the second quarter and provided a business update.

“We were excited to share the unprecedented efficacy of petosemtamab with pembrolizumab in first-line head and neck cancer at 2025 ASCO®, and were thrilled by the response from clinicians and KOLs, which we believe continues to drive strong phase 3 site activation and support our expectation that both phase 3 trials will be substantially enrolled by year end 2025,” said Bill Lundberg, M.D., President, Chief Executive Officer of Merus. “Additionally, I believe these data substantially enhance the likelihood of clinical success of petosemtamab. We are looking forward to providing initial clinical data on mCRC in the second half of 2025.”


Petosemtamab (MCLA-158: EGFR x LGR5 Biclonics®): Solid Tumors


LiGeR-HN1 phase 3 trial in 1L recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC) and LiGeR-HN2 phase 3 trial in 2/3L r/m HNSCC enrolling – with both trials expected to be substantially enrolled by YE25 and potential top line interim readout for one or both trials in 2026; phase 2 trial in 1L, 2L and 3L+ metastatic colorectal cancer (mCRC) enrolling; mCRC initial clinical data planned for 2H25

Merus provided updated interim clinical data from the phase 2 trial of petosemtamab with pembrolizumab as 1L treatment for PD-L1+ (CPS≥1) r/m HNSCC at the 2025 American Society of Clinical Oncology® (ASCO®) Annual Meeting, demonstrating a 63% response rate among 43 evaluable patients and a 79% overall survival rate at 12 months. The presentation was detailed in our press release, Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC (May 22, 2025).

LiGeR-HN1, a phase 3 trial evaluating the efficacy and safety of petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC compared to pembrolizumab, and LiGeR-HN2, a phase 3 trial evaluating the efficacy and safety of petosemtamab in 2/3L HNSCC compared to standard of care, are enrolling and we expect both trials to be substantially enrolled by YE25.

Merus believes a randomized registration trial in HNSCC with an overall response rate endpoint could potentially support accelerated approval and the overall survival results from the same study could potentially verify its clinical benefit to support regular approval for the Company’s phase 3 trial in 1L, and in phase 3 trial in 2/3L HNSCC. We expect to provide topline interim readout of one or both phase 3 registration trials in 2026.   

In February 2025, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to petosemtamab in combination with pembrolizumab for the first-line treatment of adult patients with recurrent or metastatic programmed death-ligand 1 (PD-L1) positive HNSCC with combined positive score (CPS) ≥ 1. This designation was detailed in our press release, Petosemtamab Granted Breakthrough Therapy Designation by the U.S. FDA for 1L PD-L1 Positive Head and Neck Squamous Cell Carcinoma (February 18, 2025). BTD was also granted for petosemtamab monotherapy for the treatment of patients with recurrent or metastatic HNSCC whose disease has progressed following treatment with platinum based chemotherapy and an anti-programmed cell death receptor-1 (PD-1) or anti-programmed death ligand 1 (PD-L1) antibody, detailed in our press release, Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA (May 13, 2024).

Merus provided updated interim clinical data on petosemtamab monotherapy in 2L+ r/m HNSCC at the European Society for Medical Oncology Asia Congress, demonstrating a 36% response rate among 75 evaluable patients. The oral presentation was detailed in our press release, Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC (Dec. 7, 2024).

A phase 2 trial evaluating petosemtamab in combination with standard chemotherapy in 1L and 2L mCRC, and as monotherapy in heavily pretreated (3L+) mCRC, is enrolling. We expect to provide initial clinical data for petosemtamab in mCRC in 2H25.


BIZENGRI® (zenocutuzumab-zbco: HER2 x HER3 Biclonics®)


Approved by FDA for adults with pancreatic adenocarcinoma or non–small cell lung cancer (NSCLC) that are advanced unresectable or metastatic and harbor a neuregulin 1 (NRG1) gene fusion who have disease progression on or after prior systemic therapy

Merus has exclusively licensed to Partner Therapeutics, Inc. (PTx) the right to commercialize BIZENGRI® for the treatment of NRG1+ cancer in the U.S. This was detailed in our press release, Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer (December 2, 2024).


MCLA-129 (EGFR x c-MET Biclonics®): Solid Tumors


Investigation of MCLA-129 is ongoing in METex14 NSCLC; phase 2 trial in combination with chemotherapy in 2L+ EGFR mutant (EGFRm) NSCLC enrolling

MCLA-129 is subject to a collaboration and license agreement with Betta Pharmaceuticals Co. Ltd. (Betta), which permits Betta to develop MCLA-129, and potentially commercialize exclusively in China, while Merus retains global rights outside of China.


Collaborations


Incyte Corporation


Since 2017, Merus has been working with Incyte Corporation (Incyte) under a global collaboration and license agreement focused on the research, discovery and development of bispecific antibodies utilizing Merus’ proprietary Biclonics® technology platform. For each program under the collaboration, Merus receives reimbursement for research activities and is eligible to receive potential development, regulatory and commercial milestones and sales royalties for any products, if approved. During the second quarter of 2025, Merus received the milestone payment of $1 million for the candidate nomination of a discovery program under the collaboration.


Eli Lilly and Company


In January 2021, Merus and Eli Lilly and Company (Lilly) announced a research collaboration and exclusive license agreement to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies utilizing Merus’ Biclonics® platform and proprietary CD3 panel along with the scientific and rational drug design expertise of Lilly. The collaboration is progressing well with two programs advancing through preclinical development.


Gilead Sciences


In March 2024, Merus and Gilead Sciences announced a collaboration to discover novel antibody based trispecific T-cell engagers using Merus’ patented Triclonics® platform. Under the terms of the agreement, Merus will lead early-stage research activities for two programs, with an option to pursue a third. Gilead will have the right to exclusively license programs developed under the collaboration after the completion of select research activities. If Gilead exercises its option to license any such program from the collaboration, Gilead will be responsible for additional research, development and commercialization activities for such program. The collaboration is progressing well with two programs advancing through preclinical development.


Ono Pharmaceutical


In 2018, the Company granted Ono Pharmaceutical Co., Ltd. (Ono) an exclusive, worldwide, royalty-bearing license, with the right to sublicense, research, test, make, use and market a limited number of bispecific antibody candidates based on Merus’ Biclonics® technology platform directed to an undisclosed target combination.


Biohaven


In January 2025, Merus and Biohaven announced a research collaboration and license agreement to co-develop three novel bispecific antibody drug conjugates (ADCs), leveraging Merus’ leading Biclonics® technology platform, and Biohaven’s next-generation ADC conjugation and payload platform technologies. Under the terms of the agreement, Biohaven is responsible for the preclinical ADC generation of three Merus bispecific antibodies under mutually agreed research plans. The agreement includes two Merus bispecific programs generated using the Biclonics® platform, and one program under preclinical research by Merus. Each program is subject to mutual agreement for advancement to further development, with the parties then sharing subsequent external development costs and commercialization, if advanced.


Corporate Activities


Completed public offering raising $345M gross proceeds

This equity raise is detailed in a press release: Merus N.V. Announces Pricing of Public Offering of Common Shares (June 4, 2025).


Cash Runway, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations at least into 2028

As of June 30, 2025, Merus had $892 million cash, cash equivalents and marketable securities. Based on the Company’s current operating plan, the existing cash, cash equivalents and marketable securities are expected to fund Merus’ operations at least into 2028.


Second Quarter 2025 Financial Results

Total revenue for the three months ended June 30, 2025 increased by $1.5 million as compared to the three months ended June 30, 2024, primarily as a result of increases in Incyte revenue of $1.5 million, PTx revenue of $0.5 million, and Gilead revenue of $0.1 million, partially offset by a decrease in Lilly revenue of $0.6 million.

Research and development (R&D) expense for the three months ended June 30, 2025 increased by $44.8 million as compared to the three months ended June 30, 2024. The increase in R&D expense is primarily driven by an increase of $37.9 million in clinical trial support provided by contract manufacturing and development organizations and contract research organizations, most of which is related to the petosemtamab clinical trials. The increase is also due to increases in personnel related expenses including share-based compensation of $7.2 million.

General and administrative expense for the three months ended June 30, 2025 increased by $2.7 million as compared to the three months ended June 30, 2024, primarily as a result of increases in personnel related expenses including share-based compensation of $5.0 million, increases in facilities and depreciation expense of $0.7 million, increases in legal expenses of $0.6 million, and increases in travel expenses of $0.2 million, partially offset by decreases in consulting expenses of $3.6 million and decreases in intellectual property and license expenses of $0.3 million.

Total revenue for the six months ended June 30, 2025 increased by $20.1 million as compared to the six months ended June 30, 2024, primarily as a result of commercial material revenue sold to PTx of $13.3 million and increases in collaboration revenue of $6.8 million. The collaboration revenue increase is primarily due to increases in Biohaven upfront payment amortization of $5.1 million. 

Research and development expense for the six months ended June 30, 2025 increased by $86.3 million as compared to the six months ended June 30, 2024. The increase in R&D expense is primarily driven by an increase of $73.7 million in clinical trial support provided by contract manufacturing and development organizations and contract research organizations, most of which is related to the petosemtamab clinical trials.

General and administrative expense for the six months ended June 30, 2025 increased by $8.7 million as compared to the six months ended June 30, 2024, primarily as a result as a result of increases in personnel related expenses including share-based compensation of $10.3 million, increases in facilities and depreciation expense of $1.0 million, increases in legal expenses of $0.8 million, increases in finance and human resources expenses of $0.1 million and increases in travel expenses of $0.1 million, partially offset by decreases in consulting expenses of $3.4 million.

Other income (loss), net consists of interest earned and fees paid on our cash and cash equivalents held on account, accretion of investment earnings and net foreign exchange (losses) gains on our foreign denominated cash, cash equivalents and marketable securities. Other gains or losses relate to the issuance and settlement of financial instruments.

MERUS N.V.
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(Amounts in thousands, except share and per share data)
 
  June 30, 

2025
    December 31, 

2024
 
ASSETS          
Current assets:          
Cash and cash equivalents $ 442,791     $ 293,294  
Marketable securities   267,433       243,733  
Accounts receivable   16,889       1,261  
Prepaid expenses and other current assets   41,169       30,784  
Total current assets   768,282       569,072  
Marketable securities   181,729       187,008  
Property and equipment, net   11,346       10,770  
Operating lease right-of-use assets   10,320       9,254  
Intangible assets, net   1,797       1,679  
Equity Investment   2,430        
Deferred tax assets   758       1,520  
Other assets   3,514       3,390  
Total assets $ 980,176     $ 782,693  
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable $ 21,075     $ 4,164  
Accrued expenses and other liabilities   41,387       43,957  
Income taxes payable   478       7,317  
Current portion of lease obligation   2,245       1,704  
Current portion of deferred revenue   26,394       29,934  
Total current liabilities   91,579       87,076  
Lease obligation   8,754       8,208  
Deferred revenue, net of current portion   38,107       39,482  
Total liabilities   138,440       134,766  
Commitments and contingencies – Note 6          
Shareholders’ equity:          
Common shares, €0.09 par value; 105,000,000 shares authorized at June 30, 2025 and December 31, 2024; 75,565,138 and 68,828,749 shares issued and outstanding as at June 30, 2025 and December 31, 2024, respectively   7,647       6,957  
Additional paid-in capital   2,038,795       1,664,822  
Accumulated other comprehensive income   18,373       (55,465 )
Accumulated deficit   (1,223,079 )     (968,387 )
Total shareholders’ equity   841,736       647,927  
Total liabilities and shareholders’ equity $ 980,176     $ 782,693  
               

MERUS N.V.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
(Amounts in thousands, except share and per share data)
 
  Three Months Ended

June 30,
    Six Months Ended

June 30,
 
  2025     2024     2025     2024  
Commercial material revenue $     $     $ 13,331     $  
Collaboration revenue   8,828       7,332       21,976       15,221  
Royalty revenue               9        
Total revenue   8,828       7,332       35,316       15,221  
Operating expenses:                      
Research and development   93,926       49,119       174,042       87,703  
General and administrative   25,252       22,587       47,364       38,701  
Total operating expenses   119,178       71,706       221,406       126,404  
Operating loss   (110,350 )     (64,374 )     (186,090 )     (111,183 )
Other income, net:                      
Interest income, net   7,122       7,130       14,325       12,047  
Foreign exchange gains (loss)   (51,854 )     9,519       (76,170 )     18,053  
Other expense   (1,265 )           (3,031 )      
Total other income (loss), net   (45,997 )     16,649       (64,876 )     30,100  
                       
Net loss before income taxes   (156,347 )     (47,725 )     (250,966 )     (81,083 )
Income tax expense   1,871       2,317       3,726       3,415  
Net loss $ (158,218 )   $ (50,042 )   $ (254,692 )   $ (84,498 )
Other comprehensive loss:                      
Currency translation adjustment   50,733       (8,978 )     73,838       (16,366 )
Comprehensive loss $ (107,485 )   $ (59,020 )   $ (180,854 )   $ (100,864 )
Net loss per share attributable to common shareholders:                              
Basic and diluted $ (2.23 )   $ (0.81 )   $ (3.64 )   $ (1.41 )
Weighted-average common shares outstanding:                              
Basic and diluted   71,096,937       61,851,260       69,996,121       59,968,338  
                               

About Merus N.V.

Merus is an oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website, LinkedIn and Bluesky.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding the content and timing of clinical trials, data readouts and clinical, regulatory, strategy and development updates for our product candidates; our ongoing LiGeR-HN1, LiGeR-HN2 and phase 2 mCRC trials for petosemtamab; our planned initial clinical data update on the phase 2 investigation of petosemtamab in mCRC in the 2H of 2025; the potential impact, if any, on the receipt of BTD by the FDA for petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC and petosemtamab monotherapy for the treatment of patients with recurrent or metastatic HNSCC whose disease has progressed following treatment with platinum based chemotherapy and a PD-1 or PD-L1 antibody; our expectation that the LiGeR-HN1 and LiGeR-HN2 trials will be substantially enrolled by year-end; our expectation of reporting a topline interim readout of one or both phase 3 registration trials in 2026; our belief that a randomized registration trial in HNSCC with an overall response rate endpoint could potentially support accelerated approval and the overall survival results from the same study could potentially verify its clinical benefit to support regular approval in our phase 3 trial in 1L, and in phase 3 trial in 2/3L HNSCC; our statements regarding the sufficiency of our cash, cash equivalents and marketable securities, and expectation that it will fund the Company at least into 2028; the continued investigation of MCLA-129 and enrolling of patients in the investigation of MCLA-129 in combination with chemotherapy in 2L+ EGFRm NSCLC; the benefits of the license from Merus to PTx for the commercialization of Bizengri® in the US for NRG1+ cancer, collaborations between Incyte and Merus, Lilly and Merus, Gilead and Merus, Biohaven and Merus, and license agreement between Ono and Merus; and the potential of those licenses and collaborations for future value generation, including whether and when Merus will receive any future payments, including milestones or royalties, and the amounts of such payments; whether any programs under the collaboration will be successful; and our collaboration and license agreement with Betta, which permits Betta to develop MCLA-129 and potentially commercialize exclusively in China, while Merus retains full ex-China rights, including any future clinical development by Betta of MCLA-129. These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our need for additional funding, which may not be available and which may require us to restrict our operations or require us to relinquish rights to our technologies or antibody candidates; potential delays in regulatory approval, which would impact our ability to commercialize our product candidates and affect our ability to generate revenue; the lengthy and expensive process of clinical drug development, which has an uncertain outcome; the unpredictable nature of our early stage development efforts for marketable drugs; potential delays in enrollment of patients, which could affect the receipt of necessary regulatory approvals; our reliance on third parties to conduct our clinical trials and the potential for those third parties to not perform satisfactorily; impacts of the volatility in the global economy, including global instability, including the ongoing conflicts in Europe and the Middle East; we may not identify suitable Biclonics® or bispecific antibody candidates under our collaborations or our collaborators may fail to perform adequately under our collaborations; our reliance on third parties to manufacture our product candidates, which may delay, prevent or impair our development and commercialization efforts; protection of our proprietary technology; our patents may be found invalid, unenforceable, circumvented by competitors and our patent applications may be found not to comply with the rules and regulations of patentability; we may fail to prevail in potential lawsuits for infringement of third-party intellectual property; and our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks.

These and other important factors discussed under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the period ended June 30, 2025, filed with the Securities and Exchange Commission, or SEC, on August 5, 2025, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change, except as required under applicable law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Multiclonics

®

, Biclonics

®

, Triclonics

®

, ADClonics® and BIZENGRI

®

 are registered trademarks of Merus N.V.

Please see full Prescribing Information, including Boxed WARNING, at BIZENGRI.com/pi.

Reference: 1. BIZENGRI. Prescribing information. Merus N.V.; 2024.



Investor and Media Inquiries:
Sherri Spear
Merus N.V.
SVP Investor Relations and Strategic Communications
617-821-3246
[email protected] 

Kathleen Farren
Merus N.V.
Director Investor Relations and Corporate Communications
617-230-4165
[email protected]    

OUTFRONT Media Reports Second Quarter 2025 Results

PR Newswire

Revenues of $460.2 million

Operating income of $56.2 million

Net income attributable to OUTFRONT Media Inc. of $19.5 million

Adjusted OIBDA of $124.1 million

AFFO attributable to OUTFRONT Media Inc. of $85.3 million

Quarterly dividend of $0.30 per share, payable September 30, 2025


NEW YORK
, Aug. 5, 2025 /PRNewswire/ — OUTFRONT Media Inc. (NYSE: OUT) today reported results for the quarter ended June 30, 2025.

“We undertook a number of internal actions during the second quarter, restructuring our sales function and placing key leaders in positions to accelerate and drive future growth,” said Nick Brien, Interim Chief Executive Officer of OUTFRONT Media. “With the reorganization behind us, we are now poised to take greater advantage of out-of-home’s power to influence decisions IRL and improve our share of advertisers’ budgets.”


Three Months Ended

June 30,


Six Months Ended

June 30,


$ in Millions, except per share amounts


2025


2024


2025


2024


Revenues

$460.2

$477.3

$850.9

$885.8


Organic revenues

460.2

461.0

850.9

850.9


Operating income

56.2

229.1

70.1

243.1


Adjusted OIBDA

124.1

126.0

188.3

192.5


Net income (loss) before allocation to redeemable and non-redeemable noncontrolling interests

19.5

177.0

(1.2)

149.9


Net income (loss)1

19.5

176.8

(1.1)

149.6


Net income (loss) per share1,2,3

$0.10

$1.04

($0.03)

$0.88


Funds From Operations (FFO)1

70.4

83.8

96.9

106.1


Adjusted FFO (AFFO)1

85.3

84.8

109.2

108.0


Shares outstanding3

168.0

170.5

166.8

170.2

Notes: See exhibits for reconciliations of non-GAAP financial measures; 1) References to “Net income (loss)”, “Net income (loss) per share”, “FFO” and “AFFO” mean “Net income (loss) attributable to OUTFRONT Media Inc.”, “Net income (loss) attributable to OUTFRONT Media Inc. per common share”, “FFO attributable to OUTFRONT Media Inc.” and “AFFO attributable to OUTFRONT Media Inc.,” respectively; 2) References to “per share” mean per common share for diluted earnings per weighted average share; 3) Diluted weighted average shares outstanding.  As previously disclosed, on January 17, 2025, the Company effected a reverse stock split of the Company’s common stock. All shares of the Company’s common stock and per-share data included in this document have been retroactively adjusted as though the reverse stock split has been effected prior to all periods presented.


Second Quarter 2025 Results

We currently manage our operations through two reportable operating segments — (1) Billboard and (2) Transit. On June 7, 2024, we sold all of our equity interests in Outdoor Systems Americas ULC and its subsidiaries (the “Transaction”), which hold all of the assets of our outdoor advertising business in Canada (the “Canadian Business”). Prior to its sale, the Canadian Business comprised our International operating segment, which did not meet the criteria to be a reportable segment, and accordingly, was included in Other.

The following reported results include the historical results of the Canadian Business through the date of sale.

Consolidated
Reported revenues of $460.2 million decreased $17.1 million, or 3.6%, for the second quarter of 2025 as compared to the same prior-year period. Organic revenues of $460.2 million decreased $0.8 million, or 0.2%.

Total operating expenses of $231.5 million decreased $8.3 million, or 3.5%, compared to the same prior-year period, due primarily to lost billboards, the impact of the Transaction and lower variable property lease expenses, partially offset by higher guaranteed minimum annual payments to the New York Metropolitan Transportation Authority (the “MTA”) due to inflation.

Selling, General and Administrative expenses (“SG&A”) of $110.6 million decreased $8.5 million, or 7.1%, compared to the same prior-year period, due primarily to the impact of the Transaction and lower compensation-related expenses, including severance and salaries, partially offset by the impact of market fluctuations on an unfunded equity-linked retirement plan offered by the Company to certain employees and higher professional fees, as a result of a management consulting project. We expect SG&A expenses to decline for the remainder of 2025 and the first half of 2026 compared to the prior-year periods. We will continue to evaluate methods to lower SG&A expense growth.

Adjusted OIBDA of $124.1 million decreased $1.9 million, or 1.5%, compared to the same prior-year period.

Segment Results

Billboard
Reported billboard segment revenues of $351.3 million decreased $8.9 million, or 2.5%, compared to the same prior-year period, driven by the impact of lost billboards in the period, partially offset by higher proceeds from condemnations and an increase in average revenue per display (yield), including the impact of programmatic platforms on digital billboard revenues. Organic billboard segment revenues of $351.3 million decreased $8.9 million, or 2.5%.

Operating expenses decreased $5.0 million, or 3.3%, due primarily to lost billboards and lower variable billboard property lease costs, partially offset by higher production costs and higher compensation-related expenses.

SG&A expenses decreased $2.3 million, or 3.3%, due primarily to lower credit card usage by customers.

Adjusted OIBDA of $134.4 million decreased $1.6 million, or 1.2%, compared to the same prior-year period.

Transit
Reported transit segment revenues of $106.3 million increased $5.6 million, or 5.6%, compared to the same prior-year period, due primarily to an increase in average revenue per display (yield), partially offset by the impact of new and lost transit franchise contracts in the period. Organic transit segment revenues of $106.3 million increased $5.6 million, or 5.6%.

Operating expenses increased $3.9 million, or 5.1%, due primarily to higher guaranteed minimum annual payments to the MTA due to inflation and higher variable franchise expenses.

SG&A expenses decreased $1.0 million, or 5.2%, due primarily to lower compensation-related expenses and lower professional fees.

Adjusted OIBDA increased $2.7 million, or 60.0%, compared to the same prior-year period.

Other
Reported revenues of $2.6 million decreased $13.8 million, or 84.1%, primarily driven by the impact of the Transaction, partially offset by an increase in third-party digital equipment sales. Organic revenues increased $2.5 million.

Operating expenses decreased $7.2 million, or 78.3%, due primarily to the impact of the Transaction, partially offset by higher costs related to third-party digital equipment sales.

SG&A expenses decreased $5.5 million, or 98.2%, driven primarily by the impact of the Transaction.

Adjusted OIBDA of $0.5 million decreased $1.1 million, or 68.8%, compared to the same prior-year period.

Corporate

Corporate expenses, excluding restructuring charges and stock-based compensation, increased $1.9 million, or 11.8%, to $18.0 million, due primarily to the impact of market fluctuations on an unfunded equity-linked retirement plan offered by the Company to certain employees and higher professional fees, including fees related to a management consulting project, partially offset by lower compensation-related expenses.

Interest Expense
Net interest expense in the second quarter of 2025 was $36.5 million, including amortization of deferred financing costs of $1.5 million, as compared to $41.1 million, including amortization of deferred financing costs of $1.5 million, in the same prior-year period. The decrease was due primarily to a lower average debt balance and lower interest rates. The weighted average cost of debt was 5.4% as of June 30, 2025 and 5.6% as of June 30, 2024.

Income Taxes
The provision for income taxes decreased $10.9 million, or 98.2%, in the second quarter of 2025 compared to the same prior-year period, due primarily to the impact of the Transaction. Cash paid for income taxes in the six months ended June 30, 2025 was $1.4 million.

Net Income Attributable to OUTFRONT Media Inc.
Net income attributable to OUTFRONT Media Inc. decreased $157.3 million, or 89.0%, in the second quarter of 2025 compared to the same prior-year period. Diluted weighted average shares outstanding were 168.0 million for the second quarter of 2025 compared to 170.5 million for the same prior-year period. Net income attributable to OUTFRONT Media Inc. per common share for diluted earnings per weighted average share was $0.10 in the second quarter of 2025 compared to $1.04 in the same prior-year period.

FFO
FFO attributable to OUTFRONT Media Inc. was $70.4 million in the second quarter of 2025, a decrease of $13.4 million, or 16.0%, from the same prior-year period, driven primarily by restructuring charges in 2025 and higher depreciation expense, partially offset by lower interest expense and the impact of impairment charges in 2024.

AFFO
AFFO attributable to OUTFRONT Media Inc. was $85.3 million in the second quarter of 2025, an increase of $0.5 million, or 0.6%, from the same prior-year period, due primarily to lower interest expense and lower maintenance capital expenditures, partially offset by lower Adjusted OIBDA, lower non-cash effect of straight-line rent and lower other income.

Cash Flow & Capital Expenditures
Net cash flow provided by operating activities of $100.7 million for the six months ended June 30, 2025, decreased $0.9 million, or 0.9%, compared to $101.6 million in the same prior-year period, primarily due to a larger use of cash related to accounts payable and accrued expenses, driven by higher incentive compensation payments made in 2025, the timing of receivables and the timing of tax payments related to the Transaction in 2024, partially offset by higher net income, as adjusted for non-cash items, and an increase in restructuring reserves to be paid out in future periods. Total capital expenditures increased $0.6 million, or 1.4%, to $42.9 million for the six months ended June 30, 2025, compared to the same prior-year period.

Dividends
In the six months ended June 30, 2025, we paid cash dividends of $105.3 million, including $100.9 million on our common stock and vested restricted share units granted to employees and $4.4 million on our Series A Convertible Perpetual Preferred Stock (the “Series A Preferred Stock”). We announced on August 5, 2025, that our board of directors has approved a quarterly cash dividend on our common stock of $0.30 per share payable on September 30, 2025, to stockholders of record at the close of business on September 5, 2025.

Balance Sheet and Liquidity
As of June 30, 2025, our liquidity position included unrestricted cash of $28.5 million and $494.7 million of availability under our $500.0 million revolving credit facility, net of $5.3 million of issued letters of credit against the letter of credit facility sublimit under the revolving credit facility, and $80.0 million of additional availability under our accounts receivable securitization facility. During the three months ended June 30, 2025, no shares of our common stock were sold under our at-the-market equity offering program, of which $232.5 million remains available. As of June 30, 2025, the maximum number of shares of our common stock that could be required to be issued on conversion of the outstanding shares of the Series A Preferred Stock was approximately 7.8 million shares. Total indebtedness as of June 30, 2025 was $2.6 billion, excluding $14.9 million of deferred financing costs, and includes a $400.0 million term loan, $450.0 million of senior secured notes, $1.7 billion of senior unsecured notes, and $70.0 million borrowings under our accounts receivable securitization facility.

Conference Call
We will host a conference call to discuss the results on August 5, 2025, at 4:30 p.m. Eastern Time. The conference call numbers are 833-470-1428 (U.S. callers) and 404-975-4839 (International callers) and the passcode for both is 217110. Live and replay versions of the conference call will be webcast in the Investor Relations section of our website, www.outfront.com.

Supplemental Materials
In addition to this press release, we have provided a supplemental investor presentation which can be viewed on our website, www.outfront.com.

About OUTFRONT Media Inc. 
OUTFRONT is one of the largest and most trusted out-of-home media companies in the U.S., helping brands connect with audiences in the moments and environments that matter most. As OUTFRONT evolves, it’s defining a new era of in-real-life (IRL) marketing, turning public spaces into platforms for creativity, connection, and cultural relevance. With a nationwide footprint across billboards, digital displays, transit systems, and other out-of-home formats, OUTFRONT turns creative into powerful real-world experiences. Its in-house agency, OUTFRONT STUDIOS, and award-winning innovation team, XLabs, deliver standout storytelling, supported by advanced technology and data tools that can drive measurable impact.


Contacts:


Investors


Media

Stephan Bisson

Courtney Richards

Investor Relations

Events & Communications

(212) 297-6573

(646) 876-9404

[email protected]

[email protected]

Non-GAAP Financial Measures
In addition to the results prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) provided throughout this document, this document and the accompanying tables include non-GAAP financial measures as described below. We calculate organic revenues as reported revenues excluding revenues associated with the impact of the Transaction (“non-organic revenues”). We provide organic revenues to understand the underlying growth rate of revenue excluding the impact of non-organic revenue items. Our management believes organic revenues are useful to users of our financial data because it enables them to better understand the level of growth of our business period to period.  We calculate and define “Adjusted OIBDA” as operating income (loss) before depreciation, amortization, net (gain) loss on dispositions, stock-based compensation, restructuring charges and impairment charges. We calculate Adjusted OIBDA margin by dividing Adjusted OIBDA by total revenues. Adjusted OIBDA and Adjusted OIBDA margin are among the primary measures we use for managing our business, evaluating our operating performance and planning and forecasting future periods, as each is an important indicator of our operational strength and business performance. Our management believes users of our financial data are best served if the information that is made available to them allows them to align their analysis and evaluation of our operating results along the same lines that our management uses in managing, planning and executing our business strategy. Our management also believes that the presentations of Adjusted OIBDA and Adjusted OIBDA margin, as supplemental measures, are useful in evaluating our business because eliminating certain non-comparable items highlight operational trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures.  It is management’s opinion that these supplemental measures provide users of our financial data with an important perspective on our operating performance and also make it easier for users of our financial data to compare our results with other companies that have different financing and capital structures or tax rates. When used herein, references to “FFO” and “AFFO” mean “FFO attributable to OUTFRONT Media Inc.” and “AFFO attributable to OUTFRONT Media Inc.,” respectively. We calculate FFO in accordance with the definition established by the National Association of Real Estate Investment Trusts (“NAREIT”). FFO reflects net income (loss) attributable to OUTFRONT Media Inc. adjusted to exclude gains and losses from the sale of real estate assets, impairment charges, depreciation and amortization of real estate assets, amortization of direct lease acquisition costs and the same adjustments for our equity-based investments and redeemable and non-redeemable noncontrolling interests, as well as the related income tax effect of adjustments, as applicable. We calculate AFFO as FFO adjusted to include cash paid for direct lease acquisition costs as such costs are generally amortized over a period ranging from four weeks to one year and therefore are incurred on a regular basis. AFFO also includes cash paid for maintenance capital expenditures since these are routine uses of cash that are necessary for our operations. In addition, AFFO excludes restructuring charges and losses on extinguishment of debt, as well as certain non-cash items, including non-real estate depreciation and amortization, impairment charges on non-real estate assets, stock-based compensation expense, accretion expense, the non-cash effect of straight-line rent, amortization of deferred financing costs and the same adjustments for our redeemable and non-redeemable noncontrolling interests, along with the non-cash portion of income taxes, and the related income tax effect of adjustments, as applicable. We use FFO and AFFO measures for managing our business and for planning and forecasting future periods, and each is an important indicator of our operational strength and business performance, especially compared to other real estate investment trusts (“REITs”). Our management believes users of our financial data are best served if the information that is made available to them allows them to align their analysis and evaluation of our operating results along the same lines that our management uses in managing, planning and executing our business strategy. Our management also believes that the presentations of FFO and AFFO, as supplemental measures, are useful in evaluating our business because adjusting results to reflect items that have more bearing on the operating performance of REITs highlight trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures. It is management’s opinion that these supplemental measures provide users of our financial data with an important perspective on our operating performance and also make it easier to compare our results to other companies in our industry, as well as to REITs. Since organic revenues, Adjusted OIBDA, Adjusted OIBDA margin, FFO and AFFO are not measures calculated in accordance with GAAP, they should not be considered in isolation of, or as a substitute for, revenues, operating income (loss) and net income (loss) attributable to OUTFRONT Media Inc., the most directly comparable GAAP financial measures, as indicators of operating performance. These measures, as we calculate them, may not be comparable to similarly titled measures employed by other companies. In addition, these measures do not necessarily represent funds available for discretionary use and are not necessarily a measure of our ability to fund our cash needs.

Please see Exhibits 4-6 of this release for a reconciliation of the above non-GAAP financial measures to the most directly comparable GAAP financial measures.

Cautionary Statement Regarding Forward-Looking Statements
We have made statements in this document that are forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by the use of forward-looking terminology such as “believes,” “expects,” “could,” “would,” “may,” “might,” “will,” “should,” “seeks,” “likely,” “intends,” “plans,” “projects,” “predicts,” “estimates,” “forecast” or “anticipates” or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions related to our capital resources, portfolio performance and results of operations. Forward-looking statements involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: declines in advertising and general economic conditions; the severity and duration of pandemics, and the impact on our business, financial condition and results of operations; competition; government regulation; our ability to operate our digital display platform; losses and costs resulting from recalls and product liability, warranty and intellectual property claims; our ability to obtain and renew key municipal contracts on favorable terms; taxes, fees and registration requirements; decreased government compensation for the removal of lawful billboards; content-based restrictions on outdoor advertising; seasonal variations; acquisitions and other strategic transactions that we may pursue could have a negative effect on our results of operations; dependence on our management team and other key employees; experiencing a cybersecurity incident; changes in regulations and consumer concerns regarding privacy, information security and data, or any failure or perceived failure to comply with these regulations or our internal policies; asset impairment charges for our long-lived assets and goodwill; environmental, health and safety laws and regulations; expectations relating to environmental, social and governance considerations; our substantial indebtedness; restrictions in the agreements governing our indebtedness; incurrence of additional debt; interest rate risk exposure from our variable-rate indebtedness; our ability to generate cash to service our indebtedness; cash available for distributions; hedging transactions; the ability of our board of directors to cause us to issue additional shares of stock without common stockholder approval; certain provisions of Maryland law may limit the ability of a third party to acquire control of us; our rights and the rights of our stockholders to take action against our directors and officers are limited; our failure to remain qualified to be taxed as a REIT; REIT distribution requirements; availability of external sources of capital; we may face other tax liabilities even if we remain qualified to be taxed as a REIT; complying with REIT requirements may cause us to liquidate investments or forgo otherwise attractive investments or business opportunities; our ability to contribute certain contracts to a taxable REIT subsidiary (“TRS”); our planned use of TRSs may cause us to fail to remain qualified to be taxed as a REIT; REIT ownership limits; complying with REIT requirements may limit our ability to hedge effectively; the ability of our board of directors to revoke our REIT election at any time without stockholder approval; the Internal Revenue Service may deem the gains from sales of our outdoor advertising assets to be subject to a 100% prohibited transaction tax; establishing operating partnerships as part of our REIT structure; completing the Company’s restructuring and reduction in force plan (the “Plan”) may be more difficult, costly, or time consuming for the Company and its management than expected and the anticipated benefits of the Plan, including but not limited to projected cost savings, may not be fully realized or realized at all; and other factors described in our filings with the Securities and Exchange Commission (the “SEC”), including but not limited to the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025. All forward-looking statements in this document apply as of the date of this document or as of the date they were made and, except as required by applicable law, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes.

Revision of Previously Issued Financial Information

In the third quarter of 2024, we identified an error related to the accounting for noncontrolling interests in our consolidated joint ventures, which include buy/sell clauses. The error related to the appropriate classification of these noncontrolling interests as redeemable and recognition of these redeemable noncontrolling interests at the maximum redemption value for each period. The Company assessed the materiality of the error on its previously issued financial statements in accordance with the SEC’s Staff Accounting Bulletin (“SAB”) No. 99 and SAB No. 108 and concluded that the amount was not material, individually or in the aggregate, to any of its previously issued financial statements, but would have been material to certain of our financial statements in the current period. Accordingly, we have revised our previously issued financial information. All relevant prior period amounts affected by these revisions have been corrected in the applicable financial information included in the exhibits below. Any prior periods not presented herein may be revised in future filings to the extent necessary.

The impact of the revisions has been reflected throughout this document, including in the applicable financial information included in the exhibits below. There is no impact to net cash provided by operating activities, investing activities, or financing activities in our Consolidated Statements of Cash Flows, which is included in the exhibits below.


EXHIBITS

 


Exhibit 1:  CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 See Notes on Page 15


Three Months Ended


Six Months Ended


June 30,


June 30,


(in millions, except per share amounts)


2025


2024


2025


2024

Revenues

$              460.2

$              477.3

$              850.9

$              885.8

Expenses:

Operating

231.5

239.8

452.8

478.5

Selling, general and administrative

110.6

119.1

225.3

229.6

Restructuring charges

19.8

19.8

Net (gain) loss on dispositions

1.1

(155.2)

1.2

(155.1)

Impairment charges

8.8

17.9

Depreciation

23.6

18.4

47.2

36.9

Amortization

17.4

17.3

34.5

34.9

Total expenses

404.0

248.2

780.8

642.7

Operating income

56.2

229.1

70.1

243.1

Interest expense, net

(36.5)

(41.1)

(72.5)

(82.5)

Loss on extinguishment of debt

(1.2)

(1.2)

Other income, net

1.1

1.1

Income (loss) before provision for income taxes and equity in earnings of investee companies

19.7

187.9

(2.4)

160.5

Provision for income taxes

(0.2)

(11.1)

(0.7)

(10.6)

Equity in earnings of investee companies, net of tax

0.2

1.9

Net income (loss) before allocation to redeemable and non-redeemable noncontrolling interests

19.5

177.0

(1.2)

149.9

Net income (loss) attributable to redeemable and non-redeemable noncontrolling interests

0.2

(0.1)

0.3

Net income (loss) attributable to OUTFRONT Media Inc.

$                19.5

$              176.8

$                 (1.1)

$              149.6


Net income (loss) per common share:

Basic

$                0.10

$                1.08

$               (0.03)

$                0.90

Diluted

$                0.10

$                1.04

$               (0.03)

$                0.88


Weighted average shares outstanding:

Basic

167.1

161.9

166.8

161.7

Diluted

168.0

170.5

166.8

170.2

 


Exhibit 2:  CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
(Unaudited)

See Notes on Page 15


As of


(in millions)


June 30,

2025


December 31,

2024


Assets:

Current assets:

Cash and cash equivalents

$                 28.5

$                 46.9

Receivables, less allowance ($21.0 in 2025 and $20.6 in 2024)

299.6

305.3

Prepaid lease and franchise costs

2.8

4.0

Other prepaid expenses

14.2

17.8

Other current assets

10.0

11.8

Total current assets

355.1

385.8

Property and equipment, net

647.5

648.9

Goodwill

2,006.4

2,006.4

Intangible assets

635.2

652.0

Operating lease assets

1,486.7

1,503.8

Other assets

18.1

18.3


Total assets

$            5,149.0

$            5,215.2


Liabilities:

Current liabilities:

Accounts payable

$                 40.6

$                 51.4

Accrued compensation

48.9

56.7

Accrued interest

34.2

34.5

Accrued lease and franchise costs

66.3

82.8

Other accrued expenses

59.6

54.3

Deferred revenues

44.5

42.8

Short-term debt

70.0

10.0

Short-term operating lease liabilities

178.6

168.7

Other current liabilities

37.8

19.6

Total current liabilities

580.5

520.8

Long-term debt, net

2,484.8

2,482.5

Asset retirement obligation

34.3

33.9

Operating lease liabilities

1,331.0

1,351.8

Other liabilities

38.6

42.2


Total liabilities

4,469.2

4,431.2

Commitments and contingencies

Redeemable noncontrolling interests

19.4

13.6

Preferred stock (2025 – 50.0 shares authorized, and 0.1 shares of Series A Preferred Stock

   issued and outstanding; 2024 – 50.0 shares authorized, and 0.1 shares issued and

   outstanding)

119.8

119.8


Stockholders’ equity:

Common stock (2025 – 450.0 shares authorized, and 167.1 shares issued and

   outstanding; 2024 – 450.0 shares authorized, and 166.0 issued and outstanding)

1.7

1.7

Additional paid-in capital

2,489.8

2,493.6

Distribution in excess of earnings

(1,952.3)

(1,846.2)

Accumulated other comprehensive loss

(0.1)

(0.1)

Total stockholders’ equity

539.1

649.0

Noncontrolling interests

1.5

1.6


Total liabilities and equity

$            5,149.0

$            5,215.2

 


Exhibit 3:  CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

See Notes on Page 15


Six Months Ended


June 30,


(in millions)


2025


2024


Operating activities:

Net income (loss) attributable to OUTFRONT Media Inc.

$                (1.1)

$             149.6

Adjustments to reconcile net income (loss) to net cash flow provided by operating activities:

Net income (loss) attributable to redeemable and non-redeemable noncontrolling interests

(0.1)

0.3

Depreciation and amortization

81.7

71.8

Deferred tax benefit

(1.2)

Stock-based compensation

17.7

14.8

Provision for doubtful accounts

2.9

2.2

Accretion expense

1.4

1.5

Net (gain) loss on dispositions

1.2

(155.1)

Loss on extinguishment of debt

1.2

Equity in earnings of investee companies, net of tax

(1.9)

0.0

Distributions from investee companies

0.3

0.8

Amortization of deferred financing costs and debt discount and premium

3.0

3.1

Change in assets and liabilities, net of investing and financing activities:

Decrease in receivables

2.8

11.0

Decrease in prepaid expenses and other current assets

5.9

3.8

Decrease in accounts payable and accrued expenses

(36.2)

(26.8)

Increase in operating lease assets and liabilities

7.7

8.6

Increase in deferred revenues

1.7

6.6

Increase (decrease) in income taxes

(0.7)

10.6

Decrease in assets and liabilities held for sale, net

(2.1)

Other, net

14.4

0.9


Net cash flow provided by operating activities

100.7

101.6


Investing activities:

Capital expenditures

(42.9)

(42.3)

Acquisitions

(8.5)

(7.6)

MTA franchise rights

(12.5)

Net proceeds from dispositions

0.9

309.4

Return of investments in investee companies

1.5


Net cash flow provided by (used for) investing activities

(61.5)

259.5


Financing activities:

Repayments of long-term debt borrowings

(200.0)

Proceeds from borrowings under short-term debt facilities

90.0

95.0

Repayments of borrowings under short-term debt facilities

(30.0)

(130.0)

Payments of deferred financing costs

(0.1)

(0.2)

Taxes withheld for stock-based compensation

(12.2)

(7.5)

Dividends

(105.3)

(104.4)


Net cash flow used for financing activities

(57.6)

(347.1)

 


Exhibit 3:  CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
(Unaudited)
 See Notes on Page 15


Six Months Ended


June 30,


(in millions)


2025


2024

Effect of exchange rate changes on cash and cash equivalents

(0.4)


Net increase (decrease) in cash and cash equivalents

(18.4)

13.6

Cash and cash equivalents at beginning of period

46.9

36.0

Cash and cash equivalents at end of period

$               28.5

$               49.6


Supplemental disclosure of cash flow information:

Cash paid for income taxes

$                  1.4

$                  1.2

Cash paid for interest

70.1

79.9


Non-cash investing and financing activities:

Accrued purchases of property and equipment

10.0

7.4

Accrued MTA franchise rights

1.7

Taxes withheld for stock-based compensation

3.6

0.2

 


Exhibit 4:  SUPPLEMENTAL DISCLOSURES REGARDING NON-GAAP FINANCIAL INFORMATION 
(Unaudited) See Notes on Page 15


Three Months Ended June 30, 2025


(in millions, except percentages)


Billboard


Transit


Other


Corporate


Consolidated


Revenues

$           351.3

$           106.3

$               2.6

$                    —

$           460.2

Organic revenues(a)

$           351.3

$           106.3

$               2.6

$                    —

$           460.2

Non-organic revenues(b)

$                 —

$                —

$                —

$                    —

$                 —

Operating income (loss)

$             88.6

$             (0.9)

$               0.5

$               (32.0)

$             56.2

Restructuring charges

8.2

3.6

5.8

17.6

Net (gain) loss on dispositions

1.2

(0.1)

1.1

Impairment charges

Depreciation

20.7

2.9

23.6

Amortization

15.7

1.7

17.4

Stock-based compensation

8.2

8.2


Adjusted OIBDA

$           134.4

$               7.2

$               0.5

$               (18.0)

$           124.1

Adjusted OIBDA margin

38.3 %

6.8 %

19.2 %

*

27.0 %


Three Months Ended June 30, 2024


(in millions, except percentages)


Billboard


Transit


Other


Corporate


Consolidated


Revenues

$           360.2

$           100.7

$             16.4

$                    —

$           477.3

Organic revenues(a)

$           360.2

$           100.7

$               0.1

$                    —

$           461.0

Non-organic revenues(b)

$                 —

$                —

$             16.3

$                    —

$             16.3

Operating income (loss)

$           102.7

$             (6.8)

$           156.9

$               (23.7)

$           229.1

Net (gain) loss on dispositions

0.1

(155.3)

(155.2)

Impairment charges

8.8

8.8

Depreciation

16.7

1.7

18.4

Amortization

16.5

0.8

17.3

Stock-based compensation

7.6

7.6


Adjusted OIBDA

$           136.0

$               4.5

$               1.6

$               (16.1)

$           126.0

Adjusted OIBDA margin

37.8 %

4.5 %

9.8 %

*

26.4 %


Six Months Ended June 30, 2025


(in millions, except percentages)


Billboard


Transit


Other


Corporate


Consolidated


Revenues

$            662.0

$           184.0

$               4.9

$                     —

$           850.9

Organic revenues(a)

$            662.0

$           184.0

$               4.9

$                     —

$           850.9

Non-organic revenues(b)

$                 —

$                —

$                —

$                     —

$                 —

Operating income (loss)

$            149.6

$           (17.9)

$               1.0

$                (62.6)

$             70.1

Restructuring charges

8.2

3.6

5.8

17.6

Net (gain) loss on dispositions

1.9

(0.7)

1.2

Depreciation

42.3

4.9

47.2

Amortization

31.4

3.1

34.5

Stock-based compensation

17.7

17.7


Adjusted OIBDA

$            233.4

$             (7.0)

$               1.0

$                (39.1)

$           188.3

Adjusted OIBDA margin

35.3 %

(3.8) %

20.4 %

*

22.1 %


Six Months Ended June 30, 2024


(in millions, except percentages)


Billboard


Transit


Other


Corporate


Consolidated


Revenues

$            674.1

$           176.4

$             35.3

$                     —

$           885.8

Organic revenues(a)

$            674.1

$           176.4

$               0.4

$                     —

$           850.9

Non-organic revenues(b)

$                 —

$                —

$             34.9

$                     —

$             34.9

Operating income (loss)

$            166.4

$           (34.0)

$           157.8

$                (47.1)

$           243.1

Net (gain) loss on dispositions

0.1

0.1

(155.3)

(155.1)

Impairment charges

17.9

17.9

Depreciation

33.4

3.5

36.9

Amortization

33.2

1.7

34.9

Stock-based compensation

14.8

14.8


Adjusted OIBDA

$            233.1

$           (10.8)

$               2.5

$                (32.3)

$           192.5

Adjusted OIBDA margin

34.6 %

(6.1) %

7.1 %

*

21.7 %

 


Exhibit 5:  SUPPLEMENTAL DISCLOSURES REGARDING NON-GAAP FINANCIAL MEASURES  
(Unaudited) See Notes on Page 15


Three Months Ended


Six Months Ended


June 30,


June 30,


(in millions)


2025


2024


2025


2024


Net income (loss) attributable to OUTFRONT Media Inc.

$                19.5

$              176.8

$                 (1.1)

$              149.6

Depreciation of billboard advertising structures

19.2

13.5

38.0

27.1

Amortization of real estate-related intangible assets

15.0

15.9

30.1

32.0

Amortization of direct lease acquisition costs

15.6

16.0

28.8

29.1

Net loss on disposition of real estate assets

1.1

(155.2)

1.2

(155.1)

Impairment charge(c)

6.4

13.1

Adjustment related to redeemable and non-redeemable noncontrolling interests

(0.1)

(0.1)

(0.2)

Income tax effect of adjustments(d)

10.5

10.5


FFO attributable to OUTFRONT Media Inc.

$                70.4

$                83.8

$                96.9

$              106.1

Non-cash portion of income taxes

(1.2)

(0.5)

(0.7)

(1.1)

Cash paid for direct lease acquisition costs

(13.4)

(13.4)

(29.8)

(28.7)

Maintenance capital expenditures

(7.0)

(7.7)

(13.3)

(12.4)

Restructuring charges(e)

19.8

19.8

Other depreciation

4.4

4.9

9.2

9.8

Other amortization

2.4

1.4

4.4

2.9

Impairment charge on non-real estate assets(c)

2.4

4.8

Stock-based compensation

6.0

7.6

15.5

14.8

Non-cash effect of straight-line rent

2.4

2.9

3.5

6.0

Accretion expense

0.7

0.7

1.4

1.5

Amortization of deferred financing costs

1.5

1.5

3.0

3.1

Loss on extinguishment of debt

1.2

1.2

Income tax effect of adjustments(d)

(0.7)

(0.7)


AFFO attributable to OUTFRONT Media Inc.

$                85.3

$                84.8

$              109.2

$              108.0

 


Exhibit 6:  SUPPLEMENTAL DISCLOSURES REGARDING NON-GAAP FINANCIAL MEASURES  
(Unaudited) See Notes on Page 15


Three Months Ended


Six Months Ended


June 30,


June 30,


(in millions)


2025


2024


2025


2024


Adjusted OIBDA

$              124.1

$              126.0

$              188.3

$              192.5

Interest expense, net, less amortization of deferred financing costs

(35.0)

(39.6)

(69.5)

(79.4)

Cash paid for income taxes(f)

(1.4)

(1.1)

(1.4)

(1.2)

Direct lease acquisition costs

2.2

2.6

(1.0)

0.4

Maintenance capital expenditures

(7.0)

(7.7)

(13.3)

(12.4)

Equity in earnings of investee companies, net of tax

0.2

1.9

Non-cash effect of straight-line rent

2.4

2.9

3.5

6.0

Accretion expense

0.7

0.7

1.4

1.5

Other income, net

1.1

1.1

Adjustment related to redeemable and non-redeemable noncontrolling interests

(0.3)

(0.5)

Income tax effect of adjustments(d)

(0.7)

(0.7)


AFFO attributable to OUTFRONT Media Inc.

$                85.3

$                84.8

$              109.2

$              108.0

 


Exhibit 7:  OPERATING EXPENSES


(Unaudited) See Notes on Page 15


Three Months Ended


Six Months Ended


June 30,


%


June 30,


%


(in millions, except percentages)


2025


2024


Change


2025


2024


Change

Operating expenses:

Billboard property lease

$              111.8

$              122.2

(8.5) %

$              221.0

$              243.9

(9.4) %

Transit franchise

62.8

60.5

3.8

120.8

119.5

1.1

Posting, maintenance and other

56.9

57.1

(0.4)

111.0

115.1

(3.6)

Total operating expenses

$              231.5

$              239.8

(3.5)

$              452.8

$              478.5

(5.4)

 


Exhibit 8:  EXPENSES BY SEGMENT


(Unaudited) See Notes on Page 15


Three Months Ended


Six Months Ended


June 30,


%


June 30,


%


(in millions, except percentages)


2025


2024


Change


2025


2024


Change

Billboard:

Billboard property lease

$              111.8

$              117.9

(5.2) %

$              221.0

$              233.4

(5.3) %

Billboard posting, maintenance and other

36.7

35.6

3.1

72.4

72.2

0.3

Billboard operating expenses

148.5

153.5

(3.3)

$              293.4

$              305.6

(4.0)

Billboard SG&A expenses

68.4

70.7

(3.3)

$              135.2

$              135.4

(0.1)

Transit:

Transit franchise

62.8

59.7

5.2

$              120.8

$              117.7

2.6

Transit posting, maintenance and other

18.2

17.4

4.6

34.8

33.5

3.9

Transit operating expenses

81.0

77.1

5.1

$              155.6

$              151.2

2.9

Transit SG&A expenses

18.1

19.1

(5.2)

$                35.4

$                36.0

(1.7)

NOTES TO EXHIBITS

PRIOR PERIOD PRESENTATION CONFORMS TO CURRENT REPORTING CLASSIFICATIONS.

(a)

Organic revenues exclude revenues associated with the impact of the sale of our equity interests in Outdoor Systems Americas ULC and its subsidiaries (the “Transaction”), which hold all of the assets of our outdoor advertising business in Canada (“non-organic revenues”).

(b)

In the three and six months ended June 30, 2024, non-organic revenues reflect the impact of the Transaction.

(c)

Impairment charge related to our Transit reporting unit and MTA asset group.

(d)

Income tax effect related to Restructuring charges in 2025 and net gain on disposition of real estate assets in 2024.

(e)


Restructuring charges associated with a restructuring and reduction in force plan, consists of severance payments, employee benefits and related costs, and professional fees, and includes approximately $2.2 million in non-cash charges for stock-based compensation.

(f)

Cash paid for income taxes is presented in this table net of cash paid for income taxes related to a net gain on disposition of real estate assets associated with the Transaction.

*

Calculation not meaningful.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/outfront-media-reports-second-quarter-2025-results-302522316.html

SOURCE OUTFRONT Media Inc.

Oblong Taps $TAO Expert Siam Kidd to Lead Strategic Advisory Committee and Accelerate Decentralized AI Expansion

Oblong Taps $TAO Expert Siam Kidd to Lead Strategic Advisory Committee and Accelerate Decentralized AI Expansion

DSV Fund CIO joins to scale Oblong’s $TAO treasury into the leading public vehicle for decentralized AI

Kidd brings institutional expertise to unlock value across Bittensor’s $1B+ AI subnet ecosystem and ignite next wave of growth

DENVER–(BUSINESS WIRE)–
Oblong (Nasdaq:OBLG), dedicated to advancing decentralized artificial intelligence through strategic treasury investments in Bittensor ($TAO), is thrilled to announce the formation of its Advisory Committee, with Siam Kidd appointed as its inaugural member. This milestone underscores Oblong’s commitment to building a robust platform for investors seeking exposure to the rapidly growing decentralized AI ecosystem.

  • Siam is a globally recognized crypto investor, trader, and thought leader with over 21 years of experience in financial markets, including M&A and hedge fund management.

  • As Co-Founder and Chief Investment Officer of DSV Fund, the world’s first hedge fund exclusively dedicated to Bittensor ($TAO), Kidd has pioneered institutional-grade strategies for decentralized AI investments. His leadership has positioned DSV to capitalize on $TAO’s explosive growth within Bittensor’s subnet ecosystem, which now drives over 50 million daily AI inferences and a combined subnet market cap nearing $1 billion.

  • A former RAF pilot, Kidd brings a disciplined, data-driven approach to navigating volatile markets. His deep expertise in $TAO’s tokenomics and subnet operations enables him to craft strategies that maximize Bittensor’s potential as the “FTSE100 of decentralized AI,” framing it as a scalable, censorship-resistant alternative to centralized AI giants.

“Decentralized AI is reshaping the future of technology, and Bittensor is at the forefront of this revolution,” said Kidd. “I’m excited to join Oblong’s Advisory Committee to help build a treasury strategy that captures the diverse potential of this ecosystem, delivering value to investors while advancing open-source innovation.”

The Advisory Committee will provide strategic guidance on optimizing Oblong’s $TAO-focused treasury, identifying high-impact investment opportunities in development teams on the Bittensor platform, known as subnets, and fostering partnerships within the decentralized AI space. Kidd’s appointment signals Oblong’s dedication to establishing credibility and delivering long-term value for retail and institutional investors.

“Siam’s expertise and vision make him the ideal first member of our Advisory Committee,” said Pete Holst, CEO of Oblong. “His proven track record in leveraging Bittensor’s ecosystem will guide our $TAO treasury strategy, positioning Oblong as a premier vehicle for investors in the decentralized AI revolution.”

Oblong is actively expanding its Advisory Committee to include additional experts in AI, blockchain, and finance, further strengthening its strategic position.

About Oblong, Inc.

Oblong (Nasdaq: OBLG) is building a robust cryptocurrency treasury focused on decentralized artificial intelligence (AI) and the acquisition of $TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI. By leveraging the power of decentralized AI, Oblong aims to provide investors with unparalleled exposure to the future of open-source intelligence. The Company also provides innovative video collaboration and network solutions, centered around our patented Mezzanine™ product line and managed services.

Forward-looking and cautionary statements

This press release and any oral statements made regarding the subject of this release contain forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, that address activities that Oblong assumes, plans, expects, believes, intends, projects, estimates, or anticipates (and other similar expressions) will, should, or may occur in the future are forward-looking statements and include, but are not limited to, statements regarding market opportunity and the Company’s new Bittensor-centric AI and digital asset strategy. Oblong’s actual results may differ materially from its expectations, estimates, and projections, and consequently, you should not rely on these forward-looking statements as predictions of future events. Without limiting the generality of the foregoing, forward-looking statements contained in this press release include statements relating to the Company’s plans to i) identify high-impact investment opportunities in development teams on the Bittensor platform, known as subnets, and fostering partnerships within the decentralized AI space and ii) establishing credibility and delivering long-term value for retail and institutional investors. The forward-looking statements are based on management’s current belief, based on currently available information, as to the outcome and timing of future events and involve factors, risks, and uncertainties, including market and other conditions and the volatility of market price for our securities, that may cause actual results in future periods to differ materially from such statements. A list and description of these and other risk factors can be found in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, the Company’s Form 8-K filed on June 6, 2025 and in other filings made by the Company with the SEC from time to time. Any of these factors could cause Oblong’s actual results and plans to differ materially from those in the forward-looking statements. Therefore, the Company cannot give any assurance that its future results will be as estimated. The Company does not intend to, and disclaims any obligation to, correct, update, or revise any information contained herein.

Investor Relations Contact

David Clark

[email protected]

(213) 683-8863 ext. 5

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Professional Services Technology Blockchain Cryptocurrency Finance Artificial Intelligence

MEDIA:

Global Medical REIT Announces Second Quarter 2025 Financial Results

Global Medical REIT Announces Second Quarter 2025 Financial Results

– Appoints Mark Decker, Jr. as Chief Executive Officer –

– Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio –

– Reaffirms Full Year 2025 AFFO Guidance –

BETHESDA, Md.–(BUSINESS WIRE)–
Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), today announced financial results for the three and six months ended June 30, 2025 and other data.

Mark Decker, Jr., Chief Executive Officer and President stated, “I’m excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the business, please join our call tomorrow.”

Second Quarter 2025 and Other Highlights

  • Net loss attributable to common stockholders was $0.8 million, or $0.01 per diluted share, as compared to $3.1 million, or $0.05 per diluted share, in the comparable prior year period.

  • Funds from operations attributable to common stockholders and noncontrolling interest (“FFO”) of $14.3 million, or $0.20 per share and unit, as compared to $13.9 million, or $0.20 per share and unit, in the comparable prior year period.

  • Adjusted funds from operations attributable to common stockholders and noncontrolling interest (“AFFO”) of $16.6 million, or $0.23 per share and unit, as compared to $15.7 million, or $0.22 per share and unit, in the comparable prior year period.

  • In April 2025, we completed the acquisition of the remaining two properties in a previously announced five-property medical portfolio encompassing an aggregate of 297,724 leasable square feet for an aggregate purchase price of $38.1 million with aggregate annualized base rent of $3.6 million.

  • In April 2025, we sold a medical facility in Chipley, Florida, receiving gross proceeds of $1.4 million, resulting in a gain of $0.2 million.

  • In May 2025, an affiliate of CHRISTUS Health began fully occupying our 84,674 square foot Beaumont, TX facility pursuant to its fifteen-year triple-net lease. Annual base rent for the first lease year will be $2.9 million with 2.5% annual rent increases thereafter.

  • In June 2025, the Board of Directors appointed Mark Decker, Jr. as Chief Executive Officer, President and as a member of the Board of Directors.

Six Month and Other 2025 Highlights

  • Net income attributable to common stockholders was $1.3 million, or $0.02 per diluted share, as compared to net loss attributable to common stockholders of $2.4 million, or $0.04 per diluted share, in the comparable prior year period.

  • FFO of $29.0 million, or $0.40 per share and unit, as compared to $28.8 million, or $0.41 per share and unit, in the comparable prior year period.

  • AFFO of $32.6 million, or $0.45 per share and unit, as compared to $32.2 million, or $0.46 per share and unit, in the comparable prior year period.

  • Completed the acquisition of a previously announced five-property portfolio of medical real estate for a purchase price of $69.6 million encompassing an aggregate of 486,598 leasable square feet with aggregate annualized base rent of $6.3 million.

  • Completed three dispositions that generated aggregate gross proceeds of $9.6 million, resulting in an aggregate gain of $1.6 million.

Financial Results

Rental revenue for the second quarter of 2025 increased 10.7% year-over-year to $37.9 million. The increase primarily resulted from the impact of acquisitions that were completed subsequent to June 30, 2024, partially offset by dispositions during that period.

Total expenses for the second quarter were $37.5 million, compared to $32.8 million for the comparable prior year period. This increase reflects increased G&A costs primarily associated with the Company’s CEO succession plan, as well as increased costs related to the Company’s acquisitions that were completed subsequent to June 30, 2024, partially offset by dispositions during that period.

Interest expense for the second quarter was $8.0 million, compared to $7.0 million for the comparable prior year period. The increase was primarily due to higher average borrowings and slightly higher interest rates during the three months ended June 30, 2025, compared to the prior year period.

Net loss attributable to common stockholders for the second quarter was $0.8 million, or $0.01 per diluted share, compared to $3.1 million, or $0.05 per diluted share, in the comparable prior year period.

The Company reported FFO of $14.3 million, or $0.20 per share and unit, and AFFO of $16.6 million, or $0.23 per share and unit, for the second quarter of 2025, compared to FFO of $13.9 million, or $0.20 per share and unit, and AFFO of $15.7 million, or $0.22 per share and unit, in the comparable prior year period.

Investment Activity

In April 2025, the Company completed the acquisition of a previously announced five-property portfolio of medical real estate for an aggregate purchase price of $69.6 million encompassing an aggregate of 486,598 leasable square feet at a cap rate of 9.0% and aggregate annualized base rent of $6.3 million. This investment adds high quality assets to our portfolio at a large discount to replacement cost while also providing a strong cash yield.

During the quarter, the Company completed the disposition of a medical facility in Chipley, Florida, receiving gross proceeds of $1.4 million, resulting in a gain of $0.2 million, completing our exit of investments in the Panama City, FL market.

Portfolio Update

As of June 30, 2025, the Company’s portfolio was 94.5% occupied and comprised of 5.2 million leasable square feet with an annualized base rent of $117.5 million. As of June 30, 2025, the weighted average lease term for the Company’s portfolio was 5.6 years with weighted average annual rent escalations of 2.1%.

Balance Sheet and Capital

At June 30, 2025, total debt outstanding, including outstanding borrowings on the credit facility and notes payable (both net of unamortized debt issuance costs), was $713.0 million and the Company’s leverage was 47.2%. As of June 30, 2025, the Company’s total debt carried a weighted average interest rate of 4.09% and a weighted average remaining term of 1.6 years.

As of August 4, 2025, the Company’s borrowing capacity under the credit facility was $177 million.

Regarding the $350 million Term Loan A component of the credit facility that matures in May 2026, we are in active discussions with our credit facility lenders related to refinancing this obligation. As part of this process, we are also discussing extending the maturity date of the Revolver. Based on various factors, including current market conditions, the performance of our assets, and our lender discussions to date, we are not anticipating any significant adverse changes to the financial terms of the credit facility and expect to complete these transactions during the fourth quarter of 2025. Although we expect to complete the refinancing during the fourth quarter of 2025, subject to market and other conditions, there can be no assurance that the refinancing will be completed as expected or at all.

The Company did not issue any shares of common stock under its ATM program during the second quarter of 2025 or from July 1, 2025 through August 4, 2025.

Dividends

As previously announced, on May 28, 2025, the Board of Directors (the “Board”) declared a $0.15 per share cash dividend to common stockholders and unitholders of record as of June 20, 2025, which was paid on July 9, 2025, representing the Company’s second quarter 2025 dividend payment. The adjusted dividend allows for free cash flow for reinvestment and results in a FAD payout ratio of less than 80%.

Additionally, on May 28, 2025, the Board declared a $0.46875 per share cash dividend to holders of record as of July 15, 2025, of the Company’s Series A Preferred Stock, which was paid on July 31, 2025. This dividend represents the Company’s quarterly dividend on its Series A Preferred Stock for the period from April 30, 2025 through July 30, 2025.

2025 Guidance

The Company is reaffirming its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93. Guidance is based on the following primary assumptions and other factors:

  • No additional acquisitions or dispositions other than activity that has been either completed or announced.

  • No additional equity or debt issuances other than normal course Revolver borrowing/repayments.

  • AFFO guidance excludes one-time obligations related to the CEO succession plan.

The Company’s 2025 guidance is based on the above and additional assumptions that are subject to change many of which are outside of the Company’s control. There can be no assurance that the Company’s actual results will not be materially different than these expectations. If actual results vary from these assumptions, the Company’s expectations may change.

AFFO is a non-GAAP financial measure. The Company does not provide a reconciliation of such forward-looking non-GAAP measure to the most directly comparable financial measure calculated and presented in accordance with GAAP because certain information required for such reconciliation is not available without unreasonable efforts due to the difficulty of projecting event-driven transactional and other non-core operating items in any future period. The magnitude of these items, however, may be significant.

SUPPLEMENTAL INFORMATION

Details regarding these results can be found in the Company’s supplemental financial package available on the Investor Relations section of the Company’s website at http://investors.globalmedicalreit.com/.

CONFERENCE CALL AND WEBCAST INFORMATION

The Company will host a live webcast and conference call on Wednesday, August 6, 2025 at 9:00 a.m. Eastern Time. The webcast is located on the “Investor Relations” section of the Company’s website at http://investors.globalmedicalreit.com/.

To Participate via Telephone:

Dial in at least five minutes prior to start time and reference Global Medical REIT Inc.

Domestic: 1-800-343-5172

International: 1-203-518-9856

Conference ID: GMRQ2

Replay:

An audio replay of the conference call will be posted on the Company’s website.

NON‐GAAP FINANCIAL MEASURES

General

Management considers certain non-GAAP financial measures to be useful supplemental measures of the Company’s operating performance. For the Company, non-GAAP measures consist of Funds From Operations attributable to common stockholders and noncontrolling interest (“FFO”), Adjusted Funds From Operations attributable to common stockholders and noncontrolling interest (“AFFO”), Funds Available For Distribution attributable to common stockholders and noncontrolling interest (“FAD”) and Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (“EBITDAre” and “Adjusted EBITDAre”). A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. The Company reports non-GAAP financial measures because these measures are observed by management to also be among the most predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these non-GAAP financial measures.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company’s financial performance, or as alternatives to cash flow from operating activities as measures of the Company’s liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company’s needs. Management believes that in order to facilitate a clear understanding of the Company’s historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented elsewhere herein.

FFO and AFFO

FFO and AFFO are non-GAAP financial measures within the meaning of the rules of the United States Securities and Exchange Commission (“SEC”). The Company considers FFO and AFFO to be important supplemental measures of its operating performance and believes FFO is frequently used by securities analysts, investors, and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. In accordance with the National Association of Real Estate Investment Trusts’ (“NAREIT”) definition, FFO means net income or loss computed in accordance with GAAP before noncontrolling interests of holders of OP units and LTIP units, excluding gains (or losses) from sales of property and extraordinary items, property impairment losses, less preferred stock dividends, plus real estate-related depreciation and amortization (excluding amortization of debt issuance costs and the amortization of above and below market leases), and after adjustments for unconsolidated partnerships and joint ventures calculated to reflect FFO on the same basis. Because FFO excludes real estate-related depreciation and amortization (other than amortization of debt issuance costs and above and below market lease amortization expense), the Company believes that FFO provides a performance measure that, when compared period-over-period, reflects the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and interest costs, providing perspective not immediately apparent from the closest GAAP measurement, net income or loss.

AFFO is a non-GAAP measure used by many investors and analysts to measure a real estate company’s operating performance by removing the effect of items that do not reflect ongoing property operations. Management calculates AFFO by modifying the NAREIT computation of FFO by adjusting it for certain cash and non-cash items and certain recurring and non-recurring items. For the Company these items include: (a) recurring acquisition and disposition costs, (b) loss on the extinguishment of debt, (c) recurring straight line deferred rental revenue, (d) recurring stock-based compensation expense, (e) recurring amortization of above and below market leases, (f) recurring amortization of debt issuance costs, (g) severance and transition related expense and (h) other items related to unconsolidated partnerships and joint ventures.

Management believes that reporting AFFO in addition to FFO is a useful supplemental measure for the investment community to use when evaluating the operating performance of the Company on a comparative basis.

FAD

We calculate FAD by subtracting from AFFO capital expenditures, including tenant improvements, and leasing commissions. Management believes FAD is useful in analyzing the portion of cash flow that is available for distribution to stockholders and unitholders. Investors, analysts and the Company utilize FAD as an indicator of common dividend potential. The FAD payout ratio, which represents distributions to common stockholders and unitholders expressed as a percentage of FAD, facilitates the comparison of dividend coverage between REITs.

EBITDAre and Adjusted EBITDAre

We calculate EBITDAre in accordance with standards established by NAREIT and define EBITDAre as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, property impairment losses, and adjustments for unconsolidated partnerships and joint ventures to reflect EBITDAre on the same basis, as applicable.

We define Adjusted EBITDAre as EBITDAre plus loss on extinguishment of debt, non-cash stock compensation expense, non-cash intangible amortization related to above and below market leases, severance and transition related expense, transaction expense, adjustments related to our investments in unconsolidated joint ventures, and other normalizing items. Management considers EBITDAre and Adjusted EBITDAre important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

ANNUALIZED BASE RENT

Annualized base rent represents monthly base rent for June 2025 (or, for recent acquisitions, monthly base rent for the month of acquisition), multiplied by 12 (or base rent net of annualized expenses for properties with gross leases). Accordingly, this methodology produces an annualized amount as of a point in time but does not take into account future (i) contractual rental rate increases, (ii) leasing activity or (iii) lease expirations. Additionally, leases that are accounted for on a cash-collected basis or that are in a free rent period are not included in annualized base rent.

CAPITALIZATION RATE

The capitalization rate (“cap rate”) for an acquisition is calculated by dividing current Annualized Base Rent by contractual purchase price. For the portfolio cap rate, certain adjustments, including for subsequent capital invested, are made to the contractual purchase price.

FORWARD-LOOKING STATEMENTS

Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “plan,” “predict,” “project,” “will,” “continue” and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding our earnings, our liquidity, our tenants’ ability to pay rent to us, expected financial performance (including future cash flows associated with our joint venture or new tenants or the expansion of current properties), 2025 AFFO guidance, future dividends or other financial items; any other statements concerning our plans, strategies, objectives and expectations for future operations and future portfolio occupancy rates, our pipeline of acquisition opportunities and expected acquisition activity, including the timing and/or successful completion of any acquisitions and expected rent receipts on these properties, our expected disposition activity, including the timing and/or successful completion of any dispositions and the expected use of proceeds therefrom, and any statements regarding future economic conditions or performance are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A – Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

ABOUT GMRE

GMRE is a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Additional information about GMRE can be obtained on its website at www.globalmedicalreit.com.

GLOBAL MEDICAL REIT INC.

Condensed Consolidated Balance Sheets

(unaudited, and in thousands, except par values)

 

 

As of

 

 

June 30,

2025

 

December 31,

2024

Assets

 

 

 

 

 

 

Investment in real estate:

 

 

 

 

 

 

Land

 

$

173,123

 

 

$

174,300

 

Building

 

 

1,095,324

 

 

 

1,044,019

 

Site improvements

 

 

24,966

 

 

 

23,973

 

Tenant improvements

 

 

80,019

 

 

 

69,679

 

Acquired lease intangible assets

 

 

147,376

 

 

 

138,945

 

 

 

 

1,520,808

 

 

 

1,450,916

 

Less: accumulated depreciation and amortization

 

 

(316,649

)

 

 

(288,921

)

Investment in real estate, net

 

 

1,204,159

 

 

 

1,161,995

 

Cash and cash equivalents

 

 

6,580

 

 

 

6,815

 

Restricted cash

 

 

2,646

 

 

 

2,127

 

Tenant receivables, net

 

 

7,826

 

 

 

7,424

 

Due from related parties

 

 

461

 

 

 

270

 

Escrow deposits

 

 

556

 

 

 

711

 

Deferred assets

 

 

28,672

 

 

 

28,208

 

Derivative asset

 

 

10,396

 

 

 

18,613

 

Goodwill

 

 

5,903

 

 

 

5,903

 

Investment in unconsolidated joint venture

 

 

1,917

 

 

 

2,066

 

Other assets

 

 

27,843

 

 

 

22,354

 

Total assets

 

$

1,296,959

 

 

$

1,256,486

 

 

 

 

 

 

 

 

Liabilities and Equity

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Credit Facility, net of unamortized debt issuance costs of $3,768 and $4,868 at June 30, 2025 and December 31, 2024, respectively

 

$

698,832

 

 

$

631,732

 

Notes payable, net of unamortized debt issuance costs of $4 and $22 at June 30, 2025 and December 31, 2024, respectively

 

 

14,153

 

 

 

14,399

 

Accounts payable and accrued expenses

 

 

19,006

 

 

 

16,468

 

Dividends payable

 

 

11,985

 

 

 

16,520

 

Security deposits

 

 

3,407

 

 

 

3,324

 

Other liabilities

 

 

18,438

 

 

 

14,191

 

Acquired lease intangible liability, net

 

 

6,117

 

 

 

3,936

 

Total liabilities

 

 

771,938

 

 

 

700,570

 

Commitments and Contingencies

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at June 30, 2025 and December 31, 2024, respectively (liquidation preference of $77,625 at June 30, 2025 and December 31, 2024, respectively)

 

 

74,959

 

 

 

74,959

 

Common stock, $0.001 par value, 500,000 shares authorized; 66,879 shares and 66,871 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively

 

 

67

 

 

 

67

 

Additional paid-in capital

 

 

734,290

 

 

 

734,223

 

Accumulated deficit

 

 

(316,510

)

 

 

(293,736

)

Accumulated other comprehensive income

 

 

10,396

 

 

 

18,613

 

Total Global Medical REIT Inc. stockholders’ equity

 

 

503,202

 

 

 

534,126

 

Noncontrolling interest

 

 

21,819

 

 

 

21,790

 

Total equity

 

 

525,021

 

 

 

555,916

 

Total liabilities and equity

 

$

1,296,959

 

 

$

1,256,486

 

 

 

 

 

 

 

 

GLOBAL MEDICAL REIT INC.

Condensed Consolidated Statements of Operations

(unaudited, and in thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

 

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental revenue

 

$

37,880

 

 

$

34,214

 

 

$

72,475

 

 

$

69,283

 

 

 

Other income

 

 

89

 

 

 

27

 

 

 

112

 

 

 

77

 

 

 

Total revenue

 

 

37,969

 

 

 

34,241

 

 

 

72,587

 

 

 

69,360

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

6,025

 

 

 

4,589

 

 

 

9,645

 

 

 

9,035

 

 

 

Operating expenses

 

 

8,216

 

 

 

7,236

 

 

 

15,800

 

 

 

14,619

 

 

 

Depreciation expense

 

 

11,307

 

 

 

10,127

 

 

 

21,614

 

 

 

20,240

 

 

 

Amortization expense

 

 

3,984

 

 

 

3,866

 

 

 

7,504

 

 

 

7,838

 

 

 

Interest expense

 

 

8,009

 

 

 

6,992

 

 

 

15,176

 

 

 

13,883

 

 

 

Total expenses

 

 

37,541

 

 

 

32,810

 

 

 

69,739

 

 

 

65,615

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income before other income (expense)

 

 

428

 

 

 

1,431

 

 

 

2,848

 

 

 

3,745

 

 

 

Gain (loss) on sale of investment properties

 

 

207

 

 

 

(3,383

)

 

 

1,565

 

 

 

(3,383

)

 

 

Equity loss from unconsolidated joint venture

 

 

(50

)

 

 

 

 

 

(91

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

585

 

 

$

(1,952

)

 

$

4,322

 

 

$

362

 

 

 

Less: Preferred stock dividends

 

 

(1,455

)

 

 

(1,455

)

 

 

(2,911

)

 

 

(2,911

)

 

 

Less: Net loss (income) attributable to noncontrolling interest

 

 

70

 

 

 

 

260

 

 

 

 

 

(108

 

)

 

 

 

195

 

 

 

 

Net (loss) income attributable to common stockholders

 

$

(800

)

 

$

(3,147

)

 

$

1,303

 

 

$

(2,354

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders per share – basic and diluted

 

$

 

(0.01

 

)

 

 

$

 

(0.05

 

)

 

 

$

 

0.02

 

 

 

 

$

 

(0.04

 

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding – basic and diluted

 

 

66,879

 

 

 

65,588

 

 

 

66,876

 

 

 

65,580

 

 

 

 

Global Medical REIT Inc.

Reconciliation of Net Income to FFO, AFFO and FAD

(unaudited, and in thousands, except per share and unit amounts)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

June 30,

Six Months Ended

June 30,

 

2025

2024

2025

 

2024

 

 

Net income (loss)

$

585

 

$

(1,952

)

$

4,322

 

 

$

362

 

Less: Preferred stock dividends

 

(1,455

)

 

(1,455

)

 

(2,911

)

 

 

(2,911

)

Depreciation and amortization expense

 

15,266

 

 

13,969

 

 

29,072

 

 

 

27,992

 

Depreciation and amortization expense from unconsolidated joint venture

 

73

 

 

 

 

122

 

 

 

 

(Gain) loss on sale of investment properties

 

(207

)

 

3,383

 

 

(1,565

)

 

 

3,383

 

FFO attributable to common stockholders and noncontrolling interest

$

14,262

 

$

13,945

 

$

29,040

 

 

$

28,826

 

Amortization of (below) above market leases, net

 

(60

)

 

249

 

 

392

 

 

 

500

 

Straight line deferred rental revenue

 

(479

)

 

(363

)

 

(536

)

 

 

(763

)

Stock-based compensation expense

 

1,728

 

 

1,319

 

 

1,879

 

 

 

2,552

 

Amortization of debt issuance costs and other

 

559

 

 

563

 

 

1,118

 

 

 

1,125

 

Severance and transition related expense

 

567

 

 

 

 

671

 

 

 

 

Other adjustments from unconsolidated joint venture

 

20

 

 

 

 

51

 

 

 

 

AFFO attributable to common stockholders and noncontrolling interest

$

16,597

 

$

15,713

 

$

32,615

 

 

$

32,240

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to common stockholders per share – basic and diluted

$

(0.01

)

$

(0.05

)

$

0.02

 

 

$

(0.04

)

FFO attributable to common stockholders and noncontrolling interest per share and unit

$

0.20

 

$

0.20

 

$

0.40

 

 

$

0.41

 

AFFO attributable to common stockholders and noncontrolling interest per share and unit

$

0.23

 

$

0.22

 

$

0.45

 

 

$

0.46

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Shares and Units Outstanding – basic and diluted

 

72,651

 

 

70,982

 

 

72,504

 

 

 

70,844

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Shares and Units Outstanding:

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares

 

66,879

 

 

65,588

 

 

66,876

 

 

 

65,580

 

Weighted Average OP Units

 

2,244

 

 

2,244

 

 

2,244

 

 

 

2,244

 

Weighted Average LTIP Units

 

3,528

 

 

3,150

 

 

3,384

 

 

 

3,020

 

Weighted Average Shares and Units Outstanding – basic and diluted

 

72,651

 

 

70,982

 

 

72,504

 

 

 

70,844

 

 

 

 

 

 

 

 

 

 

 

 

AFFO attributable to common stockholders and noncontrolling interest

$

16,597

 

$

15,713

 

$

32,615

 

 

$

32,240

 

Tenant improvements

 

(878

)

 

(1,626

)

 

(1,582

)

 

 

(2,864

 

)

Leasing commissions

 

(558

)

 

(2,003

)

 

(673

)

 

 

(2,545

 

)

Building capital

 

(1,087

)

 

(1,576

)

 

(2,994

)

 

 

(2,342

 

)

FAD attributable to common stockholders and noncontrolling interest

$

14,074

 

$

10,508

 

$

27,366

 

 

$

24,489

 

 

Global Medical REIT Inc.

Reconciliation of Net Income to EBITDAre and Adjusted EBITDAre

(unaudited, and in thousands)

 

Three Months Ended

June 30,

Six Months Ended

June 30,

 

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

Net income (loss)

$

585

 

 

$

(1,952

)

 

$

4,322

 

 

$

362

 

Interest expense

 

8,009

 

 

 

6,992

 

 

 

15,176

 

 

 

13,883

 

Depreciation and amortization expense

 

15,291

 

 

 

13,993

 

 

 

29,118

 

 

 

28,078

 

Unconsolidated joint venture EBITDAre adjustments (1)

 

114

 

 

 

 

 

 

199

 

 

 

 

(Gain) loss on sale of investment properties

 

(207

)

 

 

3,383

 

 

 

(1,565

)

 

 

3,383

 

EBITDAre

$

23,792

 

 

$

22,416

 

 

$

47,250

 

 

$

45,706

 

Stock-based compensation expense

 

1,728

 

 

 

1,319

 

 

 

1,879

 

 

 

2,552

 

Amortization of (below) above market leases, net

 

(60

)

 

 

249

 

 

 

392

 

 

 

500

 

Severance and transition related expense

 

567

 

 

 

 

 

 

671

 

 

 

 

Interest rate swap mark-to-market at unconsolidated joint

venture

 

19

 

 

 

 

 

 

55

 

 

 

 

Adjusted EBITDAre

$

26,046

 

 

$

23,984

 

 

$

50,247

 

 

$

48,758

 

 

(1) Includes joint venture interest, depreciation and amortization, and gain on sale of investment properties, if applicable, included in joint venture net income or loss.

INVESTOR RELATIONS:

Email: [email protected]
Phone: 202.524.6869

KEYWORDS: United States North America Maryland

INDUSTRY KEYWORDS: Health Other Construction & Property Hospitals Other Health Commercial Building & Real Estate Construction & Property REIT

MEDIA:

OUTFRONT Media Announces Quarterly Dividend

PR Newswire


NEW YORK
, Aug. 5, 2025 /PRNewswire/ — OUTFRONT Media Inc. (NYSE: OUT) announced today that its board of directors has declared a quarterly cash dividend on the Company’s common stock of $0.30 per share payable on September 30, 2025, to shareholders of record at the close of business on September 5, 2025.

About OUTFRONT Media Inc.
OUTFRONT is one of the largest and most trusted out-of-home media companies in the U.S., helping brands connect with audiences in the moments and environments that matter most. As OUTFRONT evolves, it’s defining a new era of in-real-life (IRL) marketing, turning public spaces into platforms for creativity, connection, and cultural relevance. With a nationwide footprint across billboards, digital displays, transit systems, and other out-of-home formats, OUTFRONT turns creative into powerful real-world experiences. Its in-house agency, OUTFRONT STUDIOS, and award-winning innovation team, XLabs, deliver standout storytelling, supported by advanced technology and data tools that can drive measurable impact.


Contacts:

 


Investors


Media

Stephan Bisson

Courtney Richards

Investor Relations

Events & Communications

(212) 297-6573

(646) 876-9404

[email protected]

[email protected]

                                                                               

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/outfront-media-announces-quarterly-dividend-302522314.html

SOURCE OUTFRONT Media Inc.

A10 Networks Reports Financial Results for the Second Quarter of 2025

A10 Networks Reports Financial Results for the Second Quarter of 2025

Company Grows Revenue and Earnings Per Share;

Cybersecurity and AI Tailwinds Reinforce Strategic Positioning

SAN JOSE, Calif.–(BUSINESS WIRE)–
A10 Networks, Inc. (NYSE: ATEN), a leading provider of secure application services and solutions, today announced financial results for its second quarter ended June 30, 2025.

Second Quarter 2025 Financial Summary

  • Revenue of $69.4 million, up 15% year-over-year compared to $60.1 million in the second quarter of 2024. Revenue for the first six months of 2025 was $135.5 million compared to $120.8 million for the first six months of 2024, an increase of approximately 12%.

  • GAAP gross margin of 78.9%; non-GAAP gross margin of 80.0%.

  • GAAP net income of $10.5 million (15.2% of revenue), or $0.14 per diluted share, compared to net income of $9.5 million (15.8% of revenue), or $0.13 per diluted share, in the second quarter of 2024.

  • Non-GAAP net income of $15.5 million (22.3% of revenue), or $0.21 per diluted share, compared to non-GAAP net income of $13.2 million (22.0% of revenue), or $0.18 per diluted share in the second quarter of 2024.

  • The Company returned $8.3 million to investors, having repurchased 229 thousand shares at an average price of $17.22 for a total of $3.9 million and having paid $4.3 million in cash dividends in the quarter. The Company has $71.1 million remaining on its $75.0 million share repurchase authorization.

  • The Board of Directors approved a quarterly cash dividend of $0.06 per share, payable September 2, 2025 to stockholders of record at the close of business on August 15, 2025.

A reconciliation between GAAP and non-GAAP information is contained in the financial statements below.

“Demand for our security and infrastructure solutions continues to grow as end markets normalized compared to same period last year, driving year-over-year revenue growth,” said Dhrupad Trivedi, President and Chief Executive Officer of A10 Networks. “The second quarter benefited from improving demand from data center expansions and AI infrastructure investments. This includes the recent selection of A10 by global leaders in AI data centers, which serves as an important validation of our security-led innovation and growing relevance in AI-centric environments.”

“A10 maintains strong operational discipline, effectively translating revenue growth into improved profitability and cash flow,” continued Trivedi. “We achieved expansion in both GAAP and non-GAAP net margins, grew earnings per share, and delivered robust cash flow from operations. We expect operating leverage to remain a key advantage moving forward.”

“The strength of our business model and customer intimacy, combined with favorable market dynamics in AI and cybersecurity, positions A10 to deliver long-term value as we continue to navigate evolving market conditions,” said Trivedi. “We remain focused on disciplined execution to drive sustained top- and bottom-line growth.”

Conference Call

Management will host a call at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) today, August 5, 2025, to discuss these results. Interested parties may access the conference call by dialing (888) 506-0062 (toll-free) or (973) 528-0011 (international) and referencing access code: 117352.

A live audio webcast of the conference call will be accessible from the “Investor Relations” section of A10 Network’s website at investors.a10networks.com. The webcast will be archived for one year. A telephonic replay of the conference call will be available until August 19, 2025 and may be accessed by dialing (877) 481-4010 (toll-free) or (919) 882-2331 (international) and entering the passcode: 52680.

Forward-Looking Statements

This press release contains “forward-looking statements,” including statements regarding our quarterly dividend payments, strategy, positioning, demand, growth rate, margin profile, operating leverage, profitability and return of capital. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on assumptions that may prove to be incorrect, which could cause actual results to differ materially from those expected or implied by the forward-looking statements. Factors that may cause actual results to differ include any unforeseen need for capital which may require us to divert funds we may have otherwise used for the dividend program or stock repurchase program, which may in turn negatively impact our ability to administer the quarterly dividends or the repurchase of our common stock; a significant decline in global macroeconomic or political conditions that have an adverse impact on our business and financial results; an expansion of adversarial global trade dynamics or other changes to international trade regulations; business interruptions related to our supply chain; our ability to manage our business and expenses if customers cancel or delay orders; execution risks related to closing key deals and improving our execution; the continued market adoption of our products; our ability to successfully anticipate market needs and opportunities; our timely development of new products and features; our ability to achieve or maintain profitability; any loss or delay of expected purchases by our largest end-customers; our ability to maintain or improve our competitive position; competitive and execution risks related to cloud-based computing trends; our ability to attract and retain new end-customers and our largest end-consumers; our ability to maintain and enhance our brand and reputation; changes demanded by our customers in the deployment and payment model for our products; continued growth in markets relating to network security; the success of any future acquisitions or investments in complementary companies, products, services or technologies; the ability of our sales team to execute well; our ability to shorten our close cycles; the ability of our channel partners to sell our products; variations in product mix or geographic locations of our sales; risks associated with our presence in international markets; weaknesses or deficiencies in our internal control over financial reporting; our ability to timely file periodic reports required to be filed under the Securities Exchange Act of 1934; and other risks that are described in “Risk Factors” in our periodic filings with the Securities and Exchange Commission, including our Form 10-K filed with the Securities and Exchange Commission on February 25, 2025. We do not intend to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Non-GAAP Financial Measures

In addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), we refer to certain non-GAAP financial measures, including non-GAAP net income, non-GAAP net income per basic and diluted share (or non-GAAP EPS), non-GAAP gross profit and gross margin, non-GAAP operating expenses, non-GAAP operating income and operating margin, Adjusted EBITDA and Adjusted EBITDA margin. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies.

A10 Networks considers these non-GAAP financial measures to be important because they provide useful measures of the operating performance of the company, exclusive of unusual events or factors that do not directly affect what we consider to be our core operating performance and are used by the company’s management for that purpose.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

We define non-GAAP net income as our GAAP net income excluding: (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense, (v) tax planning expense and (vi) income tax effect of non-GAAP items (i) to (v) listed above. We define non-GAAP net income per basic and diluted share as our non-GAAP net income divided by our basic and diluted weighted-average shares outstanding. We define non-GAAP gross profit as our GAAP gross profit excluding (i) stock-based compensation and related payroll tax and (ii) amortization of purchased intangible assets. We define non-GAAP gross margin as our non-GAAP gross profit divided by our GAAP revenue. We define non-GAAP operating expenses as our GAAP operating expenses excluding (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense and (v) tax planning expense. We define non-GAAP operating income as our GAAP income from operations excluding (i) stock-based compensation and related payroll tax, (ii) acquisition-related expense, (iii) amortization of purchased intangible assets, (iv) one-time legal expense and (v) tax planning expense. We define non-GAAP operating margin as our non-GAAP operating income divided by our GAAP revenue. We define Adjusted EBITDA as our GAAP net income excluding (i) interest and other (income) expense, net, (ii) depreciation and amortization expense, (iii) provision for income taxes, (iv) stock-based compensation and related payroll tax, (v) acquisition-related expense, (vi) one-time legal expense and (vii) tax planning expense. We define Adjusted EBITDA margin as our Adjusted EBITDA divided by our GAAP revenue.

Non-GAAP financial measures are presented for supplemental informational purposes only for understanding the company’s operating results.

About A10 Networks

A10 Networks (NYSE: ATEN) provides security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments. Our 7,000+ customers span global large enterprises and communications, cloud and web service providers who must ensure business-critical applications and networks are secure, available, and efficient. Founded in 2004, A10 Networks is based in San Jose, Calif. and serves customers globally. For more information, visit A10networks.com and follow us at A10Networks.

The A10 logo and A10 Networks are trademarks or registered trademarks of A10 Networks, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

Source: A10 Networks, Inc.

A10 NETWORKS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share amounts, on a GAAP Basis)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

Net revenue:

 

 

 

 

 

 

 

Products

$

39,173

 

 

$

29,533

 

$

75,152

 

 

$

59,602

Services

 

30,210

 

 

 

30,563

 

 

60,368

 

 

 

61,169

Total net revenue

 

69,383

 

 

 

60,096

 

 

135,520

 

 

 

120,771

Cost of net revenue:

 

 

 

 

 

 

 

Products

 

8,197

 

 

 

6,813

 

 

15,460

 

 

 

13,612

Services

 

6,475

 

 

 

5,225

 

 

12,654

 

 

 

9,870

Total cost of net revenue

 

14,672

 

 

 

12,038

 

 

28,114

 

 

 

23,482

Gross profit

 

54,711

 

 

 

48,058

 

 

107,406

 

 

 

97,289

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

20,964

 

 

 

19,453

 

 

40,509

 

 

 

40,667

Research and development

 

16,256

 

 

 

14,737

 

 

32,156

 

 

 

28,800

General and administrative

 

7,180

 

 

 

5,952

 

 

15,652

 

 

 

12,693

Total operating expenses

 

44,400

 

 

 

40,142

 

 

88,317

 

 

 

82,160

Income from operations

 

10,311

 

 

 

7,916

 

 

19,089

 

 

 

15,129

Non-operating income (expense):

 

 

 

 

 

 

 

Interest income

 

2,994

 

 

 

1,761

 

 

4,784

 

 

 

3,442

Interest and other income (expense), net

 

(1,376

)

 

 

1,306

 

 

(1,466

)

 

 

3,632

Total non-operating income, net

 

1,618

 

 

 

3,067

 

 

3,318

 

 

 

7,074

Income before income taxes

 

11,929

 

 

 

10,983

 

 

22,407

 

 

 

22,203

Provision for income taxes

 

1,391

 

 

 

1,507

 

 

2,326

 

 

 

3,001

Net income

$

10,538

 

 

$

9,476

 

$

20,081

 

 

$

19,202

Net income per share:

 

 

 

 

 

 

 

Basic

$

0.15

 

 

$

0.13

 

$

0.28

 

 

$

0.26

Diluted

$

0.14

 

 

$

0.13

 

$

0.27

 

 

$

0.25

Weighted-average shares used in computing net income per share:

 

 

 

 

 

 

 

Basic

 

72,009

 

 

 

74,366

 

 

72,777

 

 

 

74,401

Diluted

 

73,117

 

 

 

75,497

 

 

74,109

 

 

 

75,432

 

A10 NETWORKS, INC.

RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME

(unaudited, in thousands, except per share amounts)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

GAAP net income

$

10,538

 

 

$

9,476

 

 

$

20,081

 

 

$

19,202

 

Non-GAAP items:

 

 

 

 

 

 

 

Stock-based compensation and related payroll tax

 

4,586

 

 

 

4,309

 

 

 

10,878

 

 

 

8,298

 

Acquisition-related expense

 

574

 

 

 

 

 

 

918

 

 

 

 

Amortization of purchased intangible assets

 

380

 

 

 

 

 

 

583

 

 

 

 

One-time legal expense

 

721

 

 

 

71

 

 

 

1,247

 

 

 

71

 

Tax planning expense

 

150

 

 

 

400

 

 

 

150

 

 

 

400

 

Income tax-effect of non-GAAP items

 

(1,496

)

 

 

(1,046

)

 

 

(3,369

)

 

 

(2,017

)

Total non-GAAP items

 

4,915

 

 

 

3,734

 

 

 

10,407

 

 

 

6,752

 

Non-GAAP net income

$

15,453

 

 

$

13,210

 

 

$

30,488

 

 

$

25,954

 

 

 

 

 

 

 

 

 

GAAP net income per share:

 

 

 

 

 

 

 

Basic

$

0.15

 

 

$

0.13

 

 

$

0.28

 

 

$

0.26

 

Diluted

$

0.14

 

 

$

0.13

 

 

$

0.27

 

 

$

0.25

 

Non-GAAP items:

 

 

 

 

 

 

 

Stock-based compensation and related payroll tax

 

0.06

 

 

 

0.05

 

 

 

0.15

 

 

 

0.11

 

Acquisition-related expense

 

0.01

 

 

 

 

 

 

0.01

 

 

 

 

Amortization of purchased intangible assets

 

0.01

 

 

 

 

 

 

0.01

 

 

 

 

One-time legal expense

 

0.01

 

 

 

 

 

 

0.02

 

 

 

 

Tax planning expense

 

 

 

 

0.01

 

 

 

 

 

 

0.01

 

Income tax-effect of non-GAAP items

 

(0.02

)

 

 

(0.01

)

 

 

(0.05

)

 

 

(0.03

)

Total non-GAAP items

 

0.07

 

 

 

0.05

 

 

 

0.14

 

 

 

0.09

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share:

 

 

 

 

 

 

 

Basic

$

0.21

 

 

$

0.18

 

 

$

0.42

 

 

$

0.35

 

Diluted

$

0.21

 

 

$

0.18

 

 

$

0.41

 

 

$

0.34

 

Weighted average shares used in computing net income per share:

 

 

 

 

 

 

 

Basic

 

72,009

 

 

 

74,366

 

 

 

72,777

 

 

 

74,401

 

Diluted

 

73,117

 

 

 

75,497

 

 

 

74,109

 

 

 

75,432

 

Net income and earnings per share excluding adjustments are non-GAAP financial measures presented as supplemental financial measures to enable a user of the financial information to understand the impact of these adjustments on reported results. These financial measures should not be considered an alternative to net income, operating income, cash flows provided by operating activities, or any other measure of financial performance or liquidity presented in accordance with U.S. GAAP. Our adjusted net income and earnings per share may not be comparable to similarly titled measures of another company because companies may not all calculate adjusted net income and earnings per share in the same manner.

A10 NETWORKS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands, except par value, on a GAAP Basis)

 

 

As of June 30, 2025

 

As of December 31, 2024

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

252,924

 

 

$

95,129

 

Marketable securities

 

114,459

 

 

 

100,429

 

Accounts receivable, net of allowances of $357 and $465, respectively

 

52,364

 

 

 

76,687

 

Inventory

 

20,082

 

 

 

22,005

 

Prepaid expenses and other current assets

 

17,233

 

 

 

13,038

 

Total current assets

 

457,062

 

 

 

307,288

 

Property and equipment, net

 

44,458

 

 

 

39,142

 

Goodwill

 

15,070

 

 

 

1,307

 

Intangible assets, net

 

7,018

 

 

 

 

Deferred tax assets, net

 

62,362

 

 

 

62,364

 

Other non-current assets

 

21,945

 

 

 

22,714

 

Total assets

$

607,915

 

 

$

432,815

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Accounts payable

$

6,999

 

 

$

12,542

 

Accrued and other liabilities

 

27,815

 

 

 

32,696

 

Deferred revenue, current

 

73,345

 

 

 

78,335

 

Total current liabilities

 

108,159

 

 

 

123,573

 

Deferred revenue, non-current

 

71,021

 

 

 

69,924

 

Long-term debt

 

218,086

 

 

 

 

Other non-current liabilities

 

6,661

 

 

 

7,489

 

Total liabilities

 

403,927

 

 

 

200,986

 

 

 

 

 

Stockholders’ equity:

Common stock, $0.00001 par value: 500,000 shares authorized; 91,450 and 90,520 shares issued and 71,992 and 73,693 shares outstanding, respectively

 

1

 

 

 

1

 

Treasury stock, at cost: 19,458 and 16,827 shares, respectively

 

(231,965

)

 

 

(180,992

)

Additional paid-in-capital

 

520,524

 

 

 

508,387

 

Dividends paid

 

(64,172

)

 

 

(55,417

)

Accumulated other comprehensive income (loss)

 

(137

)

 

 

194

 

Accumulated deficit

 

(20,263

)

 

 

(40,344

)

Total stockholders’ equity

 

203,988

 

 

 

231,829

 

Total liabilities and stockholders’ equity

$

607,915

 

 

$

432,815

 

 

A10 NETWORKS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited, in thousands, on a GAAP Basis)

 

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

Cash flows from operating activities:

 

 

 

Net income

$

20,081

 

 

$

19,202

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

7,077

 

 

 

5,507

 

Stock-based compensation

 

10,427

 

 

 

8,105

 

Other non-cash items

 

685

 

 

 

(403

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

24,031

 

 

 

16,695

 

Inventory

 

1,609

 

 

 

(3,318

)

Prepaid expenses and other assets

 

(5,865

)

 

 

(541

)

Accounts payable

 

(6,379

)

 

 

(2,859

)

Accrued liabilities

 

(5,937

)

 

 

3,640

 

Deferred revenue

 

(6,345

)

 

 

(1,378

)

Net cash provided by operating activities

 

39,384

 

 

 

44,650

 

Cash flows from investing activities:

 

 

 

Proceeds from sales of marketable securities

 

 

 

 

22,536

 

Proceeds from maturities of marketable securities

 

54,744

 

 

 

47,699

 

Purchases of marketable securities

 

(68,148

)

 

 

(106,293

)

Acquisition

 

(19,100

)

 

 

 

Capital expenditures

 

(8,737

)

 

 

(6,414

)

Net cash used in investing activities

 

(41,241

)

 

 

(42,472

)

Cash flows from financing activities:

 

 

 

Proceeds from issuance of common stock under employee equity incentive plans

 

1,710

 

 

 

1,854

 

Proceeds from the issuance of convertible notes

 

225,000

 

 

 

 

Payment of debt issuance costs

 

(7,330

)

 

 

 

Repurchase of common stock

 

(50,973

)

 

 

(14,876

)

Payments for dividends

 

(8,755

)

 

 

(8,943

)

Net cash provided by (used in) financing activities

 

159,652

 

 

 

(21,965

)

Net increase (decrease) in cash and cash equivalents

 

157,795

 

 

 

(19,787

)

Cash and cash equivalents—beginning of period

 

95,129

 

 

 

97,244

 

Cash and cash equivalents—end of period

$

252,924

 

 

$

77,457

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

Transfers between inventory and property and equipment

$

314

 

 

$

1,628

 

Capital expenditures included in accounts payable

$

289

$

1,477

 

A10 NETWORKS, INC.

RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT

(unaudited, in thousands, except percentages)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

54,711

 

 

$

48,058

 

 

$

107,406

 

 

$

97,289

 

GAAP gross margin

 

78.9

%

 

 

80.0

%

 

 

79.3

%

 

 

80.6

%

Non-GAAP adjustments:

 

 

 

 

 

 

 

Stock-based compensation and related payroll tax

 

502

 

 

 

563

 

 

 

1,148

 

 

 

1,034

 

Amortization of purchased intangible assets

 

281

 

 

 

 

 

 

431

 

 

 

 

Non-GAAP gross profit

$

55,494

 

 

$

48,621

 

 

$

108,985

 

 

$

98,323

 

Non-GAAP gross margin

 

80.0

%

 

 

80.9

%

 

 

80.4

%

 

 

81.4

%

 

A10 NETWORKS, INC.

RECONCILIATION OF GAAP TOTAL OPERATING EXPENSES

TO NON-GAAP TOTAL OPERATING EXPENSES

(unaudited, in thousands)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

GAAP total operating expenses

$

44,400

 

 

$

40,142

 

 

$

88,317

 

 

$

82,160

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments:

 

 

 

 

 

 

 

Stock-based compensation and related payroll tax

 

(4,084

)

 

 

(3,746

)

 

 

(9,730

)

 

 

(7,264

)

Acquisition-related expense

 

(210

)

 

 

 

 

 

(554

)

 

 

 

Amortization of purchased intangible assets

 

(99

)

 

 

 

 

 

(152

)

 

 

 

One-time legal expense

 

(721

)

 

 

(71

)

 

 

(1,247

)

 

 

(71

)

Tax planning expense

 

(150

)

 

 

(400

)

 

 

(150

)

 

 

(400

)

Non-GAAP total operating expenses

$

39,136

 

 

$

35,925

 

 

$

76,484

 

 

$

74,425

 

 

A10 NETWORKS, INC.

RECONCILIATION OF GAAP INCOME FROM OPERATIONS

TO NON-GAAP OPERATING INCOME

(unaudited, in thousands, except percentages)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

GAAP income from operations

$

10,311

 

 

$

7,916

 

 

$

19,089

 

 

$

15,129

 

GAAP operating margin

 

14.9

%

 

 

13.2

%

 

 

14.1

%

 

 

12.5

%

Non-GAAP adjustments:

 

 

 

 

 

 

 

Stock-based compensation and related payroll tax

 

4,586

 

 

 

4,309

 

 

 

10,878

 

 

 

8,298

 

Acquisition-related expense

 

210

 

 

 

 

 

 

554

 

 

 

 

Amortization of purchased intangible assets

 

380

 

 

 

 

 

 

583

 

 

 

 

One-time legal expense

 

721

 

 

 

71

 

 

 

1,247

 

 

 

71

 

Tax planning expense

 

150

 

 

 

400

 

 

 

150

 

 

 

400

 

Non-GAAP operating income

$

16,358

 

 

$

12,696

 

 

$

32,501

 

 

$

23,898

 

Non-GAAP operating margin

 

23.6

%

 

 

21.1

%

 

 

24.0

%

 

 

19.8

%

 

A10 NETWORKS, INC.

RECONCILIATION OF GAAP NET INCOME TO

EBITDA AND ADJUSTED EBITDA (NON-GAAP)

(unaudited, in thousands, except percentages)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

 

 

 

GAAP net income

$

10,538

 

 

$

9,476

 

 

$

20,081

 

 

$

19,202

 

GAAP net income margin

 

15.2

%

 

 

15.8

%

 

 

14.8

%

 

 

15.9

%

 

 

 

 

 

 

 

 

Exclude: Interest and other income, net

 

(1,618

)

 

 

(3,067

)

 

 

(3,318

)

 

 

(7,074

)

Exclude: Depreciation and amortization

 

3,681

 

 

 

2,815

 

 

 

7,280

 

 

 

5,507

 

Exclude: Provision for income taxes

 

1,391

 

 

 

1,507

 

 

 

2,326

 

 

 

3,001

 

EBITDA

 

13,992

 

 

 

10,731

 

 

 

26,369

 

 

 

20,636

 

Exclude: Stock-based compensation and related payroll tax

 

4,586

 

 

 

4,309

 

 

 

10,878

 

 

 

8,298

 

Exclude: Acquisition-related expense

 

210

 

 

 

 

 

 

554

 

 

 

 

Exclude: One-time legal expense

 

721

 

 

 

71

 

 

 

1,247

 

 

 

71

 

Exclude: Tax planning expense

 

150

 

 

 

400

 

 

 

150

 

 

 

400

 

Adjusted EBITDA

$

19,659

 

 

$

15,511

 

 

$

39,198

 

 

$

29,405

 

Adjusted EBITDA margin

 

28.3

%

 

 

25.8

%

 

 

28.9

%

 

 

24.3

%

 

Investor Contact:

Rob Fink / Tom Baumann

FNK IR

646.809.4048 / 646.349.6641

[email protected]

Brian Becker

Chief Financial Officer

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Security Technology Software Networks Artificial Intelligence Internet

MEDIA: